Document And Entity Information
Document And Entity Information - shares | 3 Months Ended | |
Mar. 31, 2019 | Apr. 23, 2019 | |
Document and Entity Information [Abstract] | ||
Entity Registrant Name | ARMOUR RESIDENTIAL REIT, INC. | |
Entity Central Index Key | 0001428205 | |
Entity Current Reporting Status | Yes | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Large Accelerated Filer | |
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2019 | |
Document Fiscal Year Focus | 2019 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false | |
Entity Emerging Growth Company | false | |
Entity Small Business | false | |
Entity Common Stock, Shares Outstanding | 59,791,877 |
Consolidated Balance Sheets (Un
Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Mar. 31, 2019 | Dec. 31, 2018 |
Assets | ||
Cash | $ 167,372 | $ 221,668 |
Cash collateral posted to counterparties | 58,996 | 10,531 |
Agency Securities (including pledged securities of $12,306,464 at March 31, 2019 and $6,743,689 at December 31, 2018) | 12,707,442 | 7,051,954 |
Derivatives, at fair value | 58,677 | 111,913 |
Accrued interest receivable | 39,609 | 22,505 |
Prepaid and other | 1,396 | 1,855 |
Subordinated loan to BUCKLER | 105,000 | 105,000 |
Total Assets | 13,972,819 | 8,464,610 |
Liabilities: | ||
Repurchase agreements | 12,143,274 | 7,037,651 |
Cash collateral posted by counterparties | 49,826 | 97,213 |
Payable for unsettled purchases | 198,172 | 166,052 |
Derivatives, at fair value | 67,065 | 24,505 |
Accrued interest payable- repurchase agreements | 21,790 | 10,268 |
Accounts payable and other accrued expenses | 6,039 | 3,608 |
Total Liabilities | 12,486,166 | 7,339,297 |
Commitments and contingencies (Note 11) | ||
Preferred stock, $0.001 par value, 50,000 shares authorized; | ||
Common stock, $0.001 par value, 125,000 shares authorized, 59,791 and 43,702 shares issued and outstanding at March 31, 2019 and December 31, 2018 | 60 | 44 |
Additional paid-in capital | 3,075,172 | 2,752,376 |
Accumulated deficit | (1,731,875) | (1,583,245) |
Accumulated other comprehensive income (loss) | 143,288 | (43,870) |
Total Stockholders’ Equity | 1,486,653 | 1,125,313 |
Total Liabilities and Stockholders’ Equity | 13,972,819 | 8,464,610 |
Series A Preferred Stock | ||
Preferred stock, $0.001 par value, 50,000 shares authorized; | ||
Preferred stock: 8.250% Series A Cumulative Preferred Stock; 2,181 issued and outstanding ($54,514 aggregate liquidation preference); 7.875% Series B Cumulative Preferred Stock; 6,369 shares issued and outstanding ($159,232 aggregate liquidation preference) | 2 | 2 |
Series B Preferred Stock | ||
Preferred stock, $0.001 par value, 50,000 shares authorized; | ||
Preferred stock: 8.250% Series A Cumulative Preferred Stock; 2,181 issued and outstanding ($54,514 aggregate liquidation preference); 7.875% Series B Cumulative Preferred Stock; 6,369 shares issued and outstanding ($159,232 aggregate liquidation preference) | 6 | 6 |
Credit Risk and Non-Agency Securities | ||
Assets | ||
Securities, trading, at fair value | 815,008 | 819,915 |
Interest-Only Securities | ||
Assets | ||
Securities, trading, at fair value | 19,319 | 20,623 |
US Treasury Securities | ||
Assets | ||
Securities, trading, at fair value | $ 0 | $ 98,646 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended |
Mar. 31, 2019 | Dec. 31, 2018 | |
Agency Securities (including pledged securities of $12,306,464 at March 31, 2019 and $6,743,689 at December 31, 2018) | $ 12,306,464 | $ 6,743,689 |
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized (in shares) | 50,000,000 | 50,000,000 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized (in shares) | 125,000,000 | 125,000,000 |
Common stock, shares issued (in shares) | 59,791,000 | 43,702,000 |
Common stock, shares outstanding (in shares) | 59,791,000 | 43,702,000 |
Series A Preferred Stock | ||
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized (in shares) | 9,610,000 | |
Preferred stock, dividend rate | 8.25% | 8.25% |
Preferred stock, shares issued (in shares) | 2,181,000 | 2,181,000 |
Preferred stock, shares outstanding (in shares) | 2,181,000 | 2,181,000 |
Preferred stock, aggregate liquidation preference | $ 54,514 | $ 54,514 |
Series B Preferred Stock | ||
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized (in shares) | 7,650,000 | |
Preferred stock, dividend rate | 7.875% | 7.875% |
Preferred stock, shares issued (in shares) | 6,369,000 | 6,369,000 |
Preferred stock, shares outstanding (in shares) | 6,369,000 | 6,369,000 |
Preferred stock, aggregate liquidation preference | $ 159,232 | $ 159,232 |
Credit Risk and Non-Agency Securities | ||
Trading securities pledged | 489,995 | 698,255 |
US Treasury Securities | ||
Trading securities pledged | $ 0 | $ 20,748 |
Consolidated Statements of Oper
Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | ||
Mar. 31, 2019 | Mar. 31, 2018 | ||
Interest Income: | |||
Agency Securities, net of amortization of premium and fees | $ 79,832 | $ 52,253 | |
Total Interest Income | 94,790 | 68,169 | |
Interest expense- repurchase agreements | (60,978) | (32,018) | |
Net Interest Income | 33,812 | 36,151 | |
Other Income (Loss): | |||
Realized loss on sale of Agency Securities (reclassified from Other comprehensive income (loss)) | (2,910) | (32,603) | |
Other than temporary impairment of Agency Securities (reclassified from Other comprehensive income (loss)) | 0 | (12,090) | |
Subtotal | (3,475) | (40,536) | |
Realized loss on derivatives | [1] | (22,131) | (38,604) |
Unrealized gain (loss) on derivatives | (113,067) | 97,201 | |
Subtotal | (135,198) | 58,597 | |
Total Other Income (Loss) | (138,673) | 18,061 | |
Expenses: | |||
Management fees | 7,258 | 6,801 | |
Professional fees | 1,035 | 1,172 | |
Insurance | 165 | 165 | |
Compensation | 787 | 977 | |
Other | 275 | 350 | |
Total Expenses | 9,520 | 9,465 | |
Net Income (Loss) | (114,381) | 44,747 | |
Dividends on preferred stock | (4,259) | (4,253) | |
Net Income (Loss) available (related) to common stockholders | $ (118,640) | $ 40,494 | |
Net Income (Loss) per share available (related) to common stockholders (Note 14): | |||
Basic (in dollars per share) | $ (2.21) | $ 0.97 | |
Diluted (in dollars per share) | (2.21) | 0.96 | |
Dividends declared per common share (in dollars per share) | $ 0.57 | $ 0.57 | |
Weighted average common shares outstanding: | |||
Basic (in shares) | 53,630 | 41,887 | |
Diluted (in shares) | 53,630 | 42,331 | |
Credit Risk and Non-Agency Securities | |||
Interest Income: | |||
Interest income, trading | $ 13,592 | $ 14,006 | |
Other Income (Loss): | |||
Gain (loss) on securities | 496 | 1,283 | |
Interest-Only Securities | |||
Interest Income: | |||
Interest income, trading | 345 | 442 | |
Other Income (Loss): | |||
Gain (loss) on securities | (368) | 298 | |
US Treasury Securities | |||
Interest Income: | |||
Interest income, trading | 482 | 844 | |
Other Income (Loss): | |||
Gain (loss) on securities | (693) | 2,576 | |
Subordinated Loans | |||
Interest Income: | |||
Interest income, trading | $ 539 | $ 624 | |
[1] | Interest expense related to our interest rate swap contracts is recorded in realized loss on derivatives on the consolidated statements of operations. For additional information, see financial statement Note 10 . |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Statement of Comprehensive Income [Abstract] | ||
Net Income (Loss) | $ (114,381) | $ 44,747 |
Other comprehensive income (loss): | ||
Reclassification adjustment for realized loss on sale of available for sale Agency Securities | 2,910 | 32,603 |
Reclassification adjustment for other than temporary impairment of available for sale Agency Securities | 0 | 12,090 |
Net unrealized gain (loss) on available for sale Agency Securities | 184,248 | (145,410) |
Other comprehensive income (loss) | 187,158 | (100,717) |
Comprehensive Income (Loss) | $ 72,777 | $ (55,970) |
Consolidated Statement of Stock
Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands | Total | Series A Preferred Stock | Series B Preferred Stock | Preferred StockSeries A Preferred Stock | Preferred StockSeries B Preferred Stock | Additional Paid-in Capital | Additional Paid-in CapitalSeries A Preferred Stock | Additional Paid-in CapitalSeries B Preferred Stock | Additional Paid-in CapitalCommon Stock | Common Stock | Accumulated Deficit | Accumulated DeficitSeries A Preferred Stock | Accumulated DeficitSeries B Preferred Stock | Accumulated Other Comprehensive Income (Loss) |
Beginning balance at Dec. 31, 2017 | $ 1,326,051 | |||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||
Preferred dividends | $ (1,124) | $ (3,129) | ||||||||||||
Common stock dividends | (24,138) | |||||||||||||
Stock based compensation, net of withholding requirements | 644 | |||||||||||||
Net Income (Loss) | 44,747 | |||||||||||||
Other comprehensive income | (100,717) | |||||||||||||
Ending balance at Mar. 31, 2018 | 1,244,966 | |||||||||||||
Beginning balance (in shares) at Dec. 31, 2018 | 2,181 | 6,369 | 43,702 | |||||||||||
Beginning balance at Dec. 31, 2018 | 1,125,313 | $ 2 | $ 6 | $ 2,752,376 | $ 53,172 | $ 154,147 | $ 2,545,057 | $ 44 | $ (1,583,245) | $ (43,870) | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||
Preferred dividends | $ (1,124) | $ (3,135) | $ (1,124) | $ (3,135) | ||||||||||
Common stock dividends | (29,814) | (29,814) | ||||||||||||
Issuance of common stock, net (in shares) | 16,064 | |||||||||||||
Issuance of common stock, net | 321,992 | 321,976 | 321,976 | $ 16 | ||||||||||
Stock based compensation, net of withholding requirements (in shares) | 25 | |||||||||||||
Stock based compensation, net of withholding requirements | 644 | 644 | 644 | |||||||||||
Net Income (Loss) | (114,381) | (114,381) | ||||||||||||
Other comprehensive income | 187,158 | 187,158 | ||||||||||||
Ending balance (in shares) at Mar. 31, 2019 | 2,181 | 6,369 | 59,791 | |||||||||||
Ending balance at Mar. 31, 2019 | $ 1,486,653 | $ 2 | $ 6 | $ 3,075,172 | $ 53,172 | $ 154,147 | $ 2,867,853 | $ 60 | $ (1,731,875) | $ 143,288 |
Consolidated Statement of Sto_2
Consolidated Statement of Stockholders' Equity (Parenthetical) | 3 Months Ended | 12 Months Ended |
Mar. 31, 2019 | Dec. 31, 2018 | |
Series A Preferred Stock | ||
Preferred stock, dividend rate | 8.25% | 8.25% |
Series B Preferred Stock | ||
Preferred stock, dividend rate | 7.875% | 7.875% |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Cash Flows From Operating Activities: | ||
Net Income (Loss) | $ (114,381,000) | $ 44,747,000 |
Adjustments to reconcile net income (loss) to net cash and cash collateral posted to counterparties provided by (used in) operating activities: | ||
Net amortization of premiums on investments | 6,347,000 | 9,794,000 |
Accretion of net discount on Credit Risk and Non-Agency Securities | (932,000) | (1,006,000) |
Realized loss on sale of Agency Securities | 2,910,000 | 32,603,000 |
Other than temporary impairment of Agency Securities | 0 | 12,090,000 |
Stock based compensation | 644,000 | 644,000 |
Changes in operating assets and liabilities: | ||
(Increase) decrease in accrued interest receivable | (17,178,000) | 1,971,000 |
Decrease in prepaid and other assets | 459,000 | 56,000 |
Change in derivatives, at fair value | 95,796,000 | (99,558,000) |
Increase (decrease) in accrued interest payable- repurchase agreements | 11,522,000 | (1,178,000) |
Increase in accounts payable and other accrued expenses | 2,431,000 | 2,270,000 |
Net cash and cash collateral posted to counterparties used in operating activities | (11,334,000) | (607,000) |
Cash Flows From Investing Activities: | ||
Purchases of Agency Securities | (6,608,566,000) | 0 |
Principal repayments of Agency Securities | 145,777,000 | 167,649,000 |
Principal repayments of Credit Risk and Non-Agency Securities | 6,335,000 | 9,168,000 |
Proceeds from sales of Agency Securities | 1,017,396,000 | 1,068,996,000 |
(Decrease) increase in cash collateral posted by counterparties | (47,387,000) | 98,128,000 |
Net cash and cash collateral posted to counterparties provided by (used in) investing activities | (5,388,039,000) | 675,821,000 |
Cash Flows From Financing Activities: | ||
Issuance of common stock, net of expenses | 321,992,000 | 0 |
Proceeds from repurchase agreements | 50,656,945,000 | 35,593,550,000 |
Principal repayments on repurchase agreements | (45,551,322,000) | (36,295,752,000) |
Common stock dividends paid | (29,814,000) | (24,138,000) |
Net cash and cash collateral posted to counterparties provided by (used in) financing activities | 5,393,542,000 | (727,961,000) |
Net Increase (decrease) in cash and cash collateral posted to counterparties | (5,831,000) | (52,747,000) |
Cash and cash collateral posted to counterparties - beginning of period | 232,199,000 | 282,394,000 |
Cash and cash collateral posted to counterparties - end of period | 226,368,000 | 229,647,000 |
Supplemental Disclosure: | ||
Cash paid during the period for interest | 98,627,000 | 53,651,000 |
Non-Cash Investing Activities: | ||
Receivable for unsettled sales | 0 | 68,796,000 |
Payable for unsettled purchases | 198,172,000 | 227,409,000 |
Net unrealized gain (loss) on available for sale Agency Securities | 184,248,000 | (145,410,000) |
Series B Preferred Stock | ||
Cash Flows From Financing Activities: | ||
Issuance of Series B Preferred stock, net of expenses | 0 | 2,632,000 |
Preferred stock dividends paid | (3,135,000) | (3,129,000) |
Series A Preferred Stock | ||
Cash Flows From Financing Activities: | ||
Preferred stock dividends paid | (1,124,000) | (1,124,000) |
Interest-Only Securities | ||
Adjustments to reconcile net income (loss) to net cash and cash collateral posted to counterparties provided by (used in) operating activities: | ||
Net amortization of premiums on investments | 936,000 | 1,117,000 |
Gain (loss) on securities | 368,000 | (298,000) |
US Treasury Securities | ||
Adjustments to reconcile net income (loss) to net cash and cash collateral posted to counterparties provided by (used in) operating activities: | ||
Net amortization of premiums on investments | (453,000) | 0 |
Gain (loss) on securities | 693,000 | (2,576,000) |
(Gain) loss on U.S. Treasury Securities | 693,000 | (2,576,000) |
Cash Flows From Investing Activities: | ||
Purchases of U.S. Treasury Securities | (101,039,000) | (668,120,000) |
Proceeds from sales of U.S. Treasury Securities | 199,445,000 | 0 |
Credit Risk and Non-Agency Securities | ||
Adjustments to reconcile net income (loss) to net cash and cash collateral posted to counterparties provided by (used in) operating activities: | ||
Gain (loss) on securities | $ (496,000) | $ (1,283,000) |
Organization and Nature of Busi
Organization and Nature of Business Operations | 3 Months Ended |
Mar. 31, 2019 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and Nature of Business Operations | Note 1 - Organization and Nature of Business Operations References to “we,” “us,” “our,” or the “Company” are to ARMOUR Residential REIT, Inc. (“ARMOUR”) and its subsidiaries. References to “ACM” are to ARMOUR Capital Management LP, a Delaware limited partnership. References to “BUCKLER” are to BUCKLER Securities, LLC, a Delaware limited liability company and a FINRA-regulated broker-dealer, controlled by ACM and certain executive officers of ARMOUR. Refer to the Glossary of Terms for definitions of capitalized terms and abbreviations used in this report. ARMOUR is an externally managed Maryland corporation incorporated in 2008. The Company is managed by ACM, an investment advisor registered with the Securities and Exchange Commission (the “SEC”), (see Note 11 - Commitments and Contingencies and Note 16 - Related Party Transactions for additional discussion). We have elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the "Code”). Our qualification as a REIT depends on our ability to meet, on a continuing basis, various complex requirements under the Code relating to, among other things, the sources of our gross income, the composition and values of our assets, our distribution levels and the concentration of ownership of our capital stock. We believe that we are organized in conformity with the requirements for qualification as a REIT under the Code and our manner of operations enables us to meet the requirements for taxation as a REIT for federal income tax purposes. As a REIT, we will generally not be subject to federal income tax on the REIT taxable income that we currently distribute to our stockholders. If we fail to qualify as a REIT in any taxable year and do not qualify for certain statutory relief provisions, we will be subject to federal income tax at regular corporate rates. Even if we qualify as a REIT for U.S. federal income tax purposes, we may still be subject to some federal, state and local taxes on our income. |
Basis of Presentation and Calcu
Basis of Presentation and Calculation | 3 Months Ended |
Mar. 31, 2019 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation and Consolidation | Note 2 - Basis of Presentation and Consolidation The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X promulgated by the SEC. Accordingly, the condensed financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2019 are not necessarily indicative of the results that may be expected for the calendar year ending December 31, 2019 . These unaudited consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in our annual report on Form 10-K for the year ended December 31, 2018 . The unaudited consolidated financial statements include the accounts of ARMOUR Residential REIT, Inc. and its subsidiaries. All intercompany accounts and transactions have been eliminated. The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates affecting the accompanying condensed consolidated financial statements include the valuation of MBS |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2019 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Note 3 - Summary of Significant Accounting Policies Cash Cash includes cash on deposit with financial institutions. We may maintain deposits in federally insured financial institutions in excess of federally insured limits. However, management believes we are not exposed to significant credit risk due to the financial position and creditworthiness of the depository institutions in which those deposits are held. Cash Collateral Posted To/By Counterparties Cash collateral posted to/by counterparties represents cash posted by us to counterparties or posted by counterparties to us as collateral. Cash collateral posted to/by counterparties may include collateral for interest rate swap contracts (including swaptions and basis swap contracts), and repurchase agreements on our MBS and our Agency Securities purchased or sold on a to-be-announced basis (“TBA Agency Securities”). Investments in Securities, at Fair Value We generally intend to hold most of our securities for extended periods of time. We may, from time to time, sell any of our securities as part of the overall management of our securities portfolio. Management determines the appropriate classifications of the securities at the time they are acquired and evaluates the appropriateness of such classifications at each balance sheet date. Purchases and sales of our securities are recorded on the trade date. Agency Securities - At March 31, 2019 and December 31, 2018 , all of our Agency Securities were classified as available for sale securities. Agency Securities classified as available for sale are reported at their estimated fair values with unrealized gains and losses excluded from earnings and reported as part of the consolidated statements of comprehensive income (loss). Credit Risk and Non-Agency Securities - At March 31, 2019 and December 31, 2018 , all of our Credit Risk and Non-Agency Securities were classified as trading securities. Credit Risk and Non-Agency Securities classified as trading are reported at their estimated fair values with unrealized gains and losses included in Other Income (Loss) as a component of the consolidated statements of operations. Interest-Only Securities - At March 31, 2019 and December 31, 2018 , all of our Interest-Only Securities were classified as trading securities. Interest-Only Securities represent the right to receive a specified proportion of the contractual interest flows of specific Agency MBS. Interest-Only Securities classified as trading are reported at their estimated fair values with unrealized gains and losses included in Other Income (Loss) as a component of the consolidated statements of operations. U.S. Treasury Securities - At December 31, 2018 , all of our U.S. Treasury Securities were classified as trading securities and are reported at their estimated fair values with unrealized gains and losses included in Other Income (Loss) as a component of the consolidated statements of operations. We did not have any U.S. Treasury Securities at March 31, 2019 . Receivables and Payables for Unsettled Sales and Purchases We account for purchases and sales of securities on the trade date, including purchases and sales for forward settlement. Receivables and payables for unsettled trades represent the agreed trade price multiplied by the outstanding balance of the securities at the balance sheet date. Accrued Interest Receivable and Payable Accrued interest receivable includes interest accrued between payment dates on securities. Accrued interest payable includes interest payable on our repurchase agreements and may, at certain times, contain interest payable on U.S. Treasury Securities sold short. Repurchase Agreements We finance the acquisition of the majority of our MBS through the use of repurchase agreements. Our repurchase agreements are secured by our MBS and bear interest rates that have historically moved in close relationship to the Federal Funds Rate and the London Interbank Offered Rate (“LIBOR”). Under these repurchase agreements, we sell MBS to a lender and agree to repurchase the same MBS in the future for a price that is higher than the original sales price. The difference between the sales price that we receive and the repurchase price that we pay represents interest paid to the lender. A repurchase agreement operates as a financing arrangement under which we pledge our MBS as collateral to secure a loan which is equal in value to a specified percentage of the estimated fair value of the pledged collateral. We retain beneficial ownership of the pledged collateral. At the maturity of a repurchase agreement, we are required to repay the loan and concurrently receive back our pledged collateral from the lender or, with the consent of the lender, we may renew such agreement at the then prevailing interest rate. The repurchase agreements may require us to pledge additional assets to the lender in the event the estimated fair value of the existing pledged collateral declines. In addition to the repurchase agreement financing discussed above, at certain times we have entered into reverse repurchase agreements with certain of our repurchase agreement counterparties. Under a typical reverse repurchase agreement, we purchase U.S. Treasury Securities from a borrower in exchange for cash and agree to sell the same securities in the future in exchange for a price that is higher than the original purchase price. The difference between the purchase price originally paid and the sale price represents interest received from the borrower. Reverse repurchase agreement receivables and repurchase agreement liabilities are presented net when they meet certain criteria, including being with the same counterparty, being governed by the same master repurchase agreement (“MRA”), settlement through the same brokerage or clearing account and maturing on the same day. We did not have any reverse repurchase agreements outstanding at March 31, 2019 and December 31, 2018 . Derivatives, at Fair Value We recognize all derivatives as either assets or liabilities at fair value on our consolidated balance sheets. All changes in the fair values of our derivatives are reflected in our consolidated statements of operations. We designate derivatives as hedges for tax purposes and any unrealized derivative gains or losses would not affect our distributable net taxable income. These transactions include interest rate swap contracts, interest rate swaptions and basis swap contracts. We also may utilize forward contracts for the purchase or sale of TBA Agency Securities. We account for TBA Agency Securities as derivative instruments if it is reasonably possible that we will not take or make physical delivery of the Agency Security upon settlement of the contract. We account for TBA dollar roll transactions as a series of derivative transactions. We may also purchase and sell TBA Agency Securities as a means of investing in and financing Agency Securities (thereby increasing our “at risk” leverage) or as a means of disposing of or reducing our exposure to Agency Securities (thereby reducing our “at risk” leverage). Pursuant to TBA Agency Securities, we agree to purchase or sell, for future delivery, Agency Securities with certain principal and interest terms and certain types of collateral, but the particular Agency Securities to be delivered are not identified until shortly before the TBA settlement date. We may also choose, prior to settlement, to move the settlement of these securities out to a later date by entering into an offsetting short or long position (referred to as a “pair off”), net settling the paired off positions for cash, and simultaneously purchasing or selling a similar TBA Agency Security for a later settlement date. This transaction is commonly referred to as a “dollar roll.” When it is reasonably possible that we will pair off a TBA Agency Security, we account for that contract as a derivative. Revenue Recognition Agency Securities - Interest income is earned and recognized on Agency Securities based on their unpaid principal amounts and their contractual terms. Recognition of interest income commences on the settlement date of the purchase transaction and continues through the settlement date of the sale transaction. Premiums and discounts associated with the purchase of Multi-Family MBS, which are generally not subject to prepayment, are amortized or accreted into interest income over the contractual lives of the securities using a level yield method. Premiums and discounts associated with the purchase of other Agency Securities are amortized or accreted into interest income over the actual lives of the securities, reflecting actual prepayments as they occur. • Fair Value of Agency Securities: We invest in Agency Securities representing interests in or obligations backed by pools of fixed rate, hybrid adjustable rate and adjustable rate mortgage loans. GAAP requires us to classify our investments as either trading, available for sale or held to maturity securities. Management determines the appropriate classifications of the securities at the time they are acquired and evaluates the appropriateness of such classifications at each balance sheet date. We currently classify all of our Agency Securities as available for sale. Agency Securities classified as available for sale are reported at their estimated fair values with unrealized gains and losses excluded from earnings and reported as part of the statements of comprehensive income (loss). • Agency Security purchase and sale transactions (including purchase of TBA Agency Securities): Purchases and Sales are recorded on the trade date to the extent it is probable that we will take or make timely physical delivery of the related securities. Gains or losses realized from the sale of securities are included in income and are determined using the specific identification method. • Impairment of Assets: We evaluate Agency Securities for other than temporary impairment at least on a quarterly basis and more frequently when economic or market concerns warrant such evaluation. We consider an impairment to be other than temporary if we (1) have the intent to sell the Agency Securities, (2) believe it is more likely than not that we will be required to sell the securities before recovery (for example, because of liquidity requirements or contractual obligations) or (3) a credit loss exists. Impairment losses recognized establish a new cost basis for the related Agency Securities. Credit Risk and Non-Agency Securities and Interest-Only Securities - Interest income on Credit Risk and Non-Agency Securities and Interest-Only Securities is recognized using the effective yield method over the life of the securities based on the future cash flows expected to be received. Future cash flow projections and related effective yields are determined for each security and updated quarterly. Other than temporary impairments, which establish a new cost basis in the security for purposes of calculating effective yields, are recognized when the fair value of a security is less than its cost basis and there has been an adverse change in the future cash flows expected to be received. Other changes in future cash flows expected to be received are recognized prospectively over the remaining life of the security. U.S. Treasury Securities - Interest income on U.S. Treasury Securities is recognized based on their unpaid principal amounts and their contractual terms. Recognition of interest income commences on the settlement date of the purchase transaction and continues through the settlement date of the sale transaction. Comprehensive Income (Loss) |
Recent Accounting Pronouncement
Recent Accounting Pronouncements | 3 Months Ended |
Mar. 31, 2019 | |
Accounting Changes and Error Corrections [Abstract] | |
Recent Accounting Pronouncements | Note 4 - Recent Accounting Pronouncements We consider the applicability and impact of all Accounting Standards Updates issued by the Financial Accounting Standards Board. Those not listed below were deemed to be either not applicable, are not expected to have a significant impact on our consolidated financial statements when adopted, or did not have a significant impact on our consolidated financial statements upon adoption. In the current year we have adopted Accounting Standard ASU 2018–07, Improvements to Nonemployee Share–Based Payment Accounting (Topic 718) . The standard is effective for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. The standard largely aligns the accounting for share–based payment awards issued to employees and nonemployees. Equity–classified share–based payment awards issued to nonemployees are measured on the grant date, instead of being remeasured through the performance completion date (generally the vesting date). The standard was applied on a modified retrospective basis through a cumulative–effect adjustment to retained earnings as of the beginning of the fiscal year when adopted. The cumulative effective adjustment was recorded in our consolidated statement of stockholders' equity as of January 1, 2019, and did not have a material to the Company's financial condition or the results of operations. In 2018, we adopted Accounting Standards ASU 2016-18 , Statement of Cash Flows (Topic 230) - Restricted Cash which resulted in the presentation of cash collateral posted to counterparties with cash on the consolidated statements of cash flows when reconciling the total beginning and ending amounts. Prior period results have been revised to conform to the current presentation. In July 2016, the Financial Accounting Standards Board issued ASU 2016-13, Financial Instruments–Credit Losses (Topic 326) |
Fair Value of Financial Instrum
Fair Value of Financial Instruments | 3 Months Ended |
Mar. 31, 2019 | |
Fair Value Disclosures [Abstract] | |
Fair Value of Financial Instruments | Note 5 - Fair Value of Financial Instruments Our valuation techniques for financial instruments use observable and unobservable inputs. Observable inputs reflect readily obtainable data from third party sources, while unobservable inputs reflect management’s market assumptions. The Accounting Standards Codification Topic No. 820, “Fair Value Measurement,” classifies these inputs into the following hierarchy: Level 1 Input s - Quoted prices for identical instruments in active markets. Level 2 Inputs - Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable. Level 3 Inputs - Prices determined using significant unobservable inputs. Unobservable inputs may be used in situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period). Unobservable inputs reflect management’s assumptions about the factors that market participants would use in pricing an asset or liability, and would be based on the best information available. At the beginning of each quarter, we assess the assets and liabilities that are measured at fair value on a recurring basis to determine if any transfers between levels in the fair value hierarchy are needed. The following describes the valuation methodologies used for our assets and liabilities measured at fair value, as well as the general classification of such instruments pursuant to the valuation hierarchy. Any transfers between levels are assumed to occur at the beginning of the reporting period. Cash and Cash Collateral - Cash includes cash on deposit with financial institutions. The carrying amount of cash is deemed to be its fair value and is classified as Level 1. Cash balances posted by us to counterparties or posted by counterparties to us as collateral are classified as Level 2 because they are integrally related to the Company's repurchase financing and interest rate swap agreements, which are classified as Level 2. Agency Securities - Fair value for the Agency Securities in our securities portfolio is based on obtaining a valuation for each Agency Security from third party pricing services and/or dealer quotes. The third party pricing services use common market pricing methods that may include pricing models that may incorporate such factors as coupons, prepayment speeds, spread to the Treasury curves and interest rate swap curves, duration, periodic and life caps and credit enhancement. If the fair value of an Agency Security is not available from the third party pricing services or such data appears unreliable, we obtain pricing indications from up to three dealers who make markets in similar Agency Securities. Management reviews pricing used to ensure that current market conditions are properly reflected. This review includes, but is not limited to, comparisons of similar market transactions or alternative third party pricing services, dealer pricing indications and comparisons to a third party pricing model. Fair values obtained from the third party pricing services for similar instruments are classified as Level 2 securities if the inputs to the pricing models used are consistent with the Level 2 definition. If quoted prices for a security are not reasonably available from the third party pricing service, but dealer pricing indications are, the security will be classified as a Level 2 security. If neither is available, management will determine the fair value based on characteristics of the security that we receive from the issuer and based on available market information and classify it as a Level 3 security. At March 31, 2019 and December 31, 2018 , all of our Agency Security fair values are classified as Level 2 based on the inputs used by our third party pricing services and dealer quotes. Credit Risk and Non-Agency Securities - The fair value for the Credit Risk and Non-Agency Securities in our securities portfolio is based on obtaining a valuation for each Credit Risk and Non-Agency Security from third party pricing services and/or dealer quotes. The third party pricing services incorporate such factors as collateral type, bond structure and priority of payments, coupons, prepayment speeds, defaults, delinquencies and severities. If the fair value of a Credit Risk and Non-Agency Security is not available from the third party pricing services or such data appears unreliable, we obtain pricing indications from up to three dealers who make markets in similar Credit Risk and Non-Agency Securities. Management reviews pricing used to ensure that current market conditions are properly reflected. This review includes, but is not limited to, comparisons of similar market transactions or alternative third party pricing services, dealer pricing indications and comparisons to fair value determined using a third party pricing model. Fair values obtained from the third party pricing services for similar instruments are classified as Level 2 securities if the inputs to the pricing models used are consistent with the Level 2 definition. If quoted prices for a security are not reasonably available from the third party pricing service, but dealer pricing indications are, the security will be classified as a Level 2 security. If neither is available, management will determine the fair value based on characteristics of the security that we receive from the issuer and based on available market information and classify it as a Level 3 security. At March 31, 2019 and December 31, 2018 , all of our Credit Risk and Non-Agency Securities are classified as Level 2 based on the inputs used by our third party pricing services and dealer quotes. Interest-Only Securities - The fair value for the Interest-Only Securities in our securities portfolio is based on obtaining a valuation for each Interest-Only Security from third party pricing services and/or dealer quotes. The third party pricing services use common market pricing methods that may include pricing models consistent with those models used to price Agency Securities underlying the Interest-Only Securities that may incorporate such factors as coupons, prepayment speeds, spread to the Treasury curves and interest rate swap curves, duration, periodic and life caps and credit enhancement. If the fair value of an Interest-Only Security is not available from the third party pricing services or such data appears unreliable, we obtain pricing indications from up to three dealers who make markets in similar Interest-Only Securities. Management reviews pricing used to ensure that current market conditions are properly reflected. This review includes, but is not limited to, comparisons of similar market transactions or alternative third party pricing services, dealer pricing indications and comparisons to a third party pricing model. Fair values obtained from the third party pricing services for similar instruments are classified as Level 2 securities if the inputs to the pricing models used are consistent with the Level 2 definition. If quoted prices for a security are not reasonably available from the third party pricing service, but dealer pricing indications are, the security will be classified as a Level 2 security. If neither is available, management will determine the fair value based on characteristics of the security that we receive from the issuer and based on available market information and classify it as a Level 3 security. At March 31, 2019 and December 31, 2018 , all of our Interest-Only Security fair values are classified as Level 2 based on the inputs used by our third party pricing services and dealer quotes. U.S. Treasury Securities - Fair value for the U.S. Treasury Securities in our securities portfolio is based on obtaining a valuation for each U.S. Treasury Securities from third party pricing services and/or dealer quotes. At December 31, 2018 , all of our U.S. Treasury Securities are classified as Level 1, as quoted unadjusted prices are available in active markets for identical assets. We did not have any U.S. Treasury Securities at March 31, 2019 . Receivables and Payables for Unsettled Sales and Purchases - The carrying amount is generally deemed to be fair value because of the relatively short time to settlement. Such receivables and payables are classified as Level 2 because they are effectively secured by the related securities and could potentially be subject to counterparty credit considerations. Repurchase Agreements - The fair value of repurchase agreements reflects the present value of the contractual cash flows discounted at the estimated LIBOR based market interest rates at the valuation date for repurchase agreements with a term equivalent to the remaining term to interest rate repricing, which may be at maturity, of our repurchase agreements. The fair value of the repurchase agreements approximates their carrying amount due to the short-term nature of these financial instruments. Our repurchase agreements are classified as Level 2. Derivative Transactions - The fair values of our interest rate swap contracts, interest rate swaptions and basis swaps are valued using information provided by third party pricing services that incorporate common market pricing methods that may include current interest rate curves, forward interest rate curves and market spreads to interest rate curves. We estimate the fair value of TBA Agency Securities based on similar methods used to value our Agency Securities. Management compares the pricing information received to dealer quotes to ensure that the current market conditions are properly reflected. The fair values of our interest rate swap contracts, interest rate swaptions, basis swap contracts and TBA Agency Securities are classified as Level 2. The following tables provide a summary of our assets and liabilities that are measured at fair value on a recurring basis at March 31, 2019 and December 31, 2018 . Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Balance, March 31, 2019 Assets at Fair Value: Agency Securities $ — $ 12,707,442 $ — $ 12,707,442 Credit Risk and Non-Agency Securities $ — $ 815,008 $ — $ 815,008 Interest-Only Securities $ — $ 19,319 $ — $ 19,319 Derivatives $ — $ 58,677 $ — $ 58,677 Liabilities at Fair Value: Derivatives $ — $ 67,065 $ — $ 67,065 There were no transfers of assets or liabilities between the levels of the fair value hierarchy during the three months ended March 31, 2019 . Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Balance at December 31, 2018 Assets at Fair Value: Agency Securities $ — $ 7,051,954 $ — $ 7,051,954 Credit Risk and Non-Agency Securities $ — $ 819,915 $ — $ 819,915 Interest-Only Securities $ — $ 20,623 $ — $ 20,623 U.S. Treasury Securities $ 98,646 $ — $ — $ 98,646 Derivatives $ — $ 111,913 $ — $ 111,913 Liabilities at Fair Value: Derivatives $ — $ 24,505 $ — $ 24,505 There were no transfers of assets or liabilities between the levels of the fair value hierarchy during the year ended December 31, 2018 . The following tables provide a summary of the carrying values and fair values of our financial assets and liabilities not carried at fair value but for which fair value is required to be disclosed at March 31, 2019 and December 31, 2018 . March 31, 2019 Fair Value Measurements using: Carrying Value Fair Value Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Financial Assets: Cash $ 167,372 $ 167,372 $ 167,372 $ — $ — Cash collateral posted to counterparties $ 58,996 $ 58,996 $ — $ 58,996 $ — Accrued interest receivable $ 39,609 $ 39,609 $ — $ 39,609 $ — Subordinated loan to BUCKLER $ 105,000 $ 105,000 $ — $ 105,000 $ — Financial Liabilities: Repurchase agreements $ 12,143,274 $ 12,143,274 $ — $ 12,143,274 $ — Cash collateral posted by counterparties $ 49,826 $ 49,826 $ — $ 49,826 $ — Payable for unsettled purchases $ 198,172 $ 198,172 $ — $ 198,172 $ — Accrued interest payable- repurchase agreements $ 21,790 $ 21,790 $ — $ 21,790 $ — December 31, 2018 Fair Value Measurements using: Carrying Value Fair Value Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Financial Assets: Cash $ 221,668 $ 221,668 $ 221,668 $ — $ — Cash collateral posted to counterparties $ 10,531 $ 10,531 $ — $ 10,531 $ — Accrued interest receivable $ 22,505 $ 22,505 $ — $ 22,505 $ — Subordinated loans to BUCKLER $ 105,000 105,000 $ — $ 105,000 $ — Financial Liabilities: Repurchase agreements $ 7,037,651 $ 7,037,651 $ — $ 7,037,651 $ — Cash collateral posted by counterparties $ 97,213 $ 97,213 $ — $ 97,213 $ — Payable for unsettled purchases $ 166,052 $ 166,052 $ — $ 166,052 $ — Accrued interest payable- repurchase agreements $ 10,268 $ 10,268 $ — $ 10,268 $ — |
Agency Securities
Agency Securities | 3 Months Ended |
Mar. 31, 2019 | |
Investments, Debt and Equity Securities [Abstract] | |
Agency Securities | Note 6 - Agency Securities At March 31, 2019 and December 31, 2018 , investments in Agency Securities accounted for 93.8% and 88.2% of our securities portfolio. We evaluated our Agency Securities with unrealized losses at March 31, 2019 , March 31, 2018 and December 31, 2018 , to determine whether there was an other than temporary impairment. All of our Agency Securities are issued and guaranteed by GSEs or Ginnie Mae. The GSEs have a long term credit rating of AA+. At those dates, we also considered whether we intended to sell Agency Securities and whether it was more likely than not that we could meet our liquidity requirements and contractual obligations without selling Agency Securities. Results of this evaluation for the three months ended March 31, 2019 - No other than temporary impairment was recognized for the three months ended March 31, 2019 . Results of this evaluation for the three months ended March 31, 2018 and for the year ended December 31, 2018 - During the first quarter of 2018, we recognized additional losses on Agency Securities, previously identified during 2017, totaling $(12,090) in our consolidated financial statements of operations. We determined that there was no other than temporary impairment of our remaining Agency Securities at March 31, 2018 and December 31, 2018 . At March 31, 2019 , we had the following Agency Securities in an unrealized gain or loss position as presented below. The components of the carrying value of our Agency Securities at March 31, 2019 are also presented below. Our Agency Securities had a weighted average coupon of 3.91% at March 31, 2019 . March 31, 2019 Amortized Cost Gross Unrealized Loss Gross Unrealized Gain Fair Value Percent of Total Fannie Mae ARMs & Hybrids $ 18,736 $ (228 ) $ 73 $ 18,581 0.15 % Multi-Family MBS 2,761,386 (2,350 ) 62,774 2,821,810 22.21 10 Year Fixed 12,684 (211 ) 32 12,505 0.10 15 Year Fixed 965,248 (3 ) 13,875 979,120 7.71 20 Year Fixed 3,401 (99 ) — 3,302 0.03 30 Year Fixed 5,645,556 (12,673 ) 57,061 5,689,944 44.76 Total Fannie Mae $ 9,407,011 $ (15,564 ) $ 133,815 $ 9,525,262 74.96 % Freddie Mac 10 Year Fixed 8,928 (49 ) 62 8,941 0.07 15 Year Fixed 238,230 (86 ) 2,440 240,584 1.89 30 Year Fixed 2,051,441 (3,652 ) 23,410 2,071,199 16.30 Total Freddie Mac $ 2,298,599 $ (3,787 ) $ 25,912 $ 2,320,724 18.26 % Ginnie Mae ARMs & Hybrids 29,270 (455 ) 2 28,817 0.23 10 Year Fixed 223 — — 223 0.00 30 Year Fixed 829,051 — 3,365 832,416 6.55 Total Ginnie Mae $ 858,544 $ (455 ) $ 3,367 $ 861,456 6.78 % Total Agency Securities $ 12,564,154 $ (19,806 ) $ 163,094 $ 12,707,442 100.00 % At December 31, 2018 , we had the following securities in an unrealized gain or loss position as presented below. The components of the carrying value of our Agency Securities at December 31, 2018 are also presented below. Our Agency Securities had a weighted average coupon of 3.94% at December 31, 2018 . December 31, 2018 Amortized Cost Gross Unrealized Loss Gross Unrealized Gain Fair Value Percent of Total Fannie Mae ARMs & Hybrids $ 19,929 $ (249 ) $ 73 $ 19,753 0.28 % Multi-Family MBS 1,710,346 (17,128 ) 9,345 1,702,563 24.14 10 Year Fixed 115,654 (292 ) 129 115,491 1.64 15 Year Fixed 684,678 (388 ) 3,864 688,154 9.76 20 Year Fixed 3,734 (156 ) — 3,578 0.05 30 Year Fixed 2,803,125 (28,545 ) 3,349 2,777,929 39.39 Total Fannie Mae $ 5,337,466 $ (46,758 ) $ 16,760 $ 5,307,468 75.26 % Freddie Mac 10 Year Fixed 9,515 (68 ) — 9,447 0.13 15 Year Fixed 70,164 (272 ) 157 70,049 0.99 25 Year Fixed 37,939 (1,668 ) — 36,271 0.51 30 Year Fixed 1,299,695 (11,807 ) 500 1,288,388 18.28 Total Freddie Mac 1,417,313 (13,815 ) 657 1,404,155 19.91 % Ginnie Mae ARMs & Hybrids 30,708 (466 ) 1 30,243 0.43 10 Year Fixed 231 (1 ) — 230 0.00 30 Year Fixed 310,106 (255 ) 7 309,858 4.40 Total Ginnie Mae 341,045 (722 ) 8 340,331 4.83 % Total Agency Securities 7,095,824 (61,295 ) 17,425 7,051,954 100.00 % Recognition of interest income commences on the settlement date of the purchase transaction and continues through the settlement date of the sale transaction. At March 31, 2019 , we had investment related payables with respect to unsettled purchases of Agency Securities of $198,172 , we did not have any investment related receivables. At December 31, 2018 , we had investment related payables with respect to unsettled purchases of Agency Securities of $166,052 , we did not have any investment related receivables. Actual maturities of Agency Securities are generally shorter than stated contractual maturities because actual maturities of Agency Securities are affected by the contractual lives of the underlying mortgages, periodic payments of principal and prepayments of principal. The following table summarizes the weighted average lives of our Agency Securities at March 31, 2019 and December 31, 2018 . March 31, 2019 December 31, 2018 Weighted Average Life of all Agency Securities Fair Value Amortized Cost Fair Value Amortized Less than one year $ 24 $ 24 $ 75 $ 77 Greater than or equal to one year and less than three years 26,533 26,819 25,841 26,264 Greater than or equal to three years and less than five years 4,403,226 4,368,346 1,334,663 1,331,577 Greater than or equal to five years 8,277,659 8,168,965 5,691,375 5,737,906 Total Agency Securities $ 12,707,442 $ 12,564,154 $ 7,051,954 $ 7,095,824 We use a third party model to calculate the weighted average lives of our Agency Securities. Weighted average life is calculated based on expectations for estimated prepayments for the underlying mortgage loans of our Agency Securities. These estimated prepayments are based on assumptions such as interest rates, current and future home prices, housing policy and borrower incentives. The weighted average lives of our Agency Securities at March 31, 2019 and December 31, 2018 in the table above are based upon market factors, assumptions, models and estimates from the third party model and also incorporate management’s judgment and experience. The actual weighted average lives of our Agency Securities could be longer or shorter than estimated. The following table presents the unrealized losses and estimated fair value of our Agency Securities by length of time that such securities have been in a continuous unrealized loss position at March 31, 2019 and December 31, 2018 . Unrealized Loss Position For: Less than 12 Months 12 Months or More Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses March 31, 2019 $ 500,445 $ (1,511 ) $ 1,251,564 $ (18,295 ) $ 1,752,009 $ (19,806 ) December 31, 2018 $ 2,651,518 $ (18,135 ) $ 1,197,533 $ (43,160 ) $ 3,849,051 $ (61,295 ) During the three months ended March 31, 2019 , we sold $1,017,396 of Agency Securities, which resulted in realized losses of $(2,910) . During the three months ended March 31, 2018 , we sold $1,137,792 (inclusive of ( $68,796 receivable for unsettled sales) of Agency Securities, which resulted in a realized loss of $(32,603) Note 7 - Credit Risk and Non-Agency Securities At March 31, 2019 and December 31, 2018 , investments in Credit Risk and Non-Agency Securities accounted for 6.0% and 10.3% of our securities portfolio. The components of the carrying value of our Credit Risk and Non-Agency Securities at March 31, 2019 are presented in the table below. Credit Risk and Non-Agency Securities March 31, 2019 Fair Value Amortized Cost Principal Amount Weighted Average Coupon Credit Risk Transfer $ 727,216 $ 650,452 $ 657,069 6.90% Legacy Prime Fixed 13,060 12,258 15,583 6.02% Legacy ALT-A Fixed 45,542 41,389 57,380 5.83% Legacy Prime Hybrid 8,358 7,716 9,122 3.86% Legacy ALT-A Hybrid 3,643 3,104 3,854 4.16% New Issue Prime Fixed 17,189 16,440 17,357 3.69% Total Credit Risk and Non-Agency Securities $ 815,008 $ 731,359 $ 760,365 6.71% The components of the carrying value of our Credit Risk and Non-Agency Securities at December 31, 2018 are presented in the table below. Credit Risk and Non-Agency Securities December 31, 2018 Fair Value Amortized Cost Principal Amount Weighted Average Coupon Credit Risk Transfer $ 729,983 $ 653,681 $ 661,181 6.92% Legacy Prime Fixed 13,394 12,698 16,051 6.02% Legacy ALT-A Fixed 46,853 42,534 58,730 5.84% Legacy Prime Hybrid 8,623 7,987 9,479 3.62% Legacy ALT-A Hybrid 3,724 3,164 3,967 4.06% New Issue Prime Fixed 17,338 16,767 17,714 3.69% Total Credit Risk and Non-Agency Securities $ 819,915 $ 736,831 $ 767,122 6.73% Our Credit Risk Transfer securities are collaterized by residential mortgage loans meeting agency criteria. However, our securities principal and interest are not guaranteed by the agencies. Credit Risk Transfer securities include tranches issued since 2014. Our Legacy and New Issue Prime Fixed securities are collaterized by residential mortgage loans not guaranteed by any agency. Legacy Prime Fixed, Legacy Alt-A Fixed securities include tranches issued between 2005-2007. New Issue Prime Fixed securities include tranches issued in 2013. The following table summarizes the weighted average lives of our Credit Risk and Non-Agency Securities at March 31, 2019 and December 31, 2018 . March 31, 2019 December 31, 2018 Weighted Average Life of all Credit Risk and Non-Agency Securities Fair Value Amortized Cost Fair Value Amortized Cost Greater than or equal to three years and less than five years $ 580,023 $ 519,669 $ 188,063 $ 169,692 Greater than or equal to five years 234,985 211,690 631,852 567,139 Total Credit Risk and Non-Agency Securities $ 815,008 $ 731,359 $ 819,915 $ 736,831 We use a third party model to calculate the weighted average lives of our Credit Risk and Non-Agency Securities. Weighted average life is calculated based on expectations for estimated prepayments for the underlying mortgage loans of our Credit Risk and Non-Agency Securities. These estimated prepayments are based on assumptions such as interest rates, current and future home prices, housing policy and borrower incentives. The weighted average lives of our Credit Risk and Non-Agency Securities at March 31, 2019 and December 31, 2018 , in the tables above are based upon market factors, assumptions, models and estimates from the third party model and also incorporate management’s judgment and experience. The actual weighted average lives of our Credit Risk and Non-Agency Securities could be longer or shorter than estimated. T he following table presents the unrealized losses and estimated fair value of our Credit Risk and Non-Agency Securities by length of time that such securities have been in a continuous unrealized loss position at March 31, 2019 and December 31, 2018 . Unrealized Loss Position For: Less than 12 Months 12 Months or More Total As of Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses March 31, 2019 $ — $ — $ — $ — $ — $ — December 31, 2018 $ 1,860 $ (13 ) $ — $ — $ 1,860 $ (13 ) Our Credit Risk and Non-Agency Securities are subject to risk of loss with regard to principal and interest payments and at March 31, 2019 and December 31, 2018 Note 8 - U.S. Treasury Securities We did not have any U.S. Treasury Securities at March 31, 2019 . At December 31, 2018 , investments in U.S. Treasury Securities accounted for 1.2% of our securities portfolio. At December 31, 2018 , we had the following U.S. Treasury Securities in an unrealized gain or loss position as presented below. The components of the carrying value of our U.S. Treasury Securities at December 31, 2018 are also presented below. U.S. Treasury Securities Amortized Cost Gross Unrealized Loss Gross Unrealized Gain Fair Value December 31, 2018 98,703 (57 ) — 98,646 The following table presents the unrealized losses and estimated fair value of our U.S. Treasury Securities by length of time that such securities have been in a continuous unrealized loss position at December 31, 2018 . Unrealized Loss Position For: Less than 12 Months 12 Months or More Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses December 31, 2018 $ 98,646 $ (57 ) $ — $ — $ 98,646 $ (57 ) During the three months ended March 31, 2019 , we sold $199,445 of U.S. Treasury Securities, which resulted in a realized loss of $(750) |
Credit Risk and Non-Agency Secu
Credit Risk and Non-Agency Securities | 3 Months Ended |
Mar. 31, 2019 | |
Investments, Debt and Equity Securities [Abstract] | |
Credit Risk and Non-Agency Securities | Note 6 - Agency Securities At March 31, 2019 and December 31, 2018 , investments in Agency Securities accounted for 93.8% and 88.2% of our securities portfolio. We evaluated our Agency Securities with unrealized losses at March 31, 2019 , March 31, 2018 and December 31, 2018 , to determine whether there was an other than temporary impairment. All of our Agency Securities are issued and guaranteed by GSEs or Ginnie Mae. The GSEs have a long term credit rating of AA+. At those dates, we also considered whether we intended to sell Agency Securities and whether it was more likely than not that we could meet our liquidity requirements and contractual obligations without selling Agency Securities. Results of this evaluation for the three months ended March 31, 2019 - No other than temporary impairment was recognized for the three months ended March 31, 2019 . Results of this evaluation for the three months ended March 31, 2018 and for the year ended December 31, 2018 - During the first quarter of 2018, we recognized additional losses on Agency Securities, previously identified during 2017, totaling $(12,090) in our consolidated financial statements of operations. We determined that there was no other than temporary impairment of our remaining Agency Securities at March 31, 2018 and December 31, 2018 . At March 31, 2019 , we had the following Agency Securities in an unrealized gain or loss position as presented below. The components of the carrying value of our Agency Securities at March 31, 2019 are also presented below. Our Agency Securities had a weighted average coupon of 3.91% at March 31, 2019 . March 31, 2019 Amortized Cost Gross Unrealized Loss Gross Unrealized Gain Fair Value Percent of Total Fannie Mae ARMs & Hybrids $ 18,736 $ (228 ) $ 73 $ 18,581 0.15 % Multi-Family MBS 2,761,386 (2,350 ) 62,774 2,821,810 22.21 10 Year Fixed 12,684 (211 ) 32 12,505 0.10 15 Year Fixed 965,248 (3 ) 13,875 979,120 7.71 20 Year Fixed 3,401 (99 ) — 3,302 0.03 30 Year Fixed 5,645,556 (12,673 ) 57,061 5,689,944 44.76 Total Fannie Mae $ 9,407,011 $ (15,564 ) $ 133,815 $ 9,525,262 74.96 % Freddie Mac 10 Year Fixed 8,928 (49 ) 62 8,941 0.07 15 Year Fixed 238,230 (86 ) 2,440 240,584 1.89 30 Year Fixed 2,051,441 (3,652 ) 23,410 2,071,199 16.30 Total Freddie Mac $ 2,298,599 $ (3,787 ) $ 25,912 $ 2,320,724 18.26 % Ginnie Mae ARMs & Hybrids 29,270 (455 ) 2 28,817 0.23 10 Year Fixed 223 — — 223 0.00 30 Year Fixed 829,051 — 3,365 832,416 6.55 Total Ginnie Mae $ 858,544 $ (455 ) $ 3,367 $ 861,456 6.78 % Total Agency Securities $ 12,564,154 $ (19,806 ) $ 163,094 $ 12,707,442 100.00 % At December 31, 2018 , we had the following securities in an unrealized gain or loss position as presented below. The components of the carrying value of our Agency Securities at December 31, 2018 are also presented below. Our Agency Securities had a weighted average coupon of 3.94% at December 31, 2018 . December 31, 2018 Amortized Cost Gross Unrealized Loss Gross Unrealized Gain Fair Value Percent of Total Fannie Mae ARMs & Hybrids $ 19,929 $ (249 ) $ 73 $ 19,753 0.28 % Multi-Family MBS 1,710,346 (17,128 ) 9,345 1,702,563 24.14 10 Year Fixed 115,654 (292 ) 129 115,491 1.64 15 Year Fixed 684,678 (388 ) 3,864 688,154 9.76 20 Year Fixed 3,734 (156 ) — 3,578 0.05 30 Year Fixed 2,803,125 (28,545 ) 3,349 2,777,929 39.39 Total Fannie Mae $ 5,337,466 $ (46,758 ) $ 16,760 $ 5,307,468 75.26 % Freddie Mac 10 Year Fixed 9,515 (68 ) — 9,447 0.13 15 Year Fixed 70,164 (272 ) 157 70,049 0.99 25 Year Fixed 37,939 (1,668 ) — 36,271 0.51 30 Year Fixed 1,299,695 (11,807 ) 500 1,288,388 18.28 Total Freddie Mac 1,417,313 (13,815 ) 657 1,404,155 19.91 % Ginnie Mae ARMs & Hybrids 30,708 (466 ) 1 30,243 0.43 10 Year Fixed 231 (1 ) — 230 0.00 30 Year Fixed 310,106 (255 ) 7 309,858 4.40 Total Ginnie Mae 341,045 (722 ) 8 340,331 4.83 % Total Agency Securities 7,095,824 (61,295 ) 17,425 7,051,954 100.00 % Recognition of interest income commences on the settlement date of the purchase transaction and continues through the settlement date of the sale transaction. At March 31, 2019 , we had investment related payables with respect to unsettled purchases of Agency Securities of $198,172 , we did not have any investment related receivables. At December 31, 2018 , we had investment related payables with respect to unsettled purchases of Agency Securities of $166,052 , we did not have any investment related receivables. Actual maturities of Agency Securities are generally shorter than stated contractual maturities because actual maturities of Agency Securities are affected by the contractual lives of the underlying mortgages, periodic payments of principal and prepayments of principal. The following table summarizes the weighted average lives of our Agency Securities at March 31, 2019 and December 31, 2018 . March 31, 2019 December 31, 2018 Weighted Average Life of all Agency Securities Fair Value Amortized Cost Fair Value Amortized Less than one year $ 24 $ 24 $ 75 $ 77 Greater than or equal to one year and less than three years 26,533 26,819 25,841 26,264 Greater than or equal to three years and less than five years 4,403,226 4,368,346 1,334,663 1,331,577 Greater than or equal to five years 8,277,659 8,168,965 5,691,375 5,737,906 Total Agency Securities $ 12,707,442 $ 12,564,154 $ 7,051,954 $ 7,095,824 We use a third party model to calculate the weighted average lives of our Agency Securities. Weighted average life is calculated based on expectations for estimated prepayments for the underlying mortgage loans of our Agency Securities. These estimated prepayments are based on assumptions such as interest rates, current and future home prices, housing policy and borrower incentives. The weighted average lives of our Agency Securities at March 31, 2019 and December 31, 2018 in the table above are based upon market factors, assumptions, models and estimates from the third party model and also incorporate management’s judgment and experience. The actual weighted average lives of our Agency Securities could be longer or shorter than estimated. The following table presents the unrealized losses and estimated fair value of our Agency Securities by length of time that such securities have been in a continuous unrealized loss position at March 31, 2019 and December 31, 2018 . Unrealized Loss Position For: Less than 12 Months 12 Months or More Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses March 31, 2019 $ 500,445 $ (1,511 ) $ 1,251,564 $ (18,295 ) $ 1,752,009 $ (19,806 ) December 31, 2018 $ 2,651,518 $ (18,135 ) $ 1,197,533 $ (43,160 ) $ 3,849,051 $ (61,295 ) During the three months ended March 31, 2019 , we sold $1,017,396 of Agency Securities, which resulted in realized losses of $(2,910) . During the three months ended March 31, 2018 , we sold $1,137,792 (inclusive of ( $68,796 receivable for unsettled sales) of Agency Securities, which resulted in a realized loss of $(32,603) Note 7 - Credit Risk and Non-Agency Securities At March 31, 2019 and December 31, 2018 , investments in Credit Risk and Non-Agency Securities accounted for 6.0% and 10.3% of our securities portfolio. The components of the carrying value of our Credit Risk and Non-Agency Securities at March 31, 2019 are presented in the table below. Credit Risk and Non-Agency Securities March 31, 2019 Fair Value Amortized Cost Principal Amount Weighted Average Coupon Credit Risk Transfer $ 727,216 $ 650,452 $ 657,069 6.90% Legacy Prime Fixed 13,060 12,258 15,583 6.02% Legacy ALT-A Fixed 45,542 41,389 57,380 5.83% Legacy Prime Hybrid 8,358 7,716 9,122 3.86% Legacy ALT-A Hybrid 3,643 3,104 3,854 4.16% New Issue Prime Fixed 17,189 16,440 17,357 3.69% Total Credit Risk and Non-Agency Securities $ 815,008 $ 731,359 $ 760,365 6.71% The components of the carrying value of our Credit Risk and Non-Agency Securities at December 31, 2018 are presented in the table below. Credit Risk and Non-Agency Securities December 31, 2018 Fair Value Amortized Cost Principal Amount Weighted Average Coupon Credit Risk Transfer $ 729,983 $ 653,681 $ 661,181 6.92% Legacy Prime Fixed 13,394 12,698 16,051 6.02% Legacy ALT-A Fixed 46,853 42,534 58,730 5.84% Legacy Prime Hybrid 8,623 7,987 9,479 3.62% Legacy ALT-A Hybrid 3,724 3,164 3,967 4.06% New Issue Prime Fixed 17,338 16,767 17,714 3.69% Total Credit Risk and Non-Agency Securities $ 819,915 $ 736,831 $ 767,122 6.73% Our Credit Risk Transfer securities are collaterized by residential mortgage loans meeting agency criteria. However, our securities principal and interest are not guaranteed by the agencies. Credit Risk Transfer securities include tranches issued since 2014. Our Legacy and New Issue Prime Fixed securities are collaterized by residential mortgage loans not guaranteed by any agency. Legacy Prime Fixed, Legacy Alt-A Fixed securities include tranches issued between 2005-2007. New Issue Prime Fixed securities include tranches issued in 2013. The following table summarizes the weighted average lives of our Credit Risk and Non-Agency Securities at March 31, 2019 and December 31, 2018 . March 31, 2019 December 31, 2018 Weighted Average Life of all Credit Risk and Non-Agency Securities Fair Value Amortized Cost Fair Value Amortized Cost Greater than or equal to three years and less than five years $ 580,023 $ 519,669 $ 188,063 $ 169,692 Greater than or equal to five years 234,985 211,690 631,852 567,139 Total Credit Risk and Non-Agency Securities $ 815,008 $ 731,359 $ 819,915 $ 736,831 We use a third party model to calculate the weighted average lives of our Credit Risk and Non-Agency Securities. Weighted average life is calculated based on expectations for estimated prepayments for the underlying mortgage loans of our Credit Risk and Non-Agency Securities. These estimated prepayments are based on assumptions such as interest rates, current and future home prices, housing policy and borrower incentives. The weighted average lives of our Credit Risk and Non-Agency Securities at March 31, 2019 and December 31, 2018 , in the tables above are based upon market factors, assumptions, models and estimates from the third party model and also incorporate management’s judgment and experience. The actual weighted average lives of our Credit Risk and Non-Agency Securities could be longer or shorter than estimated. T he following table presents the unrealized losses and estimated fair value of our Credit Risk and Non-Agency Securities by length of time that such securities have been in a continuous unrealized loss position at March 31, 2019 and December 31, 2018 . Unrealized Loss Position For: Less than 12 Months 12 Months or More Total As of Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses March 31, 2019 $ — $ — $ — $ — $ — $ — December 31, 2018 $ 1,860 $ (13 ) $ — $ — $ 1,860 $ (13 ) Our Credit Risk and Non-Agency Securities are subject to risk of loss with regard to principal and interest payments and at March 31, 2019 and December 31, 2018 Note 8 - U.S. Treasury Securities We did not have any U.S. Treasury Securities at March 31, 2019 . At December 31, 2018 , investments in U.S. Treasury Securities accounted for 1.2% of our securities portfolio. At December 31, 2018 , we had the following U.S. Treasury Securities in an unrealized gain or loss position as presented below. The components of the carrying value of our U.S. Treasury Securities at December 31, 2018 are also presented below. U.S. Treasury Securities Amortized Cost Gross Unrealized Loss Gross Unrealized Gain Fair Value December 31, 2018 98,703 (57 ) — 98,646 The following table presents the unrealized losses and estimated fair value of our U.S. Treasury Securities by length of time that such securities have been in a continuous unrealized loss position at December 31, 2018 . Unrealized Loss Position For: Less than 12 Months 12 Months or More Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses December 31, 2018 $ 98,646 $ (57 ) $ — $ — $ 98,646 $ (57 ) During the three months ended March 31, 2019 , we sold $199,445 of U.S. Treasury Securities, which resulted in a realized loss of $(750) |
U.S. Treasury Securities
U.S. Treasury Securities | 3 Months Ended |
Mar. 31, 2019 | |
Investments, Debt and Equity Securities [Abstract] | |
U.S. Treasury Securities | Note 6 - Agency Securities At March 31, 2019 and December 31, 2018 , investments in Agency Securities accounted for 93.8% and 88.2% of our securities portfolio. We evaluated our Agency Securities with unrealized losses at March 31, 2019 , March 31, 2018 and December 31, 2018 , to determine whether there was an other than temporary impairment. All of our Agency Securities are issued and guaranteed by GSEs or Ginnie Mae. The GSEs have a long term credit rating of AA+. At those dates, we also considered whether we intended to sell Agency Securities and whether it was more likely than not that we could meet our liquidity requirements and contractual obligations without selling Agency Securities. Results of this evaluation for the three months ended March 31, 2019 - No other than temporary impairment was recognized for the three months ended March 31, 2019 . Results of this evaluation for the three months ended March 31, 2018 and for the year ended December 31, 2018 - During the first quarter of 2018, we recognized additional losses on Agency Securities, previously identified during 2017, totaling $(12,090) in our consolidated financial statements of operations. We determined that there was no other than temporary impairment of our remaining Agency Securities at March 31, 2018 and December 31, 2018 . At March 31, 2019 , we had the following Agency Securities in an unrealized gain or loss position as presented below. The components of the carrying value of our Agency Securities at March 31, 2019 are also presented below. Our Agency Securities had a weighted average coupon of 3.91% at March 31, 2019 . March 31, 2019 Amortized Cost Gross Unrealized Loss Gross Unrealized Gain Fair Value Percent of Total Fannie Mae ARMs & Hybrids $ 18,736 $ (228 ) $ 73 $ 18,581 0.15 % Multi-Family MBS 2,761,386 (2,350 ) 62,774 2,821,810 22.21 10 Year Fixed 12,684 (211 ) 32 12,505 0.10 15 Year Fixed 965,248 (3 ) 13,875 979,120 7.71 20 Year Fixed 3,401 (99 ) — 3,302 0.03 30 Year Fixed 5,645,556 (12,673 ) 57,061 5,689,944 44.76 Total Fannie Mae $ 9,407,011 $ (15,564 ) $ 133,815 $ 9,525,262 74.96 % Freddie Mac 10 Year Fixed 8,928 (49 ) 62 8,941 0.07 15 Year Fixed 238,230 (86 ) 2,440 240,584 1.89 30 Year Fixed 2,051,441 (3,652 ) 23,410 2,071,199 16.30 Total Freddie Mac $ 2,298,599 $ (3,787 ) $ 25,912 $ 2,320,724 18.26 % Ginnie Mae ARMs & Hybrids 29,270 (455 ) 2 28,817 0.23 10 Year Fixed 223 — — 223 0.00 30 Year Fixed 829,051 — 3,365 832,416 6.55 Total Ginnie Mae $ 858,544 $ (455 ) $ 3,367 $ 861,456 6.78 % Total Agency Securities $ 12,564,154 $ (19,806 ) $ 163,094 $ 12,707,442 100.00 % At December 31, 2018 , we had the following securities in an unrealized gain or loss position as presented below. The components of the carrying value of our Agency Securities at December 31, 2018 are also presented below. Our Agency Securities had a weighted average coupon of 3.94% at December 31, 2018 . December 31, 2018 Amortized Cost Gross Unrealized Loss Gross Unrealized Gain Fair Value Percent of Total Fannie Mae ARMs & Hybrids $ 19,929 $ (249 ) $ 73 $ 19,753 0.28 % Multi-Family MBS 1,710,346 (17,128 ) 9,345 1,702,563 24.14 10 Year Fixed 115,654 (292 ) 129 115,491 1.64 15 Year Fixed 684,678 (388 ) 3,864 688,154 9.76 20 Year Fixed 3,734 (156 ) — 3,578 0.05 30 Year Fixed 2,803,125 (28,545 ) 3,349 2,777,929 39.39 Total Fannie Mae $ 5,337,466 $ (46,758 ) $ 16,760 $ 5,307,468 75.26 % Freddie Mac 10 Year Fixed 9,515 (68 ) — 9,447 0.13 15 Year Fixed 70,164 (272 ) 157 70,049 0.99 25 Year Fixed 37,939 (1,668 ) — 36,271 0.51 30 Year Fixed 1,299,695 (11,807 ) 500 1,288,388 18.28 Total Freddie Mac 1,417,313 (13,815 ) 657 1,404,155 19.91 % Ginnie Mae ARMs & Hybrids 30,708 (466 ) 1 30,243 0.43 10 Year Fixed 231 (1 ) — 230 0.00 30 Year Fixed 310,106 (255 ) 7 309,858 4.40 Total Ginnie Mae 341,045 (722 ) 8 340,331 4.83 % Total Agency Securities 7,095,824 (61,295 ) 17,425 7,051,954 100.00 % Recognition of interest income commences on the settlement date of the purchase transaction and continues through the settlement date of the sale transaction. At March 31, 2019 , we had investment related payables with respect to unsettled purchases of Agency Securities of $198,172 , we did not have any investment related receivables. At December 31, 2018 , we had investment related payables with respect to unsettled purchases of Agency Securities of $166,052 , we did not have any investment related receivables. Actual maturities of Agency Securities are generally shorter than stated contractual maturities because actual maturities of Agency Securities are affected by the contractual lives of the underlying mortgages, periodic payments of principal and prepayments of principal. The following table summarizes the weighted average lives of our Agency Securities at March 31, 2019 and December 31, 2018 . March 31, 2019 December 31, 2018 Weighted Average Life of all Agency Securities Fair Value Amortized Cost Fair Value Amortized Less than one year $ 24 $ 24 $ 75 $ 77 Greater than or equal to one year and less than three years 26,533 26,819 25,841 26,264 Greater than or equal to three years and less than five years 4,403,226 4,368,346 1,334,663 1,331,577 Greater than or equal to five years 8,277,659 8,168,965 5,691,375 5,737,906 Total Agency Securities $ 12,707,442 $ 12,564,154 $ 7,051,954 $ 7,095,824 We use a third party model to calculate the weighted average lives of our Agency Securities. Weighted average life is calculated based on expectations for estimated prepayments for the underlying mortgage loans of our Agency Securities. These estimated prepayments are based on assumptions such as interest rates, current and future home prices, housing policy and borrower incentives. The weighted average lives of our Agency Securities at March 31, 2019 and December 31, 2018 in the table above are based upon market factors, assumptions, models and estimates from the third party model and also incorporate management’s judgment and experience. The actual weighted average lives of our Agency Securities could be longer or shorter than estimated. The following table presents the unrealized losses and estimated fair value of our Agency Securities by length of time that such securities have been in a continuous unrealized loss position at March 31, 2019 and December 31, 2018 . Unrealized Loss Position For: Less than 12 Months 12 Months or More Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses March 31, 2019 $ 500,445 $ (1,511 ) $ 1,251,564 $ (18,295 ) $ 1,752,009 $ (19,806 ) December 31, 2018 $ 2,651,518 $ (18,135 ) $ 1,197,533 $ (43,160 ) $ 3,849,051 $ (61,295 ) During the three months ended March 31, 2019 , we sold $1,017,396 of Agency Securities, which resulted in realized losses of $(2,910) . During the three months ended March 31, 2018 , we sold $1,137,792 (inclusive of ( $68,796 receivable for unsettled sales) of Agency Securities, which resulted in a realized loss of $(32,603) Note 7 - Credit Risk and Non-Agency Securities At March 31, 2019 and December 31, 2018 , investments in Credit Risk and Non-Agency Securities accounted for 6.0% and 10.3% of our securities portfolio. The components of the carrying value of our Credit Risk and Non-Agency Securities at March 31, 2019 are presented in the table below. Credit Risk and Non-Agency Securities March 31, 2019 Fair Value Amortized Cost Principal Amount Weighted Average Coupon Credit Risk Transfer $ 727,216 $ 650,452 $ 657,069 6.90% Legacy Prime Fixed 13,060 12,258 15,583 6.02% Legacy ALT-A Fixed 45,542 41,389 57,380 5.83% Legacy Prime Hybrid 8,358 7,716 9,122 3.86% Legacy ALT-A Hybrid 3,643 3,104 3,854 4.16% New Issue Prime Fixed 17,189 16,440 17,357 3.69% Total Credit Risk and Non-Agency Securities $ 815,008 $ 731,359 $ 760,365 6.71% The components of the carrying value of our Credit Risk and Non-Agency Securities at December 31, 2018 are presented in the table below. Credit Risk and Non-Agency Securities December 31, 2018 Fair Value Amortized Cost Principal Amount Weighted Average Coupon Credit Risk Transfer $ 729,983 $ 653,681 $ 661,181 6.92% Legacy Prime Fixed 13,394 12,698 16,051 6.02% Legacy ALT-A Fixed 46,853 42,534 58,730 5.84% Legacy Prime Hybrid 8,623 7,987 9,479 3.62% Legacy ALT-A Hybrid 3,724 3,164 3,967 4.06% New Issue Prime Fixed 17,338 16,767 17,714 3.69% Total Credit Risk and Non-Agency Securities $ 819,915 $ 736,831 $ 767,122 6.73% Our Credit Risk Transfer securities are collaterized by residential mortgage loans meeting agency criteria. However, our securities principal and interest are not guaranteed by the agencies. Credit Risk Transfer securities include tranches issued since 2014. Our Legacy and New Issue Prime Fixed securities are collaterized by residential mortgage loans not guaranteed by any agency. Legacy Prime Fixed, Legacy Alt-A Fixed securities include tranches issued between 2005-2007. New Issue Prime Fixed securities include tranches issued in 2013. The following table summarizes the weighted average lives of our Credit Risk and Non-Agency Securities at March 31, 2019 and December 31, 2018 . March 31, 2019 December 31, 2018 Weighted Average Life of all Credit Risk and Non-Agency Securities Fair Value Amortized Cost Fair Value Amortized Cost Greater than or equal to three years and less than five years $ 580,023 $ 519,669 $ 188,063 $ 169,692 Greater than or equal to five years 234,985 211,690 631,852 567,139 Total Credit Risk and Non-Agency Securities $ 815,008 $ 731,359 $ 819,915 $ 736,831 We use a third party model to calculate the weighted average lives of our Credit Risk and Non-Agency Securities. Weighted average life is calculated based on expectations for estimated prepayments for the underlying mortgage loans of our Credit Risk and Non-Agency Securities. These estimated prepayments are based on assumptions such as interest rates, current and future home prices, housing policy and borrower incentives. The weighted average lives of our Credit Risk and Non-Agency Securities at March 31, 2019 and December 31, 2018 , in the tables above are based upon market factors, assumptions, models and estimates from the third party model and also incorporate management’s judgment and experience. The actual weighted average lives of our Credit Risk and Non-Agency Securities could be longer or shorter than estimated. T he following table presents the unrealized losses and estimated fair value of our Credit Risk and Non-Agency Securities by length of time that such securities have been in a continuous unrealized loss position at March 31, 2019 and December 31, 2018 . Unrealized Loss Position For: Less than 12 Months 12 Months or More Total As of Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses March 31, 2019 $ — $ — $ — $ — $ — $ — December 31, 2018 $ 1,860 $ (13 ) $ — $ — $ 1,860 $ (13 ) Our Credit Risk and Non-Agency Securities are subject to risk of loss with regard to principal and interest payments and at March 31, 2019 and December 31, 2018 Note 8 - U.S. Treasury Securities We did not have any U.S. Treasury Securities at March 31, 2019 . At December 31, 2018 , investments in U.S. Treasury Securities accounted for 1.2% of our securities portfolio. At December 31, 2018 , we had the following U.S. Treasury Securities in an unrealized gain or loss position as presented below. The components of the carrying value of our U.S. Treasury Securities at December 31, 2018 are also presented below. U.S. Treasury Securities Amortized Cost Gross Unrealized Loss Gross Unrealized Gain Fair Value December 31, 2018 98,703 (57 ) — 98,646 The following table presents the unrealized losses and estimated fair value of our U.S. Treasury Securities by length of time that such securities have been in a continuous unrealized loss position at December 31, 2018 . Unrealized Loss Position For: Less than 12 Months 12 Months or More Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses December 31, 2018 $ 98,646 $ (57 ) $ — $ — $ 98,646 $ (57 ) During the three months ended March 31, 2019 , we sold $199,445 of U.S. Treasury Securities, which resulted in a realized loss of $(750) |
Repurchase Agreements
Repurchase Agreements | 3 Months Ended |
Mar. 31, 2019 | |
Disclosure of Repurchase Agreements [Abstract] | |
Repurchase Agreements | Note 9 - Repurchase Agreements At March 31, 2019 , we had MRAs with 49 counterparties and outstanding borrowings with 23 of those counterparties. At December 31, 2018 , we had MRAs with 48 counterparties and outstanding borrowings with 23 of those counterparties. The following tables represent the contractual repricing regarding our repurchase agreements to finance our MBS at March 31, 2019 and December 31, 2018 . No amounts below are subject to offsetting. March 31, 2019 Repurchase Agreements Weighted Average Contractual Rate Weighted Average Maturity in days Haircut for Repurchase Agreements (1) Agency Securities $ 11,728,144 2.93 % 12 4.28 % Credit Risk and Non-Agency Securities 415,130 3.22 % 14 16.22 % Total or Weighted Average $ 12,143,274 2.94 % 12 4.73 % (1) The Haircut represents the weighted average margin requirement, or the percentage amount by which the collateral value must exceed the loan amount. December 31, 2018 Repurchase Agreements Weighted Average Contractual Rate Weighted Average Maturity in days Haircut for Repurchase Agreements (1) Agency Securities $ 6,456,823 2.95 % 14 4.22 % Credit Risk and Non-Agency Securities 580,828 3.23 % 14 17.79 % Total or Weighted Average $ 7,037,651 2.97 % 14 5.48 % (1) The Haircut represents the weighted average margin requirement, or the percentage amount by which the collateral value must exceed the loan amount. Our repurchase agreements require that we maintain adequate pledged collateral. A decline in the value of the MBS pledged as collateral for borrowings under repurchase agreements could result in the counterparties demanding additional collateral pledges or liquidation of some of the existing collateral to reduce borrowing levels. We manage this risk by maintaining an adequate balance of available cash and unpledged securities. An event of default or termination event under the standard MRA would give our counterparty the option to terminate all repurchase transactions existing with us and require any amount due to be payable immediately. In addition, certain of our MRAs contain a restriction that prohibits our leverage from exceeding twelve times our stockholders’ equity as well as termination events in the case of significant reductions in equity capital. We also may receive cash or securities as collateral from our derivative counterparties which we may use as additional collateral for repurchase agreements. Certain interest rate swap contracts provide for cross collateralization and cross default with repurchase agreements and other contracts with the same counterparty. The following table summarizes the maturity or repricing and the weighted average contractual rates of our repurchase agreements to finance our MBS at March 31, 2019 and December 31, 2018 . March 31, 2019 December 31, 2018 Maturing or Repricing Repurchase Agreements Weighted Average Contractual Rate Repurchase Agreements Weighted Average Contractual Rate Within 30 days $ 11,675,148 2.95 % $ 5,793,973 3.05 % 31 days to 60 days 270,086 2.67 % 1,243,678 2.60 % 61 days to 90 days 198,040 2.66 % — 0.00 % Total or Weighted Average $ 12,143,274 2.94 % $ 7,037,651 2.97 % At March 31, 2019 and December 31, 2018 , BUCKLER (See Note 16 - Related Party Transactions ) accounted for 49.2% and 49.8% of our aggregate borrowings and had an amount at risk of 16.7% and 13.0% , respectively, of our total stockholders' equity with a weighted average maturity of 7 days and 14 days , respectively, on repurchase agreements. In addition, at March 31, 2019 and December 31, 2018 , we had 1 other repurchase agreement counterparty that individually accounted for between 5% and 10% of our aggregate borrowings. In total, this counterparty accounted for approximately 5.1% and 6.8% , respectively of our repurchase agreement borrowings outstanding at March 31, 2019 and December 31, 2018 |
Derivatives
Derivatives | 3 Months Ended |
Mar. 31, 2019 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivatives | Note 10 - Derivatives We enter into derivative transactions to manage our interest rate risk exposure. These transactions may include entering into interest rate swap contracts, swaptions and basis swaps. These transactions are designed to lock in funding costs for repurchase agreements associated with our assets in such a way to help assure the realization of net interest margins. Such transactions are based on assumptions about prepayments which, if not realized, will cause transaction results to differ from expectations. Basis swap contracts allow us to exchange one floating interest rate basis for another, for example, 3 month LIBOR and Fed Funds Rates, thereby allowing us to diversify our floating rate basis exposures. We also utilize forward contracts for the purchase or sale of TBA Agency Securities. We have agreements with our derivative counterparties that provide for the posting of collateral based on the fair values of our interest rate swap contracts, swaptions, basis swap contracts and TBA Agency Securities. Through this margin process, either we or our swap counterparty may be required to pledge cash or securities as collateral. Collateral requirements vary by counterparty and change over time based on the fair value, notional amount and remaining term of the contracts. Certain interest rate swap contracts provide for cross collateralization and cross default with repurchase agreements and other contracts with the same counterparty. Interest rate swaptions generally provide us the option to enter into an interest rate swap agreement at a certain point of time in the future with a predetermined notional amount, stated term and stated rate of interest in the fixed leg and interest rate index on the floating leg. TBA Agency Securities are forward contracts for the purchase (“long position”) or sale (“short position”) of Agency Securities at a predetermined price, face amount, issuer, coupon and stated maturity on an agreed-upon future date. The specific Agency Securities delivered into the contract upon the settlement date, published each month by the Securities Industry and Financial Markets Association, are not known at the time of the transaction. We may enter into TBA Agency Securities as a means of hedging against short-term changes in interest rates. We may also enter into TBA Agency Securities as a means of acquiring or disposing of Agency Securities and we may from time to time utilize TBA dollar roll transactions to finance Agency Security purchases. We estimate the fair value of TBA Agency Securities based on similar methods used to value our Agency Securities. The following tables present information about our derivatives at March 31, 2019 and December 31, 2018 . March 31, 2019 Derivative Type Remaining / Underlying Term Weighted Average Remaining Swap/Option Term (Months) Weighted Average Rate Notional Amount Asset Fair Value (1) Liability Fair Value (1) Interest rate swap contracts 0-12 Months 8 1.21 % $ 550,000 $ 6,328 $ — Interest rate swap contracts 13-24 Months 20 1.83 % 1,675,000 12,089 — Interest rate swap contracts 25-36 Months 35 2.32 % 1,050,000 — (8,189 ) Interest rate swap contracts 37-48 Months 46 2.13 % 1,175,000 7,556 (1,018 ) Interest rate swap contracts 49-60 Months 57 1.91 % 1,150,000 11,694 (4,223 ) Interest rate swap contracts 61-72 Months 67 2.07 % 825,000 4,930 (6,008 ) Interest rate swap contracts 73-84 Months 84 1.95 % 50,000 447 — Interest rate swap contracts 85-96 Months 93 1.95 % 1,200,000 13,023 — Interest rate swap contracts 97-108 Months 106 2.33 % 625,000 — (11,538 ) Interest rate swap contracts 109-120 Months 118 2.41 % 1,475,000 — (36,089 ) TBA Agency Securities (2) 0-60 Months n/a n/a 800,000 2,610 — Total or Weighted Average $ 10,575,000 $ 58,677 $ (67,065 ) (1) See Note 5 , “ Fair Value of Financial Instruments ” for additional discussion. (2) Implied cost basis of $840,594 and implied market value of $843,204 . Includes $500,000 notional amount of forward settling TBA Agency Securities. December 31, 2018 Derivative Type Remaining / Underlying Term Weighted Average Remaining Swap / Option Term (Months) Weighted Average Rate Notional Amount Asset Fair Value (1) Liability Fair Value (1) Interest rate swap contracts 0-12 Months 11 1.21 % $ 550,000 $ 6,620 $ — Interest rate swap contracts 13-24 Months 18 1.48 % 675,000 11,136 — Interest rate swap contracts 25-36 Months 25 2.06 % 1,000,000 5,568 — Interest rate swap contracts 49-60 Months 54 1.95 % 1,725,000 32,723 — Interest rate swap contracts 61-72 Months 67 1.89 % 575,000 12,009 — Interest rate swap contracts 73-84 Months 73 2.33 % 350,000 — (1,709 ) Interest rate swap contracts 85-96 Months 95 1.93 % 1,050,000 32,240 — Interest rate swap contracts 97-108 Months 102 2.10 % 375,000 7,381 — Interest rate swap contracts 109-120 Months 114 2.62 % 1,050,000 — (22,796 ) TBA Agency Securities (2) 0-60 Months n/a n/a 900,000 4,236 — Total or Weighted Average $ 8,250,000 $ 111,913 $ (24,505 ) (1) See Note 5 , “ Fair Value of Financial Instruments ” for additional discussion. (2) Implied cost basis of $929,184 and implied market value of $933,420 . We have netting arrangements in place with all derivative counterparties pursuant to standard documentation developed by the International Swap and Derivatives Association. We are also required to post or hold cash collateral based upon the net underlying market value of our open positions with the counterparty. The following tables present information about the potential effects of netting if we were to offset the assets and liabilities of these financial instruments on the accompanying consolidated balance sheets. Currently, we present these financial instruments at their gross amounts and they are included in derivatives, at fair value on the accompanying consolidated balance sheet at March 31, 2019 . March 31, 2019 Gross Amounts Not Offset in the consolidated Balance Sheet Assets Gross and Net Amounts of Assets Presented in the consolidated Balance Sheet Financial Instruments Cash Collateral Net Amount Interest rate swap contracts $ 56,067 $ (67,065 ) $ 51,924 $ 40,926 TBA Agency Securities 2,610 — (867 ) 1,743 Totals $ 58,677 $ (67,065 ) $ 51,057 $ 42,669 March 31, 2019 Gross Amounts Not Offset in the consolidated Balance Sheet Liabilities Gross and Net Amounts of Liabilities Presented in the consolidated Balance Sheet Financial Instruments Cash Collateral Net Amount Interest rate swap contracts $ (67,065 ) $ 67,065 $ — $ — TBA Agency Securities — — — — Totals $ (67,065 ) $ 67,065 $ — $ — The following tables present information about the potential effects of netting if we were to offset the assets and liabilities of these financial instruments on the accompanying consolidated balance sheets. Currently, we present these financial instruments at their gross amounts and they are included in derivatives, at fair value on the accompanying consolidated balance sheet at December 31, 2018 . December 31, 2018 Gross Amounts Not Offset in the consolidated Balance Sheet Assets Gross and Net Amounts of Assets Presented in the consolidated Balance Sheet Financial Instruments Cash Collateral Net Amount Interest rate swap contracts $ 107,677 $ (24,505 ) $ (82,838 ) $ 334 TBA Agency Securities 4,236 — (2,593 ) 1,643 Totals $ 111,913 $ (24,505 ) $ (85,431 ) $ 1,977 December 31, 2018 Gross Amounts Not Offset in the consolidated Balance Sheet Liabilities Gross and Net Amounts of Liabilities Presented in the consolidated Balance Sheet Financial Instruments Cash Collateral Net Amount Interest rate swap contracts $ (24,505 ) $ 24,505 $ — $ — TBA Agency Securities — — — — Totals $ (24,505 ) $ 24,505 $ — $ — The following table represents the location and information regarding our derivatives which are included in Other Income in the accompanying consolidated statements of operations for the three months ended March 31, 2019 and March 31, 2018 . Income (Loss) Recognized For the Three Months Ended March 31, Derivatives Location on consolidated statements of operations 2019 2018 Interest rate swap contracts: Realized gain (loss) Realized loss on derivatives $ (39,544 ) $ 2,655 Interest income Realized loss on derivatives 53,745 22,169 Interest expense Realized loss on derivatives (45,109 ) (27,848 ) Changes in fair value Unrealized gain (loss) on derivatives (109,343 ) 92,329 $ (140,251 ) $ 89,305 TBA Agency Securities: Realized gain (loss) Realized loss on derivatives 8,777 (35,580 ) Changes in fair value Unrealized gain (loss) on derivatives (3,724 ) 4,872 $ 5,053 $ (30,708 ) Totals $ (135,198 ) $ 58,597 |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2019 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Note 11 - Commitments and Contingencies Management Agreements with ACM The Company is managed by ACM, pursuant to management agreements with ARMOUR and JAVELIN (see also Note 16 , “ Related Party Transactions ”). The management agreements entitle ACM to receive management fees payable monthly in arrears. Currently, the monthly ARMOUR management fee is 1/12th of the sum of (a) 1.5% of gross equity raised up to $1.0 billion plus (b) 0.75% of gross equity raised in excess of $1.0 billion . The cost of repurchased stock and any dividend representing a return of capital for tax purposes will reduce the amount of gross equity raised used to calculate the monthly management fee. At March 31, 2019 , the effective ARMOUR management fee was 1.00% based on gross equity raised of $2,986,934 . At March 31, 2018 , the effective ARMOUR management fee was 1.04% based on gross equity raised of $2,620,693 . The ACM monthly management fees are not calculated based on the performance of our assets. Accordingly, the payment of our monthly management fees may not decline in the event of a decline in our earnings and may cause us to incur losses. We are also responsible for any costs and expenses that ACM incurred solely on behalf of ARMOUR or JAVELIN other than the various overhead expenses specified in the terms of the management agreements. ACM is further entitled to receive termination fees from ARMOUR and JAVELIN under certain circumstances. Indemnifications and Litigation We enter into certain contracts that contain a variety of indemnifications, principally with ACM and underwriters, against third party claims for errors and omissions in connection with their services to us. We have not incurred any costs to defend lawsuits or settle claims related to these indemnification agreements. As a result, the estimated fair value of these agreements, as well as the maximum amount attributable to past events, is not material. Accordingly, we have no liabilities recorded for these agreements at March 31, 2019 and December 31, 2018 . Nine putative class action lawsuits have been filed in connection with the tender offer (the “Tender Offer”) and merger (the “Merger”) for JAVELIN. The Tender Offer and Merger are collectively defined herein as the “Transactions.” All nine suits name ARMOUR, the previous members of JAVELIN’s board of directors prior to the Merger (of which eight are current members of ARMOUR’s board of directors) (the “Individual Defendants”) and JMI Acquisition Corporation (“Acquisition” ) as defendants. Certain cases also name ACM and JAVELIN as additional defendants. The lawsuits were brought by purported holders of JAVELIN’s common stock, both individually and on behalf of a putative class of JAVELIN’s stockholders, alleging that the Individual Defendants breached their fiduciary duties owed to the plaintiffs and the putative class of JAVELIN stockholders, including claims that the Individual Defendants failed to properly value JAVELIN; failed to take steps to maximize the value of JAVELIN to its stockholders; ignored or failed to protect against conflicts of interest; failed to disclose material information about the Transactions; took steps to avoid competitive bidding and to give ARMOUR an unfair advantage by failing to adequately solicit other potential acquirors or alternative transactions; and erected unreasonable barriers to other third-party bidders. The suits also allege that ARMOUR, JAVELIN, ACM and Acquisition aided and abetted the alleged breaches of fiduciary duties by the Individual Defendants. The lawsuits seek equitable relief, including, among other relief, to enjoin consummation of the Transactions, or rescind or unwind the Transactions if already consummated, and award costs and disbursements, including reasonable attorneys’ fees and expenses. The sole Florida lawsuit was never served on the defendants, and that case was voluntarily dismissed and closed on January 20, 2017 . On April 25, 2016, the Maryland court issued an order consolidating the eight Maryland cases into one action, captioned In re JAVELIN Mortgage Investment Corp. Shareholder Litigation (Case No. 24-C-16-001542), and designated counsel for one of the Maryland cases as interim lead co-counsel. On May 26, 2016, interim lead counsel filed the Consolidated Amended Class Action Complaint for Breach of Fiduciary Duty asserting consolidated claims of breach of fiduciary duty, aiding and abetting the breaches of fiduciary duty, and waste. On June 27, 2016, defendants filed a Motion to Dismiss the Consolidated Amended Class Action Complaint for failing to state a claim upon which relief can be granted. A hearing was held on the Motion to Dismiss on March 3, 2017, and the Court reserved ruling. To date, the Court has not issued an order on the Motion to Dismiss. |
Stock Based Compensation
Stock Based Compensation | 3 Months Ended |
Mar. 31, 2019 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Stock Based Compensation | Note 12 - Stock Based Compensation We adopted the 2009 Stock Incentive Plan as amended (the “Plan”) to attract, retain and reward directors and other persons who provide services to us in the course of operations. The Plan authorizes the Board to grant awards including common stock, restricted shares of common stock (“RSUs”), stock options, performance shares, performance units, stock appreciation rights and other equity and cash-based awards (collectively, “Awards”), subject to terms as provided in the Plan. At March 31, 2019 , there were 1,875 shares of common stock issuable under the Plan, of which 1,137 remain available for future issuance. Transactions related to awards for the three months ended March 31, 2019 are summarized below: March 31, 2019 Number of Awards Weighted Average Grant Date Fair Value per Award Unvested RSU Awards Outstanding beginning of period 360 $ 24.82 Vested (28 ) $ 20.20 Unvested RSU Awards Outstanding end of period 332 $ 24.82 At March 31, 2019 , there was approximately $8,253 of unvested stock based compensation related to the Awards (based on a stock price of $24.82 per share), that we expect to recognize as an expense over the remaining average service period of 2.4 years . Our policy is to account for forfeitures as they occur. We also pay each of our non-executive Board members quarterly fees of $33 |
Stockholders' Equity
Stockholders' Equity | 3 Months Ended |
Mar. 31, 2019 | |
Equity [Abstract] | |
Stockholders' Equity | Note 13 - Stockholders' Equity The following tables present the changes in Stockholders' Equity for the following interim periods. Stockholders' Equity March 31, 2019 March 31, 2018 Balance, beginning of quarter $ 1,125,313 $ 1,326,051 Series A Preferred dividends ($0.171875 per share) (1,124 ) (1,124 ) Series B Preferred dividends ($0.1640625 per share) (3,135 ) (3,129 ) Common stock dividends ($0.19 per share) (29,814 ) (24,138 ) Issuance of Series B Preferred Stock — 2,632 Issuance of Common stock, net 321,992 — Stock based compensation, net of withholding requirements 644 644 Net income (114,381 ) 44,747 Other comprehensive loss 187,158 (100,717 ) Balance, end of quarter $ 1,486,653 $ 1,244,966 Preferred Stock At March 31, 2019 and December 31, 2018 , we were authorized to issue up to 50,000 shares of preferred stock, par value $0.001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by our Board of Directors (“Board”) or a committee thereof. We have designated 9,610 shares as 8.250% Series A Preferred Stock and 7,650 shares as 7.875% Series B Preferred Stock. At March 31, 2019 , a total of 32,740 shares of our authorized preferred stock remain available for designation as future series. Series A Cumulative Preferred Shares (“Series A Preferred Stock”) At March 31, 2019 and December 31, 2018 , we had 2,181 shares of Series A Preferred Stock issued and outstanding with a par value of $0.001 per share and a liquidation preference of $25.00 per share, or $54,514 in the aggregate. Shares designated as Series A Preferred Stock but unissued totaled 7,429 at March 31, 2019 . At March 31, 2019 and December 31, 2018 , there were no accrued or unpaid dividends on the Series A Preferred Stock. The Series A Preferred Stock is entitled to a dividend at a rate of 8.250% per year based on the $25.00 per share liquidation preference before the common stock is entitled to receive any dividends. Commencing on June 7, 2017, the Series A Preferred Stock is redeemable at $25.00 per share plus accrued and unpaid dividends exclusively at our option (subject to our right under limited circumstances to redeem the Series A Preferred Stock earlier in order to preserve our qualification as a REIT). The Series A Preferred Stock is senior to our common stock and therefore in the event of liquidation, dissolution or winding up, the Series A Preferred Stock will receive a liquidation preference of $25.00 per share plus accumulated and unpaid dividends before distributions are paid to holders of our common stock, with no right or claim to any of our remaining assets thereafter. The Series A Preferred Stock generally does not have voting rights, except if we fail to pay dividends on the Series A Preferred Stock for eighteen months , whether or not consecutive. Under such circumstances, the Series A Preferred Stock will be entitled to vote to elect two additional directors to the Board, until all unpaid dividends have been paid or declared and set aside for payment. The Series A Preferred Stock has no stated maturity, is not subject to any sinking fund or mandatory redemption and will remain outstanding indefinitely unless repurchased or redeemed by us or converted into our common stock in connection with a change of control by the holders of Series A Preferred Stock. Series B Cumulative Preferred Shares (“Series B Preferred Stock”) At March 31, 2019 and December 31, 2018 , we had 6,369 shares of Series B Preferred Stock issued and outstanding with a par value of $0.001 per share and a liquidation preference of $25.00 per share, or $159,232 , in the aggregate at March 31, 2019 and December 31, 2018 . Shares designated as Series B Preferred Stock but unissued totaled 1,281 at March 31, 2019 . At March 31, 2019 and December 31, 2018 , there were no accrued or unpaid dividends on the Series B Preferred Stock. The Series B Preferred Stock is entitled to a dividend at a rate of 7.875% per year based on the $25.00 per share liquidation preference before the common stock is entitled to receive any dividends. The Series B Preferred Stock is redeemable at $25.00 per share plus accrued and unpaid dividends exclusively at our option commencing on February 12, 2018 (subject to our right under limited circumstances to redeem the Series A Preferred Stock earlier in order to preserve our qualification as a REIT). The Series B Preferred Stock is senior to our common stock and rank on parity with the Series A Preferred Stock. In the event of liquidation, dissolution or winding up, the Series B Preferred Stock will receive a liquidation preference of $25.00 per share plus accumulated and unpaid dividends before distributions are paid to holders of our common stock, with no right or claim to any of our remaining assets thereafter. The Series B Preferred Stock generally does not have voting rights, except if we fail to pay dividends on the Series B Preferred Stock for eighteen months , whether or not consecutive. Under such circumstances, the Series B Preferred Stock will be entitled to vote to elect two additional directors to the Board, until all unpaid dividends have been paid or declared and set aside for payment. The Series B Preferred Stock has no stated maturity, is not subject to any sinking fund or mandatory redemption and will remain outstanding indefinitely unless repurchased or redeemed by us or converted into our common stock in connection with a change of control by the holders of Series B Preferred Stock. On August 30, 2017, the Company entered into an ATM Equity Offering Sales Agreement (the “Preferred B ATM Sales Agreement”) relating to an "at-the-market" offering program for our Series B Preferred Stock. In accordance with the terms of the Preferred B ATM Sales Agreement, we may offer and sell over a period of time and from time to time, up to 2,000 shares of our Series B Preferred Stock. We did not sell any shares under the agreement during this three months ended March 31, 2019 . Common Stock At March 31, 2019 and December 31, 2018 , we were authorized to issue up to 125,000 shares of common stock, par value $0.001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by our Board. We had 59,791 shares of common stock issued and outstanding at March 31, 2019 and 43,702 shares of common stock issued and outstanding at December 31, 2018 . On May 26, 2017, the Company entered into an ATM Equity Offering Sales Agreement (the “Common stock ATM Sales Agreement”) relating to the shares of our common stock. In accordance with the terms of the Common stock ATM Sales Agreement, we could offer and sell over a period of time and from time to time, up to 5,000 shares of our common stock par value $0.001 per share. The Common stock ATM Sales Agreement related to a proposed "at-the-market" offering program. On October 2, 2017, the Sales Agreement was amended and on February 16, 2019 the agreement was terminated . For the three months ended March 31, 2019 , we sold 884 shares under this agreement. Proceeds from the sale of the 884 shares were $18,540 , net of issuance costs of approximately $263 . On February 15, 2019, the Company entered into an Equity Sales Agreement (the “Common stock ATM Sales Agreement”) with BUCKLER, JMP Securities LLC and Ladenburg Thalmann & Co. Inc., as sales agents, relating to the shares of our common stock. In accordance with the terms of the Common stock ATM Sales Agreement, we may offer and sell over a period of time and from time to time, up to 7,000 shares of our common stock par value $0.001 per share. The Common stock ATM Sales Agreement relates to an "at-the-market" offering program. Under the agreement, we will pay the agent designated to sell our shares, an aggregate commission of up to 2.0% of the gross sales price per share of our common stock sold through the designated agent, under the agreement. We did not sell any shares or pay any fees under this agreement during the three months ended March 31, 2019 . See Note 16 - Related Party Transactions for discussion of additional transactions with BUCKLER. Common Stock Repurchased At March 31, 2019 and December 31, 2018 , there were 1,874 authorized shares remaining under our common stock repurchase program (the “Repurchase Program”). During the three months ended March 31, 2019 , we did not repurchase any common shares under the Repurchase Program. Under the Repurchase Program, shares may be purchased in the open market, including block trades, through privately negotiated transactions, or pursuant to a trading plan separately adopted in the future. The timing, manner, price and amount of any repurchases will be at our discretion, subject to the requirements of the Securities Exchange Act of 1934, as amended, and related rules. We are not required to repurchase any shares under the Repurchase Program and it may be modified, suspended or terminated at any time for any reason. We do not intend to purchase shares from our Board or other affiliates. Under Maryland law, such repurchased shares are treated as authorized but unissued. Dividends The following table presents our common stock dividend transactions for the three months ended March 31, 2019 . Record Date Payment Date Rate per common share Aggregate amount paid to holders of record January 15, 2019 January 28, 2019 $ 0.19 $ 8,540 February 15, 2019 February 28, 2019 $ 0.19 9,851 March 15, 2019 March 27, 2019 $ 0.19 11,423 Total dividends paid $ 29,814 The following table presents our Series A Preferred Stock dividend transactions for the three months ended March 31, 2019 . Record Date Payment Date Rate per Series A Preferred Share Aggregate amount paid to holders of record January 15, 2019 January 28, 2019 $ 0.17 $ 374.8 February 15, 2019 February 28, 2019 $ 0.17 374.8 March 15, 2019 March 27, 2019 $ 0.17 374.8 Total dividends paid $ 1,124 The following table presents our Series B Preferred Stock dividend transactions for the three months ended March 31, 2019 . Record Date Payment Date Rate per Series B Preferred Share Aggregate amount paid to holders of record January 15, 2019 January 28, 2019 $ 0.16 $ 1,045 February 15, 2019 February 28, 2019 $ 0.16 1,045 March 15, 2019 March 27, 2019 $ 0.16 1,045 Total dividends paid $ 3,135 Equity Capital Raising Activities The following table presents our equity transactions for the three months ended March 31, 2019 . Transaction Type Completion Date Number of Shares Per Share price (1) Net Proceeds Common Stock ATM Sales Agreement January 4, 2019-January 11, 2019 884 $ 20.98 $ 18,540 January Public Offering January 17, 2019 6,900 $ 20.00 $ 137,996 February Public Offering February 22, 2019-February 27, 2019 8,280 $ 19.98 $ 165,456 |
Net Income (Loss) per Common Sh
Net Income (Loss) per Common Share | 3 Months Ended |
Mar. 31, 2019 | |
Earnings Per Share [Abstract] | |
Net Income (Loss) per Common Share | Note 14 - Net Income (Loss) per Common Share The following table presents a reconciliation of net income (loss) and the shares used in calculating weighted average basic and diluted earnings per common share for the three months ended March 31, 2019 and March 31, 2018 . For the Three Months Ended March 31, 2019 2018 Net Income (Loss) $ (114,381 ) $ 44,747 Less: Preferred dividends (4,259 ) (4,253 ) Net Income (Loss) available (related) to common stockholders $ (118,640 ) $ 40,494 Weighted average common shares outstanding – basic 53,630 41,887 Add: Effect of dilutive non-vested awards, assumed vested — 444 Weighted average common shares outstanding – diluted 53,630 42,331 |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2019 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Note 15 - Income Taxes The following table reconciles our GAAP net income (loss) to estimated REIT taxable income for the three months ended March 31, 2019 and March 31, 2018 . For the Three Months Ended March 31, 2019 2018 GAAP net income (loss) (114,381 ) 44,747 Book to tax differences: TRS income (231 ) (168 ) Premium amortization expense — (435 ) Credit Risk and Non-Agency Securities (1,272 ) (1,196 ) Interest-Only Securities 548 (407 ) U.S. Treasury Securities 693 (2,576 ) Changes in interest rate contracts 143,835 (64,276 ) Other than temporary loss on Agency Securities — 12,090 Losses on Security Sales 2,910 32,603 Amortization of deferred hedging costs (13,647 ) (14,584 ) Other 4 2 Estimated REIT taxable income $ 18,459 $ 5,800 Interest rate contracts are treated as hedging transactions for U. S. federal income tax purposes. Unrealized gains and losses on open interest rate contracts are not included in the determination of REIT taxable income. Realized gains and losses on interest rate contracts terminated before their maturity are deferred and amortized over the remainder of the original term of the contract for REIT taxable income. Net capital losses realized Amount Available to offset capital gains though 2014 (341,850 ) 2019 2015 (5,182 ) 2020 2016 (31,204 ) 2021 2017 (7,375 ) 2022 2018 (216,634 ) 2023 The Company's subsidiary, ARMOUR TRS, Inc. has made an election as a taxable REIT subsidiary (“TRS”). As such, the Company's TRS is taxable as a domestic C corporation and subject to federal, state and local income taxes based upon its taxable income. The Company's TRS is subject to federal, state and local taxes. During the three months ended March 31, 2019 , we recorded $25 of income tax expense attributable to our TRS. The aggregate tax basis of our assets and liabilities was greater than our total Stockholders’ Equity at March 31, 2019 by approximately $8,127 , or approximately $0.14 per common share (based on the 59,791 common shares then outstanding). We are required and intend to timely distribute substantially all of our REIT taxable income in order to maintain our REIT status under the Code. Total dividend payments to stockholders were $34,073 for the three months ended March 31, 2019 and $28,391 for the three months ended March 31, 2018 , respectively. Our estimated REIT taxable income available for distribution as dividends was $18,459 for the three months ended March 31, 2019 and $5,800 for the three months ended March 31, 2018 , respectively. Our REIT taxable income and dividend requirements to maintain our REIT status are determined on an annual basis. Dividends paid in excess of current tax earnings and profits for the year will generally not be taxable to common stockholders. |
Related Party Transactions
Related Party Transactions | 3 Months Ended |
Mar. 31, 2019 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Note 16 - Related Party Transactions ACM The Company is managed by ACM, pursuant to management agreements with ARMOUR and JAVELIN. All of our executive officers are also employees of ACM. ACM manages our day-to-day operations, subject to the direction and oversight of the Board. The ARMOUR management agreement runs through June 18, 2024 and is thereafter automatically renewed for an additional five -year terms unless terminated under certain circumstances. The JAVELIN Management Agreement renewed on October 5, 2017, for a one -year period, with the base management fee thereunder reduced to one dollar for the entirety of the renewal term. It will be automatically renewed annually for successive one- year terms unless terminated under certain circumstances. Either party must provide 180 days prior written notice of any such termination. Under the terms of the management agreements, ACM is responsible for costs incident to the performance of its duties, such as compensation of its employees and various overhead expenses. ACM is responsible for the following primary roles: • Advising us with respect to, arranging for and managing the acquisition, financing, management and disposition of, elements of our investment portfolio; • Evaluating the duration risk and prepayment risk within the investment portfolio and arranging borrowing and hedging strategies; • Coordinating capital raising activities; • Advising us on the formulation and implementation of operating strategies and policies, arranging for the acquisition of assets, monitoring the performance of those assets and providing administrative and managerial services in connection with our day-to-day operations; and • Providing executive and administrative personnel, office space and other appropriate services required in rendering management services to us. In accordance with management agreements, we incurred $7,258 in management fees for the three months ended March 31, 2019 . For the three months ended March 31, 2018 , we incurred $6,801 in management fees. We are required to take actions as may be reasonably required to permit and enable ACM to carry out its duties and obligations. We are also responsible for any costs and expenses that ACM incurred solely on our behalf other than the various overhead expenses specified in the terms of the management agreements. For the three months ended March 31, 2019 , we reimbursed ACM $27 for other expenses incurred on our behalf. For the three months ended March 31, 2018 , we reimbursed ACM $47 for other expenses incurred on our behalf. In 2017, we elected to make restricted stock unit awards to our executive officers and other ACM employees through ACM that vest over 5 years . In November 2017, we elected to make restricted stock unit awards to the Board. We recognized stock based compensation expense of $97 and $108 for the three months ended March 31, 2019 and March 31, 2018 , respectively. BUCKLER At March 31, 2019 we have contributed $485 for a 10% ownership interest in BUCKLER. The investment is included in prepaid and other assets in our consolidated balance sheet and is accounted for using the equity method as BUCKLER maintains specific ownership accounts. The value of the investment was $117 at March 31, 2019 and $113 at December 31, 2018 , reflecting our total investment less our share of BUCKLER’s startup costs and operating losses, in accordance with the terms of the operating agreement of BUCKLER that our independent directors negotiated. The primary purpose of our investment in BUCKLER is to facilitate our access to repurchase financing, on potentially attractive terms (considering rate, term, size, haircut, relationship and funding commitment) compared to other suitable repurchase financing counterparties. Our operating agreement with BUCKLER contains certain provisions to benefit and protect the Company, including (1) sharing in any (a) defined profits realized by BUCKLER from the anticipated financing spreads resulting from repurchase financing facilitated by BUCKLER, and (b) distributions from BUCKLER to its members of net cash receipts, and (2) the realization of anticipated savings from reduced clearing, brokerage, trading and administrative fees. In addition, the independent directors of the Company, must approve in their sole discretion, any third-party business engaged by BUCKLER and may cause BUCKLER to wind up and dissolve and promptly return certain subordinated loans we provide to BUCKLER as regulatory capital (as described more fully below) if the independent directors reasonably determine that BUCKLER’s ability to provide attractive securities transactions for the Company is materially adversely affected. The Company previously entered into three subordinated loan agreements with BUCKLER, totaling $105.0 million . On March 18, 2019, these three subordinated loan agreements were consolidated into one loan of $105.0 million , maturing on April 1, 2022. BUCKLER may at its option after obtaining the approval of the Financial Industry Regulatory Authority repay all or a portion of the principal amount of the loan. The loan has a stated interest rate of zero , plus additional interest payable to us in an amount equal to the amount of interest earned by BUCKLER on the investment of the loan proceeds, generally in government securities funds. For the three months ended March 31, 2019 and March 31, 2018 , the Company earned $539 and $624 , respectively, of interest. The Company had outstanding borrowings under repurchase agreements with BUCKLER totaling $5,973,018 and $3,503,750 at March 31, 2019 and December 31, 2018 , respectively. See also Note 9 , “ Repurchase Agreements ” for transactions with BUCKLER. During the quarter ended March 31, 2019 , we incurred approximately $25,849 in interest payments to BUCKLER on the repurchase agreements we entered into with BUCKLER. We sold $199,445 of U.S. Treasury Securities to BUCKLER during the quarter ended March 31, 2019 and had $6,233,414 of collateral posted with BUCKLER securitizing the $5,973,018 of repurchase agreements at March 31, 2019 . See Note 13 - Stockholders' Equity |
Interest Rate Risk
Interest Rate Risk | 3 Months Ended |
Mar. 31, 2019 | |
Interest Rate Risk [Abstract] | |
Interest Rate Risk | Note 17 - Interest Rate Risk |
Subsequent Events
Subsequent Events | 3 Months Ended |
Mar. 31, 2019 | |
Subsequent Events [Abstract] | |
Subsequent Events | Note 18 - Subsequent Events A cash dividend of $0.17 per outstanding share of Series A Preferred Stock, or $375 in the aggregate, and $0.16 per outstanding share of Series B Preferred Stock, or $1,045 in the aggregate, is payable on April 29, 2019 to holders of record on April 15, 2019. We have also declared cash dividends of $0.17 and $0.16 per outstanding share of Series A Preferred Stock and Series B Preferred Stock, respectively, payable May 28, 2019 to holders of record on May 15, 2019 and payable June 27, 2019 to holders of record on June 15, 2019. A cash dividend of $0.19 per outstanding common share, or $11,424 in the aggregate, is payable on April 29, 2019 to holders of record on April 15, 2019. We have also declared a cash dividend of $0.19 |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2019 | |
Accounting Policies [Abstract] | |
Basis of Presentation | The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X promulgated by the SEC. Accordingly, the condensed financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. |
Cash | Cash |
Cash Collateral Posted To/By Counterparties | Cash Collateral Posted To/By Counterparties Cash collateral posted to/by counterparties represents cash posted by us to counterparties or posted by counterparties to us as collateral. Cash collateral posted to/by counterparties may include collateral for interest rate swap contracts (including swaptions and basis swap contracts), |
Investments in Securities, at Fair Value | Investments in Securities, at Fair Value We generally intend to hold most of our securities for extended periods of time. We may, from time to time, sell any of our securities as part of the overall management of our securities portfolio. Management determines the appropriate classifications of the securities at the time they are acquired and evaluates the appropriateness of such classifications at each balance sheet date. Purchases and sales of our securities are recorded on the trade date. Agency Securities - At March 31, 2019 and December 31, 2018 , all of our Agency Securities were classified as available for sale securities. Agency Securities classified as available for sale are reported at their estimated fair values with unrealized gains and losses excluded from earnings and reported as part of the consolidated statements of comprehensive income (loss). Credit Risk and Non-Agency Securities - At March 31, 2019 and December 31, 2018 , all of our Credit Risk and Non-Agency Securities were classified as trading securities. Credit Risk and Non-Agency Securities classified as trading are reported at their estimated fair values with unrealized gains and losses included in Other Income (Loss) as a component of the consolidated statements of operations. Interest-Only Securities - At March 31, 2019 and December 31, 2018 , all of our Interest-Only Securities were classified as trading securities. Interest-Only Securities represent the right to receive a specified proportion of the contractual interest flows of specific Agency MBS. Interest-Only Securities classified as trading are reported at their estimated fair values with unrealized gains and losses included in Other Income (Loss) as a component of the consolidated statements of operations. U.S. Treasury Securities - At December 31, 2018 , all of our U.S. Treasury Securities were classified as trading securities and are reported at their estimated fair values with unrealized gains and losses included in Other Income (Loss) as a component of the consolidated statements of operations. We did not have any U.S. Treasury Securities at March 31, 2019 . • |
Receivables and Payables for Unsettled Sales and Purchases | Receivables and Payables for Unsettled Sales and Purchases |
Accrued Interest Receivable and Payable | Accrued Interest Receivable and Payable |
Repurchase Agreements | Repurchase Agreements We finance the acquisition of the majority of our MBS through the use of repurchase agreements. Our repurchase agreements are secured by our MBS and bear interest rates that have historically moved in close relationship to the Federal Funds Rate and the London Interbank Offered Rate (“LIBOR”). Under these repurchase agreements, we sell MBS to a lender and agree to repurchase the same MBS in the future for a price that is higher than the original sales price. The difference between the sales price that we receive and the repurchase price that we pay represents interest paid to the lender. A repurchase agreement operates as a financing arrangement under which we pledge our MBS as collateral to secure a loan which is equal in value to a specified percentage of the estimated fair value of the pledged collateral. We retain beneficial ownership of the pledged collateral. At the maturity of a repurchase agreement, we are required to repay the loan and concurrently receive back our pledged collateral from the lender or, with the consent of the lender, we may renew such agreement at the then prevailing interest rate. The repurchase agreements may require us to pledge additional assets to the lender in the event the estimated fair value of the existing pledged collateral declines. In addition to the repurchase agreement financing discussed above, at certain times we have entered into reverse repurchase agreements with certain of our repurchase agreement counterparties. Under a typical reverse repurchase agreement, we purchase U.S. Treasury Securities from a borrower in exchange for cash and agree to sell the same securities in the future in exchange for a price that is higher than the original purchase price. The difference between the purchase price originally paid and the sale price represents interest received from the borrower. Reverse repurchase agreement receivables and repurchase agreement liabilities are presented net when they meet certain criteria, including being with the same counterparty, being governed by the same master repurchase agreement (“MRA”), settlement through the same brokerage or clearing account and maturing on the same day. We did not have any reverse repurchase agreements outstanding at March 31, 2019 and December 31, 2018 |
Derivatives, at Fair Value | Derivatives, at Fair Value We recognize all derivatives as either assets or liabilities at fair value on our consolidated balance sheets. All changes in the fair values of our derivatives are reflected in our consolidated statements of operations. We designate derivatives as hedges for tax purposes and any unrealized derivative gains or losses would not affect our distributable net taxable income. These transactions include interest rate swap contracts, interest rate swaptions and basis swap contracts. We also may utilize forward contracts for the purchase or sale of TBA Agency Securities. We account for TBA Agency Securities as derivative instruments if it is reasonably possible that we will not take or make physical delivery of the Agency Security upon settlement of the contract. We account for TBA dollar roll transactions as a series of derivative transactions. We may also purchase and sell TBA Agency Securities as a means of investing in and financing Agency Securities (thereby increasing our “at risk” leverage) or as a means of disposing of or reducing our exposure to Agency Securities (thereby reducing our “at risk” leverage). Pursuant to TBA Agency Securities, we agree to purchase or sell, for future delivery, Agency Securities with certain principal and interest terms and certain types of collateral, but the particular Agency Securities to be delivered are not identified until shortly before the TBA settlement date. We may also choose, prior to settlement, to move the settlement of these securities out to a later date by entering into an offsetting short or long position (referred to as a “pair off”), net settling the paired off positions for cash, and simultaneously purchasing or selling a similar TBA Agency Security for a later settlement date. This transaction is commonly referred to as a “dollar roll.” When it is reasonably possible that we will pair off a TBA Agency Security, we account for that contract as a derivative. |
Revenue Recognition | Credit Risk and Non-Agency Securities and Interest-Only Securities - Interest income on Credit Risk and Non-Agency Securities and Interest-Only Securities is recognized using the effective yield method over the life of the securities based on the future cash flows expected to be received. Future cash flow projections and related effective yields are determined for each security and updated quarterly. Other than temporary impairments, which establish a new cost basis in the security for purposes of calculating effective yields, are recognized when the fair value of a security is less than its cost basis and there has been an adverse change in the future cash flows expected to be received. Other changes in future cash flows expected to be received are recognized prospectively over the remaining life of the security. U.S. Treasury Securities - Interest income on U.S. Treasury Securities is recognized based on their unpaid principal amounts and their contractual terms. Recognition of interest income commences on the settlement date of the purchase transaction and continues through the settlement date of the sale transaction. Agency Securities - |
Impairment of Assets | Impairment of Assets: We evaluate Agency Securities for other than temporary impairment at least on a quarterly basis and more frequently when economic or market concerns warrant such evaluation. We consider an impairment to be other than temporary if we (1) have the intent to sell the Agency Securities, (2) believe it is more likely than not that we will be required to sell the securities before recovery (for example, because of liquidity requirements or contractual obligations) or (3) a credit loss exists. Impairment losses recognized establish a new cost basis for the related Agency Securities. |
Comprehensive Income (Loss) | Comprehensive Income (Loss) |
Recent Accounting Pronouncements | We consider the applicability and impact of all Accounting Standards Updates issued by the Financial Accounting Standards Board. Those not listed below were deemed to be either not applicable, are not expected to have a significant impact on our consolidated financial statements when adopted, or did not have a significant impact on our consolidated financial statements upon adoption. In the current year we have adopted Accounting Standard ASU 2018–07, Improvements to Nonemployee Share–Based Payment Accounting (Topic 718) . The standard is effective for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. The standard largely aligns the accounting for share–based payment awards issued to employees and nonemployees. Equity–classified share–based payment awards issued to nonemployees are measured on the grant date, instead of being remeasured through the performance completion date (generally the vesting date). The standard was applied on a modified retrospective basis through a cumulative–effect adjustment to retained earnings as of the beginning of the fiscal year when adopted. The cumulative effective adjustment was recorded in our consolidated statement of stockholders' equity as of January 1, 2019, and did not have a material to the Company's financial condition or the results of operations. In 2018, we adopted Accounting Standards ASU 2016-18 , Statement of Cash Flows (Topic 230) - Restricted Cash which resulted in the presentation of cash collateral posted to counterparties with cash on the consolidated statements of cash flows when reconciling the total beginning and ending amounts. Prior period results have been revised to conform to the current presentation. In July 2016, the Financial Accounting Standards Board issued ASU 2016-13, Financial Instruments–Credit Losses (Topic 326) |
Fair Value of Financial Instr_2
Fair Value of Financial Instruments (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Fair Value Disclosures [Abstract] | |
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis | The following tables provide a summary of our assets and liabilities that are measured at fair value on a recurring basis at March 31, 2019 and December 31, 2018 . Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Balance, March 31, 2019 Assets at Fair Value: Agency Securities $ — $ 12,707,442 $ — $ 12,707,442 Credit Risk and Non-Agency Securities $ — $ 815,008 $ — $ 815,008 Interest-Only Securities $ — $ 19,319 $ — $ 19,319 Derivatives $ — $ 58,677 $ — $ 58,677 Liabilities at Fair Value: Derivatives $ — $ 67,065 $ — $ 67,065 There were no transfers of assets or liabilities between the levels of the fair value hierarchy during the three months ended March 31, 2019 . Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Balance at December 31, 2018 Assets at Fair Value: Agency Securities $ — $ 7,051,954 $ — $ 7,051,954 Credit Risk and Non-Agency Securities $ — $ 819,915 $ — $ 819,915 Interest-Only Securities $ — $ 20,623 $ — $ 20,623 U.S. Treasury Securities $ 98,646 $ — $ — $ 98,646 Derivatives $ — $ 111,913 $ — $ 111,913 Liabilities at Fair Value: Derivatives $ — $ 24,505 $ — $ 24,505 |
Carrying Values and Fair Values of Financial Assets and Liabilities | The following tables provide a summary of the carrying values and fair values of our financial assets and liabilities not carried at fair value but for which fair value is required to be disclosed at March 31, 2019 and December 31, 2018 . March 31, 2019 Fair Value Measurements using: Carrying Value Fair Value Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Financial Assets: Cash $ 167,372 $ 167,372 $ 167,372 $ — $ — Cash collateral posted to counterparties $ 58,996 $ 58,996 $ — $ 58,996 $ — Accrued interest receivable $ 39,609 $ 39,609 $ — $ 39,609 $ — Subordinated loan to BUCKLER $ 105,000 $ 105,000 $ — $ 105,000 $ — Financial Liabilities: Repurchase agreements $ 12,143,274 $ 12,143,274 $ — $ 12,143,274 $ — Cash collateral posted by counterparties $ 49,826 $ 49,826 $ — $ 49,826 $ — Payable for unsettled purchases $ 198,172 $ 198,172 $ — $ 198,172 $ — Accrued interest payable- repurchase agreements $ 21,790 $ 21,790 $ — $ 21,790 $ — December 31, 2018 Fair Value Measurements using: Carrying Value Fair Value Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Financial Assets: Cash $ 221,668 $ 221,668 $ 221,668 $ — $ — Cash collateral posted to counterparties $ 10,531 $ 10,531 $ — $ 10,531 $ — Accrued interest receivable $ 22,505 $ 22,505 $ — $ 22,505 $ — Subordinated loans to BUCKLER $ 105,000 105,000 $ — $ 105,000 $ — Financial Liabilities: Repurchase agreements $ 7,037,651 $ 7,037,651 $ — $ 7,037,651 $ — Cash collateral posted by counterparties $ 97,213 $ 97,213 $ — $ 97,213 $ — Payable for unsettled purchases $ 166,052 $ 166,052 $ — $ 166,052 $ — Accrued interest payable- repurchase agreements $ 10,268 $ 10,268 $ — $ 10,268 $ — |
Agency Securities, Available fo
Agency Securities, Available for Sale (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Investments, Debt and Equity Securities [Abstract] | |
Available-for-sale Securities in an Unrealized Gain or Loss Position | At March 31, 2019 , we had the following Agency Securities in an unrealized gain or loss position as presented below. The components of the carrying value of our Agency Securities at March 31, 2019 are also presented below. Our Agency Securities had a weighted average coupon of 3.91% at March 31, 2019 . March 31, 2019 Amortized Cost Gross Unrealized Loss Gross Unrealized Gain Fair Value Percent of Total Fannie Mae ARMs & Hybrids $ 18,736 $ (228 ) $ 73 $ 18,581 0.15 % Multi-Family MBS 2,761,386 (2,350 ) 62,774 2,821,810 22.21 10 Year Fixed 12,684 (211 ) 32 12,505 0.10 15 Year Fixed 965,248 (3 ) 13,875 979,120 7.71 20 Year Fixed 3,401 (99 ) — 3,302 0.03 30 Year Fixed 5,645,556 (12,673 ) 57,061 5,689,944 44.76 Total Fannie Mae $ 9,407,011 $ (15,564 ) $ 133,815 $ 9,525,262 74.96 % Freddie Mac 10 Year Fixed 8,928 (49 ) 62 8,941 0.07 15 Year Fixed 238,230 (86 ) 2,440 240,584 1.89 30 Year Fixed 2,051,441 (3,652 ) 23,410 2,071,199 16.30 Total Freddie Mac $ 2,298,599 $ (3,787 ) $ 25,912 $ 2,320,724 18.26 % Ginnie Mae ARMs & Hybrids 29,270 (455 ) 2 28,817 0.23 10 Year Fixed 223 — — 223 0.00 30 Year Fixed 829,051 — 3,365 832,416 6.55 Total Ginnie Mae $ 858,544 $ (455 ) $ 3,367 $ 861,456 6.78 % Total Agency Securities $ 12,564,154 $ (19,806 ) $ 163,094 $ 12,707,442 100.00 % At December 31, 2018 , we had the following securities in an unrealized gain or loss position as presented below. The components of the carrying value of our Agency Securities at December 31, 2018 are also presented below. Our Agency Securities had a weighted average coupon of 3.94% at December 31, 2018 . December 31, 2018 Amortized Cost Gross Unrealized Loss Gross Unrealized Gain Fair Value Percent of Total Fannie Mae ARMs & Hybrids $ 19,929 $ (249 ) $ 73 $ 19,753 0.28 % Multi-Family MBS 1,710,346 (17,128 ) 9,345 1,702,563 24.14 10 Year Fixed 115,654 (292 ) 129 115,491 1.64 15 Year Fixed 684,678 (388 ) 3,864 688,154 9.76 20 Year Fixed 3,734 (156 ) — 3,578 0.05 30 Year Fixed 2,803,125 (28,545 ) 3,349 2,777,929 39.39 Total Fannie Mae $ 5,337,466 $ (46,758 ) $ 16,760 $ 5,307,468 75.26 % Freddie Mac 10 Year Fixed 9,515 (68 ) — 9,447 0.13 15 Year Fixed 70,164 (272 ) 157 70,049 0.99 25 Year Fixed 37,939 (1,668 ) — 36,271 0.51 30 Year Fixed 1,299,695 (11,807 ) 500 1,288,388 18.28 Total Freddie Mac 1,417,313 (13,815 ) 657 1,404,155 19.91 % Ginnie Mae ARMs & Hybrids 30,708 (466 ) 1 30,243 0.43 10 Year Fixed 231 (1 ) — 230 0.00 30 Year Fixed 310,106 (255 ) 7 309,858 4.40 Total Ginnie Mae 341,045 (722 ) 8 340,331 4.83 % Total Agency Securities 7,095,824 (61,295 ) 17,425 7,051,954 100.00 % December 31, 2018 . Unrealized Loss Position For: Less than 12 Months 12 Months or More Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses December 31, 2018 $ 98,646 $ (57 ) $ — $ — $ 98,646 $ (57 ) |
Summary of Weighted Average Lives of Agency Securities | The following table summarizes the weighted average lives of our Agency Securities at March 31, 2019 and December 31, 2018 . March 31, 2019 December 31, 2018 Weighted Average Life of all Agency Securities Fair Value Amortized Cost Fair Value Amortized Less than one year $ 24 $ 24 $ 75 $ 77 Greater than or equal to one year and less than three years 26,533 26,819 25,841 26,264 Greater than or equal to three years and less than five years 4,403,226 4,368,346 1,334,663 1,331,577 Greater than or equal to five years 8,277,659 8,168,965 5,691,375 5,737,906 Total Agency Securities $ 12,707,442 $ 12,564,154 $ 7,051,954 $ 7,095,824 |
Unrealized Losses and Estimated Fair Value of Agency Securities | The following table presents the unrealized losses and estimated fair value of our Agency Securities by length of time that such securities have been in a continuous unrealized loss position at March 31, 2019 and December 31, 2018 . Unrealized Loss Position For: Less than 12 Months 12 Months or More Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses March 31, 2019 $ 500,445 $ (1,511 ) $ 1,251,564 $ (18,295 ) $ 1,752,009 $ (19,806 ) December 31, 2018 $ 2,651,518 $ (18,135 ) $ 1,197,533 $ (43,160 ) $ 3,849,051 $ (61,295 ) |
Credit Risk and Non-Agency Se_2
Credit Risk and Non-Agency Securities (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Debt and Equity Securities, FV-NI [Line Items] | |
Summary of Weighted Average Lives of Credit Risk and Non-Agency Securities | The following table summarizes the weighted average lives of our Agency Securities at March 31, 2019 and December 31, 2018 . March 31, 2019 December 31, 2018 Weighted Average Life of all Agency Securities Fair Value Amortized Cost Fair Value Amortized Less than one year $ 24 $ 24 $ 75 $ 77 Greater than or equal to one year and less than three years 26,533 26,819 25,841 26,264 Greater than or equal to three years and less than five years 4,403,226 4,368,346 1,334,663 1,331,577 Greater than or equal to five years 8,277,659 8,168,965 5,691,375 5,737,906 Total Agency Securities $ 12,707,442 $ 12,564,154 $ 7,051,954 $ 7,095,824 |
Trading Securities, Continuous Unrealized Loss Position, Fair Value | T he following table presents the unrealized losses and estimated fair value of our Credit Risk and Non-Agency Securities by length of time that such securities have been in a continuous unrealized loss position at March 31, 2019 and December 31, 2018 . Unrealized Loss Position For: Less than 12 Months 12 Months or More Total As of Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses March 31, 2019 $ — $ — $ — $ — $ — $ — December 31, 2018 $ 1,860 $ (13 ) $ — $ — $ 1,860 $ (13 ) |
Credit Risk and Non-Agency Securities | |
Debt and Equity Securities, FV-NI [Line Items] | |
Components of Carrying Value of Credit Risk and Non-Agency Securities | The components of the carrying value of our Credit Risk and Non-Agency Securities at March 31, 2019 are presented in the table below. Credit Risk and Non-Agency Securities March 31, 2019 Fair Value Amortized Cost Principal Amount Weighted Average Coupon Credit Risk Transfer $ 727,216 $ 650,452 $ 657,069 6.90% Legacy Prime Fixed 13,060 12,258 15,583 6.02% Legacy ALT-A Fixed 45,542 41,389 57,380 5.83% Legacy Prime Hybrid 8,358 7,716 9,122 3.86% Legacy ALT-A Hybrid 3,643 3,104 3,854 4.16% New Issue Prime Fixed 17,189 16,440 17,357 3.69% Total Credit Risk and Non-Agency Securities $ 815,008 $ 731,359 $ 760,365 6.71% The components of the carrying value of our Credit Risk and Non-Agency Securities at December 31, 2018 are presented in the table below. Credit Risk and Non-Agency Securities December 31, 2018 Fair Value Amortized Cost Principal Amount Weighted Average Coupon Credit Risk Transfer $ 729,983 $ 653,681 $ 661,181 6.92% Legacy Prime Fixed 13,394 12,698 16,051 6.02% Legacy ALT-A Fixed 46,853 42,534 58,730 5.84% Legacy Prime Hybrid 8,623 7,987 9,479 3.62% Legacy ALT-A Hybrid 3,724 3,164 3,967 4.06% New Issue Prime Fixed 17,338 16,767 17,714 3.69% Total Credit Risk and Non-Agency Securities $ 819,915 $ 736,831 $ 767,122 6.73% |
Summary of Weighted Average Lives of Credit Risk and Non-Agency Securities | The following table summarizes the weighted average lives of our Credit Risk and Non-Agency Securities at March 31, 2019 and December 31, 2018 . March 31, 2019 December 31, 2018 Weighted Average Life of all Credit Risk and Non-Agency Securities Fair Value Amortized Cost Fair Value Amortized Cost Greater than or equal to three years and less than five years $ 580,023 $ 519,669 $ 188,063 $ 169,692 Greater than or equal to five years 234,985 211,690 631,852 567,139 Total Credit Risk and Non-Agency Securities $ 815,008 $ 731,359 $ 819,915 $ 736,831 |
U.S. Treasury Securities (Table
U.S. Treasury Securities (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Investments, Debt and Equity Securities [Abstract] | |
Unrealized Gain (Loss) on Investments | At December 31, 2018 , we had the following U.S. Treasury Securities in an unrealized gain or loss position as presented below. The components of the carrying value of our U.S. Treasury Securities at December 31, 2018 are also presented below. U.S. Treasury Securities Amortized Cost Gross Unrealized Loss Gross Unrealized Gain Fair Value December 31, 2018 98,703 (57 ) — 98,646 |
Available-for-sale Securities in an Unrealized Gain or Loss Position | At March 31, 2019 , we had the following Agency Securities in an unrealized gain or loss position as presented below. The components of the carrying value of our Agency Securities at March 31, 2019 are also presented below. Our Agency Securities had a weighted average coupon of 3.91% at March 31, 2019 . March 31, 2019 Amortized Cost Gross Unrealized Loss Gross Unrealized Gain Fair Value Percent of Total Fannie Mae ARMs & Hybrids $ 18,736 $ (228 ) $ 73 $ 18,581 0.15 % Multi-Family MBS 2,761,386 (2,350 ) 62,774 2,821,810 22.21 10 Year Fixed 12,684 (211 ) 32 12,505 0.10 15 Year Fixed 965,248 (3 ) 13,875 979,120 7.71 20 Year Fixed 3,401 (99 ) — 3,302 0.03 30 Year Fixed 5,645,556 (12,673 ) 57,061 5,689,944 44.76 Total Fannie Mae $ 9,407,011 $ (15,564 ) $ 133,815 $ 9,525,262 74.96 % Freddie Mac 10 Year Fixed 8,928 (49 ) 62 8,941 0.07 15 Year Fixed 238,230 (86 ) 2,440 240,584 1.89 30 Year Fixed 2,051,441 (3,652 ) 23,410 2,071,199 16.30 Total Freddie Mac $ 2,298,599 $ (3,787 ) $ 25,912 $ 2,320,724 18.26 % Ginnie Mae ARMs & Hybrids 29,270 (455 ) 2 28,817 0.23 10 Year Fixed 223 — — 223 0.00 30 Year Fixed 829,051 — 3,365 832,416 6.55 Total Ginnie Mae $ 858,544 $ (455 ) $ 3,367 $ 861,456 6.78 % Total Agency Securities $ 12,564,154 $ (19,806 ) $ 163,094 $ 12,707,442 100.00 % At December 31, 2018 , we had the following securities in an unrealized gain or loss position as presented below. The components of the carrying value of our Agency Securities at December 31, 2018 are also presented below. Our Agency Securities had a weighted average coupon of 3.94% at December 31, 2018 . December 31, 2018 Amortized Cost Gross Unrealized Loss Gross Unrealized Gain Fair Value Percent of Total Fannie Mae ARMs & Hybrids $ 19,929 $ (249 ) $ 73 $ 19,753 0.28 % Multi-Family MBS 1,710,346 (17,128 ) 9,345 1,702,563 24.14 10 Year Fixed 115,654 (292 ) 129 115,491 1.64 15 Year Fixed 684,678 (388 ) 3,864 688,154 9.76 20 Year Fixed 3,734 (156 ) — 3,578 0.05 30 Year Fixed 2,803,125 (28,545 ) 3,349 2,777,929 39.39 Total Fannie Mae $ 5,337,466 $ (46,758 ) $ 16,760 $ 5,307,468 75.26 % Freddie Mac 10 Year Fixed 9,515 (68 ) — 9,447 0.13 15 Year Fixed 70,164 (272 ) 157 70,049 0.99 25 Year Fixed 37,939 (1,668 ) — 36,271 0.51 30 Year Fixed 1,299,695 (11,807 ) 500 1,288,388 18.28 Total Freddie Mac 1,417,313 (13,815 ) 657 1,404,155 19.91 % Ginnie Mae ARMs & Hybrids 30,708 (466 ) 1 30,243 0.43 10 Year Fixed 231 (1 ) — 230 0.00 30 Year Fixed 310,106 (255 ) 7 309,858 4.40 Total Ginnie Mae 341,045 (722 ) 8 340,331 4.83 % Total Agency Securities 7,095,824 (61,295 ) 17,425 7,051,954 100.00 % December 31, 2018 . Unrealized Loss Position For: Less than 12 Months 12 Months or More Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses December 31, 2018 $ 98,646 $ (57 ) $ — $ — $ 98,646 $ (57 ) |
Repurchase Agreements (Tables)
Repurchase Agreements (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Disclosure of Repurchase Agreements [Abstract] | |
Schedule of Repurchase Agreements | The following tables represent the contractual repricing regarding our repurchase agreements to finance our MBS at March 31, 2019 and December 31, 2018 . No amounts below are subject to offsetting. March 31, 2019 Repurchase Agreements Weighted Average Contractual Rate Weighted Average Maturity in days Haircut for Repurchase Agreements (1) Agency Securities $ 11,728,144 2.93 % 12 4.28 % Credit Risk and Non-Agency Securities 415,130 3.22 % 14 16.22 % Total or Weighted Average $ 12,143,274 2.94 % 12 4.73 % (1) The Haircut represents the weighted average margin requirement, or the percentage amount by which the collateral value must exceed the loan amount. December 31, 2018 Repurchase Agreements Weighted Average Contractual Rate Weighted Average Maturity in days Haircut for Repurchase Agreements (1) Agency Securities $ 6,456,823 2.95 % 14 4.22 % Credit Risk and Non-Agency Securities 580,828 3.23 % 14 17.79 % Total or Weighted Average $ 7,037,651 2.97 % 14 5.48 % March 31, 2019 and December 31, 2018 . March 31, 2019 December 31, 2018 Maturing or Repricing Repurchase Agreements Weighted Average Contractual Rate Repurchase Agreements Weighted Average Contractual Rate Within 30 days $ 11,675,148 2.95 % $ 5,793,973 3.05 % 31 days to 60 days 270,086 2.67 % 1,243,678 2.60 % 61 days to 90 days 198,040 2.66 % — 0.00 % Total or Weighted Average $ 12,143,274 2.94 % $ 7,037,651 2.97 % |
Derivatives (Tables)
Derivatives (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Derivative Instruments | The following tables present information about our derivatives at March 31, 2019 and December 31, 2018 . March 31, 2019 Derivative Type Remaining / Underlying Term Weighted Average Remaining Swap/Option Term (Months) Weighted Average Rate Notional Amount Asset Fair Value (1) Liability Fair Value (1) Interest rate swap contracts 0-12 Months 8 1.21 % $ 550,000 $ 6,328 $ — Interest rate swap contracts 13-24 Months 20 1.83 % 1,675,000 12,089 — Interest rate swap contracts 25-36 Months 35 2.32 % 1,050,000 — (8,189 ) Interest rate swap contracts 37-48 Months 46 2.13 % 1,175,000 7,556 (1,018 ) Interest rate swap contracts 49-60 Months 57 1.91 % 1,150,000 11,694 (4,223 ) Interest rate swap contracts 61-72 Months 67 2.07 % 825,000 4,930 (6,008 ) Interest rate swap contracts 73-84 Months 84 1.95 % 50,000 447 — Interest rate swap contracts 85-96 Months 93 1.95 % 1,200,000 13,023 — Interest rate swap contracts 97-108 Months 106 2.33 % 625,000 — (11,538 ) Interest rate swap contracts 109-120 Months 118 2.41 % 1,475,000 — (36,089 ) TBA Agency Securities (2) 0-60 Months n/a n/a 800,000 2,610 — Total or Weighted Average $ 10,575,000 $ 58,677 $ (67,065 ) (1) See Note 5 , “ Fair Value of Financial Instruments ” for additional discussion. (2) Implied cost basis of $840,594 and implied market value of $843,204 . Includes $500,000 notional amount of forward settling TBA Agency Securities. December 31, 2018 Derivative Type Remaining / Underlying Term Weighted Average Remaining Swap / Option Term (Months) Weighted Average Rate Notional Amount Asset Fair Value (1) Liability Fair Value (1) Interest rate swap contracts 0-12 Months 11 1.21 % $ 550,000 $ 6,620 $ — Interest rate swap contracts 13-24 Months 18 1.48 % 675,000 11,136 — Interest rate swap contracts 25-36 Months 25 2.06 % 1,000,000 5,568 — Interest rate swap contracts 49-60 Months 54 1.95 % 1,725,000 32,723 — Interest rate swap contracts 61-72 Months 67 1.89 % 575,000 12,009 — Interest rate swap contracts 73-84 Months 73 2.33 % 350,000 — (1,709 ) Interest rate swap contracts 85-96 Months 95 1.93 % 1,050,000 32,240 — Interest rate swap contracts 97-108 Months 102 2.10 % 375,000 7,381 — Interest rate swap contracts 109-120 Months 114 2.62 % 1,050,000 — (22,796 ) TBA Agency Securities (2) 0-60 Months n/a n/a 900,000 4,236 — Total or Weighted Average $ 8,250,000 $ 111,913 $ (24,505 ) (1) See Note 5 , “ Fair Value of Financial Instruments ” for additional discussion. (2) Implied cost basis of $929,184 and implied market value of $933,420 . |
Offsetting Assets | The following tables present information about the potential effects of netting if we were to offset the assets and liabilities of these financial instruments on the accompanying consolidated balance sheets. Currently, we present these financial instruments at their gross amounts and they are included in derivatives, at fair value on the accompanying consolidated balance sheet at December 31, 2018 . December 31, 2018 Gross Amounts Not Offset in the consolidated Balance Sheet Assets Gross and Net Amounts of Assets Presented in the consolidated Balance Sheet Financial Instruments Cash Collateral Net Amount Interest rate swap contracts $ 107,677 $ (24,505 ) $ (82,838 ) $ 334 TBA Agency Securities 4,236 — (2,593 ) 1,643 Totals $ 111,913 $ (24,505 ) $ (85,431 ) $ 1,977 March 31, 2019 . March 31, 2019 Gross Amounts Not Offset in the consolidated Balance Sheet Assets Gross and Net Amounts of Assets Presented in the consolidated Balance Sheet Financial Instruments Cash Collateral Net Amount Interest rate swap contracts $ 56,067 $ (67,065 ) $ 51,924 $ 40,926 TBA Agency Securities 2,610 — (867 ) 1,743 Totals $ 58,677 $ (67,065 ) $ 51,057 $ 42,669 |
Offsetting Liabilities | March 31, 2019 Gross Amounts Not Offset in the consolidated Balance Sheet Liabilities Gross and Net Amounts of Liabilities Presented in the consolidated Balance Sheet Financial Instruments Cash Collateral Net Amount Interest rate swap contracts $ (67,065 ) $ 67,065 $ — $ — TBA Agency Securities — — — — Totals $ (67,065 ) $ 67,065 $ — $ — December 31, 2018 Gross Amounts Not Offset in the consolidated Balance Sheet Liabilities Gross and Net Amounts of Liabilities Presented in the consolidated Balance Sheet Financial Instruments Cash Collateral Net Amount Interest rate swap contracts $ (24,505 ) $ 24,505 $ — $ — TBA Agency Securities — — — — Totals $ (24,505 ) $ 24,505 $ — $ — |
Derivative Instruments, Gain (Loss) | The following table represents the location and information regarding our derivatives which are included in Other Income in the accompanying consolidated statements of operations for the three months ended March 31, 2019 and March 31, 2018 . Income (Loss) Recognized For the Three Months Ended March 31, Derivatives Location on consolidated statements of operations 2019 2018 Interest rate swap contracts: Realized gain (loss) Realized loss on derivatives $ (39,544 ) $ 2,655 Interest income Realized loss on derivatives 53,745 22,169 Interest expense Realized loss on derivatives (45,109 ) (27,848 ) Changes in fair value Unrealized gain (loss) on derivatives (109,343 ) 92,329 $ (140,251 ) $ 89,305 TBA Agency Securities: Realized gain (loss) Realized loss on derivatives 8,777 (35,580 ) Changes in fair value Unrealized gain (loss) on derivatives (3,724 ) 4,872 $ 5,053 $ (30,708 ) Totals $ (135,198 ) $ 58,597 |
Stock Based Compensation (Table
Stock Based Compensation (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Schedule of Nonvested Restricted Stock Units Activity | Transactions related to awards for the three months ended March 31, 2019 are summarized below: March 31, 2019 Number of Awards Weighted Average Grant Date Fair Value per Award Unvested RSU Awards Outstanding beginning of period 360 $ 24.82 Vested (28 ) $ 20.20 Unvested RSU Awards Outstanding end of period 332 $ 24.82 |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Equity [Abstract] | |
Schedule of Stockholders Equity | The following tables present the changes in Stockholders' Equity for the following interim periods. Stockholders' Equity March 31, 2019 March 31, 2018 Balance, beginning of quarter $ 1,125,313 $ 1,326,051 Series A Preferred dividends ($0.171875 per share) (1,124 ) (1,124 ) Series B Preferred dividends ($0.1640625 per share) (3,135 ) (3,129 ) Common stock dividends ($0.19 per share) (29,814 ) (24,138 ) Issuance of Series B Preferred Stock — 2,632 Issuance of Common stock, net 321,992 — Stock based compensation, net of withholding requirements 644 644 Net income (114,381 ) 44,747 Other comprehensive loss 187,158 (100,717 ) Balance, end of quarter $ 1,486,653 $ 1,244,966 |
Dividends Transactions | The following table presents our common stock dividend transactions for the three months ended March 31, 2019 . Record Date Payment Date Rate per common share Aggregate amount paid to holders of record January 15, 2019 January 28, 2019 $ 0.19 $ 8,540 February 15, 2019 February 28, 2019 $ 0.19 9,851 March 15, 2019 March 27, 2019 $ 0.19 11,423 Total dividends paid $ 29,814 The following table presents our Series A Preferred Stock dividend transactions for the three months ended March 31, 2019 . Record Date Payment Date Rate per Series A Preferred Share Aggregate amount paid to holders of record January 15, 2019 January 28, 2019 $ 0.17 $ 374.8 February 15, 2019 February 28, 2019 $ 0.17 374.8 March 15, 2019 March 27, 2019 $ 0.17 374.8 Total dividends paid $ 1,124 The following table presents our Series B Preferred Stock dividend transactions for the three months ended March 31, 2019 . Record Date Payment Date Rate per Series B Preferred Share Aggregate amount paid to holders of record January 15, 2019 January 28, 2019 $ 0.16 $ 1,045 February 15, 2019 February 28, 2019 $ 0.16 1,045 March 15, 2019 March 27, 2019 $ 0.16 1,045 Total dividends paid $ 3,135 |
Schedule of Stock by Class | The following table presents our equity transactions for the three months ended March 31, 2019 . Transaction Type Completion Date Number of Shares Per Share price (1) Net Proceeds Common Stock ATM Sales Agreement January 4, 2019-January 11, 2019 884 $ 20.98 $ 18,540 January Public Offering January 17, 2019 6,900 $ 20.00 $ 137,996 February Public Offering February 22, 2019-February 27, 2019 8,280 $ 19.98 $ 165,456 |
Net Income (Loss) per Common _2
Net Income (Loss) per Common Share (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Earnings Per Share [Abstract] | |
Schedule of Weighted Average Number of Shares | The following table presents a reconciliation of net income (loss) and the shares used in calculating weighted average basic and diluted earnings per common share for the three months ended March 31, 2019 and March 31, 2018 . For the Three Months Ended March 31, 2019 2018 Net Income (Loss) $ (114,381 ) $ 44,747 Less: Preferred dividends (4,259 ) (4,253 ) Net Income (Loss) available (related) to common stockholders $ (118,640 ) $ 40,494 Weighted average common shares outstanding – basic 53,630 41,887 Add: Effect of dilutive non-vested awards, assumed vested — 444 Weighted average common shares outstanding – diluted 53,630 42,331 |
Income Taxes (Tables)
Income Taxes (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Income Tax Disclosure [Abstract] | |
Schedule of Effective Income Tax Rate Reconciliation | The following table reconciles our GAAP net income (loss) to estimated REIT taxable income for the three months ended March 31, 2019 and March 31, 2018 . For the Three Months Ended March 31, 2019 2018 GAAP net income (loss) (114,381 ) 44,747 Book to tax differences: TRS income (231 ) (168 ) Premium amortization expense — (435 ) Credit Risk and Non-Agency Securities (1,272 ) (1,196 ) Interest-Only Securities 548 (407 ) U.S. Treasury Securities 693 (2,576 ) Changes in interest rate contracts 143,835 (64,276 ) Other than temporary loss on Agency Securities — 12,090 Losses on Security Sales 2,910 32,603 Amortization of deferred hedging costs (13,647 ) (14,584 ) Other 4 2 Estimated REIT taxable income $ 18,459 $ 5,800 |
Summary of Tax Credit Carryforwards | Net capital losses realized Amount Available to offset capital gains though 2014 (341,850 ) 2019 2015 (5,182 ) 2020 2016 (31,204 ) 2021 2017 (7,375 ) 2022 2018 (216,634 ) 2023 |
Fair Value of Financial Instr_3
Fair Value of Financial Instruments - Additional Information (Details) | 3 Months Ended |
Mar. 31, 2019dealer | |
Fair Value Disclosures [Abstract] | |
Number of dealers received quotes from, trading | 3 |
Fair Value of Financial Instr_4
Fair Value of Financial Instruments - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands | Mar. 31, 2019 | Dec. 31, 2018 |
Assets at Fair Value: | ||
Agency Securities | $ 12,707,442 | $ 7,051,954 |
Derivatives | 58,677 | 111,913 |
Liabilities at Fair Value: | ||
Derivatives | 67,065 | 24,505 |
Credit Risk and Non-Agency Securities | ||
Assets at Fair Value: | ||
Securities, trading | 815,008 | 819,915 |
Interest-Only Securities | ||
Assets at Fair Value: | ||
Securities, trading | 19,319 | 20,623 |
US Treasury Securities | ||
Assets at Fair Value: | ||
Securities, trading | 0 | 98,646 |
Fair Value, Measurements, Recurring | ||
Assets at Fair Value: | ||
Agency Securities | 12,707,442 | 7,051,954 |
Derivatives | 58,677 | 111,913 |
Liabilities at Fair Value: | ||
Derivatives | 67,065 | 24,505 |
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Assets at Fair Value: | ||
Agency Securities | 0 | 0 |
Derivatives | 0 | 0 |
Liabilities at Fair Value: | ||
Derivatives | 0 | 0 |
Fair Value, Measurements, Recurring | Significant Observable Inputs (Level 2) | ||
Assets at Fair Value: | ||
Agency Securities | 12,707,442 | 7,051,954 |
Derivatives | 58,677 | 111,913 |
Liabilities at Fair Value: | ||
Derivatives | 67,065 | 24,505 |
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | ||
Assets at Fair Value: | ||
Agency Securities | 0 | 0 |
Derivatives | 0 | 0 |
Liabilities at Fair Value: | ||
Derivatives | 0 | 0 |
Fair Value, Measurements, Recurring | Credit Risk and Non-Agency Securities | ||
Assets at Fair Value: | ||
Securities, trading | 815,008 | 819,915 |
Fair Value, Measurements, Recurring | Credit Risk and Non-Agency Securities | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Assets at Fair Value: | ||
Securities, trading | 0 | 0 |
Fair Value, Measurements, Recurring | Credit Risk and Non-Agency Securities | Significant Observable Inputs (Level 2) | ||
Assets at Fair Value: | ||
Securities, trading | 815,008 | 819,915 |
Fair Value, Measurements, Recurring | Credit Risk and Non-Agency Securities | Significant Unobservable Inputs (Level 3) | ||
Assets at Fair Value: | ||
Securities, trading | 0 | 0 |
Fair Value, Measurements, Recurring | Interest-Only Securities | ||
Assets at Fair Value: | ||
Securities, trading | 19,319 | 20,623 |
Fair Value, Measurements, Recurring | Interest-Only Securities | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Assets at Fair Value: | ||
Securities, trading | 0 | 0 |
Fair Value, Measurements, Recurring | Interest-Only Securities | Significant Observable Inputs (Level 2) | ||
Assets at Fair Value: | ||
Securities, trading | 19,319 | 20,623 |
Fair Value, Measurements, Recurring | Interest-Only Securities | Significant Unobservable Inputs (Level 3) | ||
Assets at Fair Value: | ||
Securities, trading | $ 0 | 0 |
Fair Value, Measurements, Recurring | US Treasury Securities | ||
Assets at Fair Value: | ||
Securities, trading | 98,646 | |
Fair Value, Measurements, Recurring | US Treasury Securities | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Assets at Fair Value: | ||
Securities, trading | 98,646 | |
Fair Value, Measurements, Recurring | US Treasury Securities | Significant Observable Inputs (Level 2) | ||
Assets at Fair Value: | ||
Securities, trading | 0 | |
Fair Value, Measurements, Recurring | US Treasury Securities | Significant Unobservable Inputs (Level 3) | ||
Assets at Fair Value: | ||
Securities, trading | $ 0 |
Fair Value of Financial Instr_5
Fair Value of Financial Instruments - Carrying Values and Fair Values of Financial Assets and Liabilities (Details) - USD ($) $ in Thousands | Mar. 31, 2019 | Dec. 31, 2018 |
Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Financial Assets: | ||
Cash | $ 167,372 | $ 221,668 |
Cash collateral posted to counterparties | 0 | 0 |
Accrued interest receivable | 0 | 0 |
Subordinated loan to BUCKLER | 0 | 0 |
Financial Liabilities: | ||
Repurchase agreements | 0 | 0 |
Cash collateral posted by counterparties | 0 | 0 |
Payable for unsettled purchases | 0 | 0 |
Accrued interest payable- repurchase agreements | 0 | 0 |
Significant Observable Inputs (Level 2) | ||
Financial Assets: | ||
Cash | 0 | 0 |
Cash collateral posted to counterparties | 58,996 | 10,531 |
Accrued interest receivable | 39,609 | 22,505 |
Subordinated loan to BUCKLER | 105,000 | 105,000 |
Financial Liabilities: | ||
Repurchase agreements | 12,143,274 | 7,037,651 |
Cash collateral posted by counterparties | 49,826 | 97,213 |
Payable for unsettled purchases | 198,172 | 166,052 |
Accrued interest payable- repurchase agreements | 21,790 | 10,268 |
Significant Unobservable Inputs (Level 3) | ||
Financial Assets: | ||
Cash | 0 | 0 |
Cash collateral posted to counterparties | 0 | 0 |
Accrued interest receivable | 0 | 0 |
Subordinated loan to BUCKLER | 0 | 0 |
Financial Liabilities: | ||
Repurchase agreements | 0 | 0 |
Cash collateral posted by counterparties | 0 | 0 |
Payable for unsettled purchases | 0 | 0 |
Accrued interest payable- repurchase agreements | 0 | 0 |
Carrying Value | ||
Financial Assets: | ||
Cash | 167,372 | 221,668 |
Cash collateral posted to counterparties | 58,996 | 10,531 |
Accrued interest receivable | 39,609 | 22,505 |
Subordinated loan to BUCKLER | 105,000 | 105,000 |
Financial Liabilities: | ||
Repurchase agreements | 12,143,274 | 7,037,651 |
Cash collateral posted by counterparties | 49,826 | 97,213 |
Payable for unsettled purchases | 198,172 | 166,052 |
Accrued interest payable- repurchase agreements | 21,790 | 10,268 |
Fair Value | ||
Financial Assets: | ||
Cash | 167,372 | 221,668 |
Cash collateral posted to counterparties | 58,996 | 10,531 |
Accrued interest receivable | 39,609 | 22,505 |
Subordinated loan to BUCKLER | 105,000 | 105,000 |
Financial Liabilities: | ||
Repurchase agreements | 12,143,274 | 7,037,651 |
Cash collateral posted by counterparties | 49,826 | 97,213 |
Payable for unsettled purchases | 198,172 | 166,052 |
Accrued interest payable- repurchase agreements | $ 21,790 | $ 10,268 |
Agency Securities - Additional
Agency Securities - Additional Information (Details) - USD ($) | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | Dec. 31, 2018 | |
Debt Securities, Available-for-sale [Line Items] | |||
Other than temporary impairment of Agency Securities (reclassified from Other comprehensive income (loss)) | $ 0 | $ (12,090,000) | |
Proceeds from sales of agency securities, net | 1,017,396,000 | 1,137,792,000 | |
Realized gain (loss) on AFS, excluding other-than-temporary impairment | (2,910,000) | (32,603,000) | |
Realized loss on sale of Agency Securities (reclassified from Other comprehensive income (loss)) | (2,910,000) | (32,603,000) | |
Reported Value Measurement | |||
Debt Securities, Available-for-sale [Line Items] | |||
Investment related receivables | 68,796,000 | ||
Mortgage-backed Securities, Issued by US Government Sponsored Enterprises | |||
Debt Securities, Available-for-sale [Line Items] | |||
Other than temporary impairment of Agency Securities (reclassified from Other comprehensive income (loss)) | $ 0 | $ (12,090,000) | |
Mortgage-backed Securities, Issued by US Government Sponsored Enterprises | Credit Risk and Non-Agency Securities | Portfolio Concentration Risk | |||
Debt Securities, Available-for-sale [Line Items] | |||
Percentage of portfolio invested | 93.80% | 88.20% | |
Agency Securities | |||
Debt Securities, Available-for-sale [Line Items] | |||
Weighted average coupon rate | 3.91% | 3.94% | |
Investment-related liabilities | $ 198,172,000 | $ 166,052,000 |
Agency Securities - Unrealized
Agency Securities - Unrealized Gain or Loss Position and Components of Carrying Value of Available for Sale Agency Securities (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended |
Mar. 31, 2019 | Dec. 31, 2018 | |
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 12,564,154 | $ 7,095,824 |
Gross Unrealized Loss | (19,806) | (61,295) |
Gross Unrealized Gain | 163,094 | 17,425 |
Fair Value | $ 12,707,442 | $ 7,051,954 |
Portfolio Concentration Risk | Available-for-sale Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Percent of Total | 100.00% | 100.00% |
Fannie Mae | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 9,407,011 | $ 5,337,466 |
Gross Unrealized Loss | (15,564) | (46,758) |
Gross Unrealized Gain | 133,815 | 16,760 |
Fair Value | $ 9,525,262 | $ 5,307,468 |
Fannie Mae | Portfolio Concentration Risk | Available-for-sale Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Percent of Total | 74.96% | 75.26% |
Fannie Mae | ARMs & Hybrids | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 18,736 | $ 19,929 |
Gross Unrealized Loss | (228) | (249) |
Gross Unrealized Gain | 73 | 73 |
Fair Value | $ 18,581 | $ 19,753 |
Fannie Mae | ARMs & Hybrids | Portfolio Concentration Risk | Available-for-sale Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Percent of Total | 0.15% | 0.28% |
Fannie Mae | Multi-Family MBS | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 2,761,386 | $ 1,710,346 |
Gross Unrealized Loss | (2,350) | (17,128) |
Gross Unrealized Gain | 62,774 | 9,345 |
Fair Value | $ 2,821,810 | $ 1,702,563 |
Fannie Mae | Multi-Family MBS | Portfolio Concentration Risk | Available-for-sale Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Percent of Total | 22.21% | 24.14% |
Fannie Mae | 10 Year Fixed | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 12,684 | $ 115,654 |
Gross Unrealized Loss | (211) | (292) |
Gross Unrealized Gain | 32 | 129 |
Fair Value | $ 12,505 | $ 115,491 |
Fannie Mae | 10 Year Fixed | Portfolio Concentration Risk | Available-for-sale Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Percent of Total | 0.10% | 1.64% |
Fannie Mae | 15 Year Fixed | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 965,248 | $ 684,678 |
Gross Unrealized Loss | (3) | (388) |
Gross Unrealized Gain | 13,875 | 3,864 |
Fair Value | $ 979,120 | $ 688,154 |
Fannie Mae | 15 Year Fixed | Portfolio Concentration Risk | Available-for-sale Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Percent of Total | 7.71% | 9.76% |
Fannie Mae | 20 Year Fixed | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 3,401 | $ 3,734 |
Gross Unrealized Loss | (99) | (156) |
Gross Unrealized Gain | 0 | 0 |
Fair Value | $ 3,302 | $ 3,578 |
Fannie Mae | 20 Year Fixed | Portfolio Concentration Risk | Available-for-sale Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Percent of Total | 0.03% | 0.05% |
Fannie Mae | 30 Year Fixed | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 5,645,556 | $ 2,803,125 |
Gross Unrealized Loss | (12,673) | (28,545) |
Gross Unrealized Gain | 57,061 | 3,349 |
Fair Value | $ 5,689,944 | $ 2,777,929 |
Fannie Mae | 30 Year Fixed | Portfolio Concentration Risk | Available-for-sale Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Percent of Total | 44.76% | 39.39% |
Freddie Mac | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 2,298,599 | $ 1,417,313 |
Gross Unrealized Loss | (3,787) | (13,815) |
Gross Unrealized Gain | 25,912 | 657 |
Fair Value | $ 2,320,724 | $ 1,404,155 |
Freddie Mac | Portfolio Concentration Risk | Available-for-sale Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Percent of Total | 18.26% | 19.91% |
Freddie Mac | 10 Year Fixed | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 8,928 | $ 9,515 |
Gross Unrealized Loss | (49) | (68) |
Gross Unrealized Gain | 62 | 0 |
Fair Value | $ 8,941 | $ 9,447 |
Freddie Mac | 10 Year Fixed | Portfolio Concentration Risk | Available-for-sale Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Percent of Total | 0.07% | 0.13% |
Freddie Mac | 15 Year Fixed | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 238,230 | $ 70,164 |
Gross Unrealized Loss | (86) | (272) |
Gross Unrealized Gain | 2,440 | 157 |
Fair Value | $ 240,584 | $ 70,049 |
Freddie Mac | 15 Year Fixed | Portfolio Concentration Risk | Available-for-sale Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Percent of Total | 1.89% | 0.99% |
Freddie Mac | 25 Year Fixed | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 37,939 | |
Gross Unrealized Loss | (1,668) | |
Gross Unrealized Gain | 0 | |
Fair Value | $ 36,271 | |
Freddie Mac | 25 Year Fixed | Portfolio Concentration Risk | Available-for-sale Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Percent of Total | 0.51% | |
Freddie Mac | 30 Year Fixed | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 2,051,441 | $ 1,299,695 |
Gross Unrealized Loss | (3,652) | (11,807) |
Gross Unrealized Gain | 23,410 | 500 |
Fair Value | $ 2,071,199 | $ 1,288,388 |
Freddie Mac | 30 Year Fixed | Portfolio Concentration Risk | Available-for-sale Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Percent of Total | 16.30% | 18.28% |
Ginnie Mae | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 858,544 | $ 341,045 |
Gross Unrealized Loss | (455) | (722) |
Gross Unrealized Gain | 3,367 | 8 |
Fair Value | $ 861,456 | $ 340,331 |
Ginnie Mae | Portfolio Concentration Risk | Available-for-sale Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Percent of Total | 6.78% | 4.83% |
Ginnie Mae | ARMs & Hybrids | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 29,270 | $ 30,708 |
Gross Unrealized Loss | (455) | (466) |
Gross Unrealized Gain | 2 | 1 |
Fair Value | $ 28,817 | $ 30,243 |
Ginnie Mae | ARMs & Hybrids | Portfolio Concentration Risk | Available-for-sale Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Percent of Total | 0.23% | 0.43% |
Ginnie Mae | 10 Year Fixed | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 223 | $ 231 |
Gross Unrealized Loss | 0 | (1) |
Gross Unrealized Gain | 0 | 0 |
Fair Value | $ 223 | $ 230 |
Ginnie Mae | 10 Year Fixed | Portfolio Concentration Risk | Available-for-sale Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Percent of Total | 0.00% | 0.00% |
Ginnie Mae | 30 Year Fixed | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 829,051 | $ 310,106 |
Gross Unrealized Loss | 0 | (255) |
Gross Unrealized Gain | 3,365 | 7 |
Fair Value | $ 832,416 | $ 309,858 |
Ginnie Mae | 30 Year Fixed | Portfolio Concentration Risk | Available-for-sale Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Percent of Total | 6.55% | 4.40% |
Agency Securities - Summary of
Agency Securities - Summary of Weighted Average Lives of Agency Securities (Details) - USD ($) $ in Thousands | Mar. 31, 2019 | Dec. 31, 2018 |
Fair Value | ||
Less than one year | $ 24 | $ 75 |
Greater than or equal to one year and less than three years | 26,533 | 25,841 |
Greater than or equal to three years and less than five years | 4,403,226 | 1,334,663 |
Greater than or equal to five years | 8,277,659 | 5,691,375 |
Total Agency Securities | 12,707,442 | 7,051,954 |
Amortized Cost | ||
Less than one year | 24 | 77 |
Greater than or equal to one year and less than three years | 26,819 | 26,264 |
Greater than or equal to three years and less than five years | 4,368,346 | 1,331,577 |
Greater than or equal to five years | 8,168,965 | 5,737,906 |
Amortized Cost | $ 12,564,154 | $ 7,095,824 |
Agency Securities - Gross Unrea
Agency Securities - Gross Unrealized Losses and Estimated Fair Value of Agency Securities (Details) - USD ($) $ in Thousands | Mar. 31, 2019 | Dec. 31, 2018 |
Fair Value | ||
Less than 12 Months | $ 500,445 | $ 2,651,518 |
12 Months or More | 1,251,564 | 1,197,533 |
Total | 1,752,009 | 3,849,051 |
Unrealized Losses | ||
Less than 12 Months | (1,511) | (18,135) |
12 Months or More | (18,295) | (43,160) |
Total | $ (19,806) | $ (61,295) |
Credit Risk and Non-Agency Se_3
Credit Risk and Non-Agency Securities - Additional Information (Details) | 3 Months Ended | 12 Months Ended |
Mar. 31, 2019 | Dec. 31, 2018 | |
Credit Risk and Non-Agency Securities | Portfolio Concentration Risk | Credit Risk and Non-Agency Securities | ||
Debt and Equity Securities, FV-NI [Line Items] | ||
Percentage of portfolio invested | 6.00% | 10.30% |
Credit Risk and Non-Agency Se_4
Credit Risk and Non-Agency Securities - Carrying Value of Non-Agency Securities (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended |
Mar. 31, 2019 | Dec. 31, 2018 | |
Credit Risk Transfer | ||
Debt and Equity Securities, FV-NI [Line Items] | ||
Fair Value | $ 727,216 | $ 729,983 |
Credit risk and non-agency securities, amortized cost | 650,452 | 653,681 |
Credit risk and non-agency securities, principal amount | $ 657,069 | $ 661,181 |
Credit risk and non-agency securities, weighted average coupon | 6.90% | 6.92% |
Legacy Prime Fixed | ||
Debt and Equity Securities, FV-NI [Line Items] | ||
Fair Value | $ 13,060 | $ 13,394 |
Credit risk and non-agency securities, amortized cost | 12,258 | 12,698 |
Credit risk and non-agency securities, principal amount | $ 15,583 | $ 16,051 |
Credit risk and non-agency securities, weighted average coupon | 6.02% | 6.02% |
Legacy ALT-A Fixed | ||
Debt and Equity Securities, FV-NI [Line Items] | ||
Fair Value | $ 45,542 | $ 46,853 |
Credit risk and non-agency securities, amortized cost | 41,389 | 42,534 |
Credit risk and non-agency securities, principal amount | $ 57,380 | $ 58,730 |
Credit risk and non-agency securities, weighted average coupon | 5.83% | 5.84% |
Legacy Prime Hybrid | ||
Debt and Equity Securities, FV-NI [Line Items] | ||
Fair Value | $ 8,358 | $ 8,623 |
Credit risk and non-agency securities, amortized cost | 7,716 | 7,987 |
Credit risk and non-agency securities, principal amount | $ 9,122 | $ 9,479 |
Credit risk and non-agency securities, weighted average coupon | 3.86% | 3.62% |
Legacy ALT-A Hybrid | ||
Debt and Equity Securities, FV-NI [Line Items] | ||
Fair Value | $ 3,643 | $ 3,724 |
Credit risk and non-agency securities, amortized cost | 3,104 | 3,164 |
Credit risk and non-agency securities, principal amount | $ 3,854 | $ 3,967 |
Credit risk and non-agency securities, weighted average coupon | 4.16% | 4.06% |
New Issue Prime Fixed | ||
Debt and Equity Securities, FV-NI [Line Items] | ||
Fair Value | $ 17,189 | $ 17,338 |
Credit risk and non-agency securities, amortized cost | 16,440 | 16,767 |
Credit risk and non-agency securities, principal amount | $ 17,357 | $ 17,714 |
Credit risk and non-agency securities, weighted average coupon | 3.69% | 3.69% |
Credit Risk and Non-Agency Securities | ||
Debt and Equity Securities, FV-NI [Line Items] | ||
Fair Value | $ 815,008 | $ 819,915 |
Credit risk and non-agency securities, amortized cost | 731,359 | 736,831 |
Credit risk and non-agency securities, principal amount | $ 760,365 | $ 767,122 |
Credit risk and non-agency securities, weighted average coupon | 6.71% | 6.73% |
Credit Risk and Non-Agency Se_5
Credit Risk and Non-Agency Securities - Weighted Average Life of all Non-Agency Securities (Details) - Credit Risk and Non-Agency Securities - USD ($) $ in Thousands | Mar. 31, 2019 | Dec. 31, 2018 |
Fair Value | ||
Greater than or equal to three years and less than five years | $ 580,023 | $ 188,063 |
Greater than or equal to five years | 234,985 | 631,852 |
Securities, trading | 815,008 | 819,915 |
Amortized Cost | ||
Greater than or equal to three years and less than five years | 519,669 | 169,692 |
Greater than or equal to five years | 211,690 | 567,139 |
Trading securities, amortized cost | $ 731,359 | $ 736,831 |
Credit Risk and Non-Agency Se_6
Credit Risk and Non-Agency Securities - Continuous Unrealized Loss Position (Details) - Credit Risk and Non-Agency Securities - USD ($) $ in Thousands | Mar. 31, 2019 | Dec. 31, 2018 |
Fair Value | ||
Less than 12 Months | $ 0 | $ 1,860 |
12 Months or More | 0 | 0 |
Total | 0 | 1,860 |
Unrealized Losses | ||
Less than 12 Months | 0 | (13) |
12 Months or More | 0 | 0 |
Total | $ 0 | $ (13) |
U.S. Treasury Securities - Addi
U.S. Treasury Securities - Additional Information (Details) - US Treasury Securities - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended |
Mar. 31, 2019 | Dec. 31, 2018 | |
Debt Securities, Available-for-sale [Line Items] | ||
Proceeds from sale of debt securities, trading | $ 199,445 | |
Debt securities, trading, realized loss | $ (750) | |
US Treasury Securities | Portfolio Concentration Risk | ||
Debt Securities, Available-for-sale [Line Items] | ||
Percentage of portfolio invested | 1.20% |
U.S. Treasury Securities - Unre
U.S. Treasury Securities - Unrealized Gain or (Loss) Position (Details) - US Treasury Securities - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2018 | Mar. 31, 2019 | |
Debt and Equity Securities, FV-NI [Line Items] | ||
Amortized Cost | $ 98,703 | |
Gross Unrealized Loss | (57) | |
Gross Unrealized Gain | 0 | |
Fair Value | $ 98,646 | $ 0 |
U.S. Treasury Securities - Un_2
U.S. Treasury Securities - Unrealized Losses and Estimated Fair Value (Details) - US Treasury Securities $ in Thousands | Dec. 31, 2018USD ($) |
Fair Value | |
Less than 12 Months | $ 98,646 |
12 Months or More | 0 |
Total | 98,646 |
Unrealized Losses | |
Less than 12 Months | (57) |
12 Months or More | 0 |
Total | $ (57) |
Repurchase Agreements - Additio
Repurchase Agreements - Additional Information (Details) | 3 Months Ended | 12 Months Ended |
Mar. 31, 2019counterparty | Dec. 31, 2018counterparty | |
Concentration Risk [Line Items] | ||
Number of counterparties with MRAs | 49 | 48 |
Number of counterparties with repurchase agreements outstanding | 23 | 23 |
Counterparty Concentration Risk | Aggregate Borrowings | ||
Concentration Risk [Line Items] | ||
Number of counterparties | 1 | 1 |
Counterparty Concentration Risk | Repurchase Agreement Borrowings | ||
Concentration Risk [Line Items] | ||
Percentage of portfolio invested | 5.10% | 6.80% |
Counterparty Concentration Risk | BUCKLER Securities, LLC | Aggregate Borrowings | ||
Concentration Risk [Line Items] | ||
Percentage of portfolio invested | 49.20% | 49.80% |
Counterparty Concentration Risk | BUCKLER Securities, LLC | Stockholders' Equity | ||
Concentration Risk [Line Items] | ||
Percentage of portfolio invested | 16.70% | 13.00% |
Weighted average maturity | 7 days | 14 days |
Minimum | Counterparty Concentration Risk | One Repurchase Agreement Counterparty | Aggregate Borrowings | ||
Concentration Risk [Line Items] | ||
Percentage of portfolio invested | 5.00% | 5.00% |
Maximum | ||
Concentration Risk [Line Items] | ||
Ratio of indebtedness to net capital | 12 | |
Maximum | Counterparty Concentration Risk | One Repurchase Agreement Counterparty | Aggregate Borrowings | ||
Concentration Risk [Line Items] | ||
Percentage of portfolio invested | 10.00% | 10.00% |
Repurchase Agreements - Contrac
Repurchase Agreements - Contractual Repricing on Repurchase Agreements (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended |
Mar. 31, 2019 | Dec. 31, 2018 | |
Assets Sold under Agreements to Repurchase [Line Items] | ||
Repurchase Agreements | $ 12,143,274 | $ 7,037,651 |
Weighted Average Contractual Rate | 2.94% | 2.97% |
Weighted Average Maturity in days | 12 days | 14 days |
Haircut for Repurchase Agreements | 4.73% | 5.48% |
Agency Securities | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Repurchase Agreements | $ 11,728,144 | $ 6,456,823 |
Weighted Average Contractual Rate | 2.93% | 2.95% |
Weighted Average Maturity in days | 12 days | 14 days |
Haircut for Repurchase Agreements | 4.28% | 4.22% |
Credit Risk and Non-Agency Securities | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Repurchase Agreements | $ 415,130 | $ 580,828 |
Weighted Average Contractual Rate | 3.22% | 3.23% |
Weighted Average Maturity in days | 14 days | 14 days |
Haircut for Repurchase Agreements | 16.22% | 17.79% |
Repurchase Agreements - Repurch
Repurchase Agreements - Repurchase Agreements by Maturity Period (Details) - USD ($) $ in Thousands | Mar. 31, 2019 | Dec. 31, 2018 |
Assets Sold under Agreements to Repurchase [Line Items] | ||
Repurchase Agreements | $ 12,143,274 | $ 7,037,651 |
Weighted Average Contractual Rate | 2.94% | 2.97% |
Within 30 days | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Repurchase Agreements | $ 11,675,148 | $ 5,793,973 |
Weighted Average Contractual Rate | 2.95% | 3.05% |
31 days to 60 days | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Repurchase Agreements | $ 270,086 | $ 1,243,678 |
Weighted Average Contractual Rate | 2.67% | 2.60% |
61 days to 90 days | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Repurchase Agreements | $ 198,040 | $ 0 |
Weighted Average Contractual Rate | 2.66% | 0.00% |
Derivatives - Interest Rate Swa
Derivatives - Interest Rate Swap Contracts, Swaptions and Futures Contracts (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended |
Mar. 31, 2019 | Dec. 31, 2018 | |
Derivative [Line Items] | ||
Notional Amount | $ 10,575,000 | $ 8,250,000 |
Asset Fair Value | 58,677 | 111,913 |
Liability Fair Value | $ (67,065) | $ (24,505) |
Interest Rate Swap 0-12 Months | ||
Derivative [Line Items] | ||
Weighted Average Remaining Swap/Option Term (Months) | 8 months | 11 months |
Weighted Average Rate | 1.21% | 1.21% |
Notional Amount | $ 550,000 | $ 550,000 |
Asset Fair Value | 6,328 | 6,620 |
Liability Fair Value | $ 0 | $ 0 |
Interest Rate Swap 13-24 Months | ||
Derivative [Line Items] | ||
Weighted Average Remaining Swap/Option Term (Months) | 20 months | 18 months |
Weighted Average Rate | 1.83% | 1.48% |
Notional Amount | $ 1,675,000 | $ 675,000 |
Asset Fair Value | 12,089 | 11,136 |
Liability Fair Value | $ 0 | $ 0 |
Interest Rate Swap 25-36 Months | ||
Derivative [Line Items] | ||
Weighted Average Remaining Swap/Option Term (Months) | 35 months | 25 months |
Weighted Average Rate | 2.32% | 2.06% |
Notional Amount | $ 1,050,000 | $ 1,000,000 |
Asset Fair Value | 0 | 5,568 |
Liability Fair Value | $ (8,189) | $ 0 |
Interest Rate Swap, 37-48 Months | ||
Derivative [Line Items] | ||
Weighted Average Remaining Swap/Option Term (Months) | 46 months | |
Weighted Average Rate | 2.13% | |
Notional Amount | $ 1,175,000 | |
Asset Fair Value | 7,556 | |
Liability Fair Value | $ (1,018) | |
Interest Rate Swap, 49-60 Months | ||
Derivative [Line Items] | ||
Weighted Average Remaining Swap/Option Term (Months) | 57 months | 54 months |
Weighted Average Rate | 1.91% | 1.95% |
Notional Amount | $ 1,150,000 | $ 1,725,000 |
Asset Fair Value | 11,694 | 32,723 |
Liability Fair Value | $ (4,223) | $ 0 |
Interest Rate Swap 61-72 Months | ||
Derivative [Line Items] | ||
Weighted Average Remaining Swap/Option Term (Months) | 67 months | 67 months |
Weighted Average Rate | 2.07% | 1.89% |
Notional Amount | $ 825,000 | $ 575,000 |
Asset Fair Value | 4,930 | 12,009 |
Liability Fair Value | $ (6,008) | $ 0 |
Interest Rate Swap 73-84 Months | ||
Derivative [Line Items] | ||
Weighted Average Remaining Swap/Option Term (Months) | 84 months | 73 months |
Weighted Average Rate | 1.95% | 2.33% |
Notional Amount | $ 50,000 | $ 350,000 |
Asset Fair Value | 447 | 0 |
Liability Fair Value | $ 0 | $ (1,709) |
Interest Rate Swap 85-96 Months | ||
Derivative [Line Items] | ||
Weighted Average Remaining Swap/Option Term (Months) | 93 months | 95 months |
Weighted Average Rate | 1.95% | 1.93% |
Notional Amount | $ 1,200,000 | $ 1,050,000 |
Asset Fair Value | 13,023 | 32,240 |
Liability Fair Value | $ 0 | $ 0 |
Interest Rate Swap 97-108 Months | ||
Derivative [Line Items] | ||
Weighted Average Remaining Swap/Option Term (Months) | 106 months | 102 months |
Weighted Average Rate | 2.33% | 2.10% |
Notional Amount | $ 625,000 | $ 375,000 |
Asset Fair Value | 0 | 7,381 |
Liability Fair Value | $ (11,538) | $ 0 |
Interest Rate Swap 109-120 Months | ||
Derivative [Line Items] | ||
Weighted Average Remaining Swap/Option Term (Months) | 118 months | 114 months |
Weighted Average Rate | 2.41% | 2.62% |
Notional Amount | $ 1,475,000 | $ 1,050,000 |
Asset Fair Value | 0 | 0 |
Liability Fair Value | (36,089) | (22,796) |
TBA Agency Securities | ||
Derivative [Line Items] | ||
Notional Amount | 800,000 | 900,000 |
Asset Fair Value | 2,610 | 4,236 |
Liability Fair Value | 0 | 0 |
Implied cost basis | 840,594 | 929,184 |
Implied market value | 843,204 | $ 933,420 |
Forward settling swap contracts | $ 500,000 | |
Minimum | Interest Rate Swap 0-12 Months | ||
Derivative [Line Items] | ||
Derivative, remaining maturity (in months) | 0 months | |
Minimum | Interest Rate Swap 13-24 Months | ||
Derivative [Line Items] | ||
Derivative, remaining maturity (in months) | 13 months | |
Minimum | Interest Rate Swap 25-36 Months | ||
Derivative [Line Items] | ||
Derivative, remaining maturity (in months) | 25 months | |
Minimum | Interest Rate Swap, 37-48 Months | ||
Derivative [Line Items] | ||
Derivative, remaining maturity (in months) | 37 months | |
Minimum | Interest Rate Swap, 49-60 Months | ||
Derivative [Line Items] | ||
Derivative, remaining maturity (in months) | 49 months | |
Minimum | Interest Rate Swap 61-72 Months | ||
Derivative [Line Items] | ||
Derivative, remaining maturity (in months) | 61 months | |
Minimum | Interest Rate Swap 73-84 Months | ||
Derivative [Line Items] | ||
Derivative, remaining maturity (in months) | 73 months | |
Minimum | Interest Rate Swap 85-96 Months | ||
Derivative [Line Items] | ||
Derivative, remaining maturity (in months) | 85 months | |
Minimum | Interest Rate Swap 97-108 Months | ||
Derivative [Line Items] | ||
Derivative, remaining maturity (in months) | 97 months | |
Minimum | Interest Rate Swap 109-120 Months | ||
Derivative [Line Items] | ||
Derivative, remaining maturity (in months) | 109 months | |
Minimum | TBA Agency Securities | ||
Derivative [Line Items] | ||
Derivative, remaining maturity (in months) | 0 months | |
Maximum | Interest Rate Swap 0-12 Months | ||
Derivative [Line Items] | ||
Derivative, remaining maturity (in months) | 12 months | |
Maximum | Interest Rate Swap 13-24 Months | ||
Derivative [Line Items] | ||
Derivative, remaining maturity (in months) | 24 months | |
Maximum | Interest Rate Swap 25-36 Months | ||
Derivative [Line Items] | ||
Derivative, remaining maturity (in months) | 36 months | |
Maximum | Interest Rate Swap, 37-48 Months | ||
Derivative [Line Items] | ||
Derivative, remaining maturity (in months) | 48 months | |
Maximum | Interest Rate Swap, 49-60 Months | ||
Derivative [Line Items] | ||
Derivative, remaining maturity (in months) | 60 months | |
Maximum | Interest Rate Swap 61-72 Months | ||
Derivative [Line Items] | ||
Derivative, remaining maturity (in months) | 72 months | |
Maximum | Interest Rate Swap 73-84 Months | ||
Derivative [Line Items] | ||
Derivative, remaining maturity (in months) | 84 months | |
Maximum | Interest Rate Swap 85-96 Months | ||
Derivative [Line Items] | ||
Derivative, remaining maturity (in months) | 96 months | |
Maximum | Interest Rate Swap 97-108 Months | ||
Derivative [Line Items] | ||
Derivative, remaining maturity (in months) | 108 months | |
Maximum | Interest Rate Swap 109-120 Months | ||
Derivative [Line Items] | ||
Derivative, remaining maturity (in months) | 120 months | |
Maximum | TBA Agency Securities | ||
Derivative [Line Items] | ||
Derivative, remaining maturity (in months) | 60 months |
Derivatives - Offsetting Assets
Derivatives - Offsetting Assets (Details) - USD ($) $ in Thousands | Mar. 31, 2019 | Dec. 31, 2018 |
Offsetting Assets [Line Items] | ||
Gross Amounts of Assets Presented in the Consolidated Balance Sheet | $ 58,677 | $ 111,913 |
Asset Fair Value | 58,677 | 111,913 |
Gross Amounts Not Offset in the Consolidated Balance Sheet, Financial Instruments | (67,065) | (24,505) |
Gross Amounts Not Offset in the Consolidated Balance Sheet, Net Cash Collateral Held | 51,057 | (85,431) |
Net Amount | 42,669 | 1,977 |
Interest rate swap contracts | ||
Offsetting Assets [Line Items] | ||
Gross Amounts of Assets Presented in the Consolidated Balance Sheet | 56,067 | 107,677 |
Asset Fair Value | 56,067 | 107,677 |
Gross Amounts Not Offset in the Consolidated Balance Sheet, Financial Instruments | (67,065) | (24,505) |
Gross Amounts Not Offset in the Consolidated Balance Sheet, Net Cash Collateral Held | 51,924 | (82,838) |
Net Amount | 40,926 | 334 |
TBA Agency Securities | ||
Offsetting Assets [Line Items] | ||
Gross Amounts of Assets Presented in the Consolidated Balance Sheet | 2,610 | 4,236 |
Asset Fair Value | 2,610 | 4,236 |
Gross Amounts Not Offset in the Consolidated Balance Sheet, Financial Instruments | 0 | 0 |
Gross Amounts Not Offset in the Consolidated Balance Sheet, Net Cash Collateral Held | (867) | (2,593) |
Net Amount | $ 1,743 | $ 1,643 |
Derivatives - Offsetting Liabil
Derivatives - Offsetting Liabilities (Details) - USD ($) $ in Thousands | Mar. 31, 2019 | Dec. 31, 2018 |
Offsetting Liabilities [Line Items] | ||
Gross Amounts of Liabilities Presented in the Condensed Consolidated Balance Sheet | $ (67,065) | $ (24,505) |
Net Amounts of Liabilities Presented in the Condensed Consolidated Balance Sheet | (67,065) | (24,505) |
Gross Amounts Not Offset in the Consolidated Balance Sheet, Financial Instruments | 67,065 | 24,505 |
Gross Amounts Not Offset in the Consolidated Balance Sheet, Cash Collateral Posted | 0 | 0 |
Net Amount | 0 | 0 |
Interest rate swap contracts | ||
Offsetting Liabilities [Line Items] | ||
Gross Amounts of Liabilities Presented in the Condensed Consolidated Balance Sheet | (67,065) | (24,505) |
Net Amounts of Liabilities Presented in the Condensed Consolidated Balance Sheet | (67,065) | (24,505) |
Gross Amounts Not Offset in the Consolidated Balance Sheet, Financial Instruments | 67,065 | 24,505 |
Gross Amounts Not Offset in the Consolidated Balance Sheet, Cash Collateral Posted | 0 | 0 |
Net Amount | 0 | 0 |
TBA Agency Securities | ||
Offsetting Liabilities [Line Items] | ||
Gross Amounts of Liabilities Presented in the Condensed Consolidated Balance Sheet | 0 | 0 |
Net Amounts of Liabilities Presented in the Condensed Consolidated Balance Sheet | 0 | 0 |
Gross Amounts Not Offset in the Consolidated Balance Sheet, Financial Instruments | 0 | 0 |
Gross Amounts Not Offset in the Consolidated Balance Sheet, Cash Collateral Posted | 0 | 0 |
Net Amount | $ 0 | $ 0 |
Derivatives - Location and Info
Derivatives - Location and Information of Derivatives (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2019 | Mar. 31, 2018 | ||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Realized gain (loss) | [1] | $ (22,131) | $ (38,604) |
Changes in fair value | (113,067) | 97,201 | |
Subtotal | (135,198) | 58,597 | |
Interest rate swap contracts | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Realized gain (loss) | (39,544) | 2,655 | |
Interest income | 53,745 | 22,169 | |
Interest expense | (45,109) | (27,848) | |
Changes in fair value | (109,343) | 92,329 | |
Subtotal | (140,251) | 89,305 | |
TBA Agency Securities | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Realized gain (loss) | 8,777 | (35,580) | |
Changes in fair value | (3,724) | 4,872 | |
Subtotal | $ 5,053 | $ (30,708) | |
[1] | Interest expense related to our interest rate swap contracts is recorded in realized loss on derivatives on the consolidated statements of operations. For additional information, see financial statement Note 10 . |
Commitments and Contingencies (
Commitments and Contingencies (Details) $ in Thousands | Apr. 25, 2016lawsuit | Apr. 24, 2016lawsuit | Mar. 01, 2016lawsuitdefendant | Mar. 31, 2019USD ($) | Mar. 31, 2018USD ($) |
Other Commitments [Line Items] | |||||
Monthly percentage of effective management fee percentage | 8.33% | ||||
Gross equity raised | $ | $ 2,986,934 | $ 2,620,693 | |||
Transactions | |||||
Other Commitments [Line Items] | |||||
Number of new claims filed | lawsuit | 1 | 8 | 9 | ||
Number of defendants that are current directors | defendant | 8 | ||||
ACM | |||||
Other Commitments [Line Items] | |||||
Percentage of gross equity raised used in calculation of management fee up to 1 Billion | 1.50% | ||||
Percentage of gross equity raised used in calculation of management fee in excess of 1 Billion | 0.75% | ||||
Effective management fee percentage | 1.00% | 1.04% |
Stock Based Compensation - Addi
Stock Based Compensation - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | |
Mar. 31, 2019 | Dec. 31, 2018 | |
Board of Directors | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Nonemployee services transaction, quarterly fee | $ 33 | |
The 2009 Stock Incentive Plan | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Common stock, shares authorized (in shares) | 1,875,000 | |
Common stock, shares outstanding (in shares) | 1,137,000 | |
Compensation cost not yet recognized | $ 8,253 | |
Period for recognition for compensation cost not yet recognized | 2 years 4 months 24 days | |
Restricted Stock | The 2009 Stock Incentive Plan | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ 24.82 | $ 24.82 |
Stock Based Compensation - Rest
Stock Based Compensation - Restricted Shares (Details) - The 2009 Stock Incentive Plan - Restricted Stock shares in Thousands | 3 Months Ended |
Mar. 31, 2019$ / sharesshares | |
Number of Awards | |
Unvested RSU Awards Outstanding beginning of period (in shares) | shares | 360 |
Vested (in shares) | shares | (28) |
Unvested RSU Awards Outstanding end of period (in shares) | shares | 332 |
Weighted Average Grant Date Fair Value per Award | |
Unvested RSU Awards Outstanding beginning of period (in dollars per share) | $ / shares | $ 24.82 |
Vested (in dollars per share) | $ / shares | 20.20 |
Unvested RSU Awards Outstanding end of period (in dollars per share) | $ / shares | $ 24.82 |
Stockholders' Equity - Schedule
Stockholders' Equity - Schedule of Stockholders' Equity (Details) - USD ($) $ / shares in Units, $ in Thousands | Mar. 27, 2019 | Feb. 28, 2019 | Jan. 28, 2019 | Mar. 31, 2019 | Mar. 31, 2018 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Beginning balance | $ 1,125,313 | $ 1,326,051 | |||
Common stock dividends | (29,814) | (24,138) | |||
Stock based compensation, net of withholding requirements | 644 | 644 | |||
Net Income (Loss) | (114,381) | 44,747 | |||
Other comprehensive income | 187,158 | (100,717) | |||
Ending balance | $ 1,486,653 | $ 1,244,966 | |||
Common stock dividends cash paid (in dollars per share) | $ 0.19 | $ 0.19 | |||
Series A Preferred Stock | |||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Preferred dividends | $ (1,124) | $ (1,124) | |||
Preferred stock, dividends declared (in dollars per share) | $ 0.17 | $ 0.17 | $ 0.17 | $ 0.171875 | $ 0.171875 |
Series B Preferred Stock | |||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Preferred dividends | $ (3,135) | $ (3,129) | |||
Preferred stock issued, net of expenses | $ 0 | $ 2,632 | |||
Preferred stock, dividends declared (in dollars per share) | 0.16 | 0.16 | 0.16 | $ 0.1640625 | $ 0.1640625 |
Common Stock | |||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Preferred stock issued, net of expenses | $ 321,992 | $ 0 | |||
Common stock dividends cash paid (in dollars per share) | $ 0.19 | $ 0.19 | $ 0.19 |
Stockholders' Equity - Addition
Stockholders' Equity - Additional Information (Details) $ / shares in Units, $ in Thousands | 3 Months Ended | 12 Months Ended | ||||
Mar. 31, 2019USD ($)director$ / sharesshares | Mar. 31, 2018USD ($) | Dec. 31, 2018USD ($)$ / sharesshares | Feb. 15, 2019$ / sharesshares | Oct. 02, 2017$ / sharesshares | Aug. 30, 2017shares | |
Class of Stock [Line Items] | ||||||
Preferred stock, shares authorized (in shares) | 50,000,000 | 50,000,000 | ||||
Preferred stock, par value (in dollars per share) | $ / shares | $ 0.001 | $ 0.001 | ||||
Preferred stock, undesignated shares authorized (in shares) | 32,740,000 | |||||
Common stock, shares authorized (in shares) | 125,000,000 | 125,000,000 | ||||
Common stock, par value (in dollars per share) | $ / shares | $ 0.001 | $ 0.001 | ||||
Common stock, shares issued (in shares) | 59,791,000 | 43,702,000 | ||||
Common stock, shares outstanding (in shares) | 59,791,000 | 43,702,000 | ||||
Remaining shares authorized to be repurchased (in shares) | 1,874,000 | 1,874,000 | ||||
At-The-Market Offering Program | ||||||
Class of Stock [Line Items] | ||||||
Common stock, shares authorized (in shares) | 7,000 | 5,000,000 | ||||
Common stock, par value (in dollars per share) | $ / shares | $ 0.001 | $ 0.001 | ||||
Commission rate | 2.00% | |||||
Series A Preferred Stock | ||||||
Class of Stock [Line Items] | ||||||
Preferred stock, shares authorized (in shares) | 9,610,000 | |||||
Preferred stock, par value (in dollars per share) | $ / shares | $ 0.001 | $ 0.001 | ||||
Preferred stock, dividend rate | 8.25% | 8.25% | ||||
Preferred stock, shares issued (in shares) | 2,181,000 | 2,181,000 | ||||
Preferred stock, shares outstanding (in shares) | 2,181,000 | 2,181,000 | ||||
Preferred stock, liquidation preference per share (in dollars per share) | $ / shares | $ 25 | $ 25 | ||||
Preferred stock, aggregate liquidation preference | $ | $ 54,514 | $ 54,514 | ||||
Preferred stock, designated but unissued shares authorized (in shares) | 7,429,000 | |||||
Preferred stock, period stock receives voting rights if dividends are not paid (in months) | 18 months | |||||
Number of additional directors elected | director | 2 | |||||
Series B Preferred Stock | ||||||
Class of Stock [Line Items] | ||||||
Preferred stock, shares authorized (in shares) | 7,650,000 | 2,000,000 | ||||
Preferred stock, par value (in dollars per share) | $ / shares | $ 0.001 | $ 0.001 | ||||
Preferred stock, dividend rate | 7.875% | 7.875% | ||||
Preferred stock, shares issued (in shares) | 6,369,000 | 6,369,000 | ||||
Preferred stock, shares outstanding (in shares) | 6,369,000 | 6,369,000 | ||||
Preferred stock, liquidation preference per share (in dollars per share) | $ / shares | $ 25 | $ 25 | ||||
Preferred stock, aggregate liquidation preference | $ | $ 159,232 | $ 159,232 | ||||
Preferred stock, designated but unissued shares authorized (in shares) | 1,281,000 | |||||
Preferred stock, period stock receives voting rights if dividends are not paid (in months) | 18 months | |||||
Number of additional directors elected | director | 2 | |||||
Shares issued | $ | $ 0 | $ 2,632 | ||||
Payments of stock issuance costs | $ | 263 | |||||
Common Stock | ||||||
Class of Stock [Line Items] | ||||||
Shares issued | $ | $ 321,992 | $ 0 |
Stockholders' Equity - Dividend
Stockholders' Equity - Dividend Transactions (Details) - USD ($) | Mar. 27, 2019 | Feb. 28, 2019 | Jan. 28, 2019 | Mar. 31, 2019 | Mar. 31, 2018 |
Class of Stock [Line Items] | |||||
Common stock dividends cash paid (in dollars per share) | $ 0.19 | $ 0.19 | |||
Aggregate amount paid to holders of record | $ 29,814,000 | $ 24,138,000 | |||
Common Stock | |||||
Class of Stock [Line Items] | |||||
Common stock dividends cash paid (in dollars per share) | $ 0.19 | $ 0.19 | $ 0.19 | ||
Aggregate amount paid to holders of record | $ 11,423,000 | $ 9,851,000 | $ 8,540,000 | $ 29,814,000 | |
Series A Preferred Stock | |||||
Class of Stock [Line Items] | |||||
Preferred stock, dividends declared (in dollars per share) | $ 0.17 | $ 0.17 | $ 0.17 | $ 0.171875 | $ 0.171875 |
Aggregate amount paid to holders of record | $ 374,800 | $ 374,800 | $ 374,800 | $ 1,124,000 | $ 1,124,000 |
Series B Preferred Stock | |||||
Class of Stock [Line Items] | |||||
Preferred stock, dividends declared (in dollars per share) | $ 0.16 | $ 0.16 | $ 0.16 | $ 0.1640625 | $ 0.1640625 |
Aggregate amount paid to holders of record | $ 1,045,000 | $ 1,045,000 | $ 1,045,000 | $ 3,135,000 | $ 3,129,000 |
Stockholders' Equity - Equity C
Stockholders' Equity - Equity Capital Raising Activities (Details) - Common Stock - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | Feb. 27, 2019 | Jan. 17, 2019 | Mar. 31, 2019 | Mar. 31, 2018 | Jan. 11, 2019 |
Class of Stock [Line Items] | |||||
Shares issued | $ 321,992 | $ 0 | |||
Common Stock At The Market Sale Agreement | |||||
Class of Stock [Line Items] | |||||
Shares issued (in shares) | 884 | ||||
Price per share (in dollars per share) | $ 20.98 | ||||
Shares issued | $ 18,540 | ||||
Public Offering | |||||
Class of Stock [Line Items] | |||||
Shares issued (in shares) | 8,280 | 6,900 | |||
Price per share (in dollars per share) | $ 19.98 | $ 20 | |||
Shares issued | $ 165,456 | $ 137,996 |
Net Income (Loss) per Common _3
Net Income (Loss) per Common Share (Details) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Earnings Per Share [Abstract] | ||
Net Income (Loss) | $ (114,381) | $ 44,747 |
Less: Preferred dividends | (4,259) | (4,253) |
Net Income (Loss) available (related) to common stockholders | $ (118,640) | $ 40,494 |
Weighted average common shares outstanding – basic (in shares) | 53,630 | 41,887 |
Add: Effect of dilutive non-vested awards, assumed vested (in shares) | 0 | 444 |
Weighted average common shares outstanding – diluted (in shares) | 53,630 | 42,331 |
Income Taxes - Reconciliation o
Income Taxes - Reconciliation of GAAP Net Income to Estimated REIT Taxable Income (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Income Tax Disclosure [Abstract] | ||
GAAP net income (loss) | $ (114,381) | $ 44,747 |
Book to tax differences: | ||
TRS income | (231) | (168) |
Premium amortization expense | 0 | (435) |
Credit Risk and Non-Agency Securities | (1,272) | (1,196) |
Interest-Only Securities | 548 | (407) |
U.S. Treasury Securities | 693 | (2,576) |
Changes in interest rate contracts | 143,835 | (64,276) |
Other than temporary loss on Agency Securities | 0 | 12,090 |
Losses on Security Sales | 2,910 | 32,603 |
Amortization of deferred hedging costs | (13,647) | (14,584) |
Other | 4 | 2 |
Estimated REIT taxable income | $ 18,459 | $ 5,800 |
Income Taxes - Net Capital Loss
Income Taxes - Net Capital Losses Realized (Details) - USD ($) $ in Thousands | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 |
Capital Loss Carryforward | |||||
Tax Credit Carryforward [Line Items] | |||||
Tax credit carryforward | $ (216,634) | $ (7,375) | $ (31,204) | $ (5,182) | $ (341,850) |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | ||
Mar. 31, 2019 | Mar. 31, 2018 | Dec. 31, 2018 | |
Income Tax Disclosure [Abstract] | |||
Income tax expense (benefit) | $ 25 | ||
Aggregate tax basis of stockholders' equity in excess of assets and liabilities | $ 8,127 | ||
Aggregate tax basis of stockholders' equity in excess of assets and liabilities (in dollars per share) | $ 0.14 | ||
Common stock, shares issued (in shares) | 59,791 | 43,702 | |
Payment of dividends | $ 34,073 | $ 28,391 | |
Estimated REIT taxable income | $ 18,459 | $ 5,800 |
Related Party Transactions (Det
Related Party Transactions (Details) - USD ($) | Mar. 31, 2019 | Mar. 31, 2019 | Mar. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2018 |
Related Party Transaction [Line Items] | |||||
Management fees | $ 7,258,000 | $ 6,801,000 | |||
US Treasury Securities | |||||
Related Party Transaction [Line Items] | |||||
Proceeds from sales of U.S. treasury securities | $ 199,445,000 | 0 | |||
ACM | |||||
Related Party Transaction [Line Items] | |||||
Period of written notice of termination (in days) | 180 days | ||||
Management agreement, annual management fee | $ 1 | ||||
Management fees | $ 7,258,000 | 6,801,000 | |||
ACM | Restricted Stock Units (RSUs) | |||||
Related Party Transaction [Line Items] | |||||
Award vesting period | 5 years | ||||
ACM | Armour Management Agreement | |||||
Related Party Transaction [Line Items] | |||||
Automatic renewal period of management agreement (in years) | 5 years | ||||
ACM | Javelin Management Agreement | |||||
Related Party Transaction [Line Items] | |||||
Automatic renewal period of management agreement (in years) | 1 year | ||||
ACM | Other Expense | |||||
Related Party Transaction [Line Items] | |||||
Management fees | $ 27,000 | 47,000 | |||
ACM | Stock Based Compensation Expense | |||||
Related Party Transaction [Line Items] | |||||
Management fees | $ 97,000 | 108,000 | |||
Corporate Joint Venture | BUCKLER Securities, LLC | |||||
Related Party Transaction [Line Items] | |||||
Payments to acquire equity method investments | $ 485,000 | ||||
Percentage of voting interests acquired | 10.00% | 10.00% | |||
Equity method investments | $ 117,000 | $ 117,000 | $ 113,000 | ||
Due to related parties | 5,973,018,000 | 5,973,018,000 | $ 3,503,750,000 | ||
Interest payable | 25,849,000 | 25,849,000 | |||
Collateral pledged | 6,233,414,000 | 6,233,414,000 | |||
Corporate Joint Venture | BUCKLER Securities, LLC | US Treasury Securities | |||||
Related Party Transaction [Line Items] | |||||
Proceeds from sales of U.S. treasury securities | 199,445,000 | ||||
Corporate Joint Venture | Required Regulatory Capital Requirement of Related Party | BUCKLER Securities, LLC | |||||
Related Party Transaction [Line Items] | |||||
Loans receivable, related parties | $ 105,000,000 | $ 105,000,000 | |||
Related party transaction, rate | 0.00% | ||||
Loans and leases receivable, related parties, proceeds | $ 539,000 | $ 624,000 |
Subsequent Events - Additional
Subsequent Events - Additional Information (Details) - USD ($) | May 28, 2019 | Apr. 29, 2019 | Mar. 27, 2019 | Feb. 28, 2019 | Jan. 28, 2019 | Mar. 31, 2019 | Mar. 31, 2018 |
Subsequent Event [Line Items] | |||||||
Common stock dividends cash paid (in dollars per share) | $ 0.19 | $ 0.19 | |||||
Aggregate amount paid to holders of record | $ 29,814,000 | $ 24,138,000 | |||||
Series A Preferred Stock | |||||||
Subsequent Event [Line Items] | |||||||
Preferred stock, dividends declared (in dollars per share) | $ 0.17 | $ 0.17 | $ 0.17 | $ 0.171875 | $ 0.171875 | ||
Aggregate amount paid to holders of record | $ 374,800 | $ 374,800 | $ 374,800 | $ 1,124,000 | $ 1,124,000 | ||
Series B Preferred Stock | |||||||
Subsequent Event [Line Items] | |||||||
Preferred stock, dividends declared (in dollars per share) | $ 0.16 | $ 0.16 | $ 0.16 | $ 0.1640625 | $ 0.1640625 | ||
Aggregate amount paid to holders of record | $ 1,045,000 | $ 1,045,000 | $ 1,045,000 | $ 3,135,000 | $ 3,129,000 | ||
Scenario, Forecast | |||||||
Subsequent Event [Line Items] | |||||||
Common stock dividends cash paid (in dollars per share) | $ 0.19 | $ 0.19 | |||||
Aggregate amount paid to holders of record | $ 11,424,000 | ||||||
Scenario, Forecast | Series A Preferred Stock | |||||||
Subsequent Event [Line Items] | |||||||
Preferred stock, dividends declared (in dollars per share) | 0.17 | $ 0.17 | |||||
Aggregate amount paid to holders of record | $ 375,000 | ||||||
Scenario, Forecast | Series B Preferred Stock | |||||||
Subsequent Event [Line Items] | |||||||
Preferred stock, dividends declared (in dollars per share) | $ 0.16 | $ 0.16 | |||||
Aggregate amount paid to holders of record | $ 1,045,000 |
Uncategorized Items - arrq12019
Label | Element | Value |
Cumulative Effect of New Accounting Principle in Period of Adoption | us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption | $ 0 |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance | us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 | $ 1,125,313,000 |
Common Stock [Member] | ||
Shares, Outstanding | us-gaap_SharesOutstanding | 43,702,000 |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance | us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 | $ 44,000 |
Retained Earnings [Member] | ||
Cumulative Effect of New Accounting Principle in Period of Adoption | us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption | (176,000) |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance | us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 | (1,583,421,000) |
Additional Paid-in Capital [Member] | ||
Cumulative Effect of New Accounting Principle in Period of Adoption | us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption | 176,000 |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance | us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 | 2,752,552,000 |
AOCI Attributable to Parent [Member] | ||
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance | us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 | (43,870,000) |
Common Stock [Member] | Additional Paid-in Capital [Member] | ||
Cumulative Effect of New Accounting Principle in Period of Adoption | us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption | 176,000 |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance | us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 | $ 2,545,233,000 |
Series B Preferred Stock [Member] | Preferred Stock [Member] | ||
Shares, Outstanding | us-gaap_SharesOutstanding | 6,369,000 |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance | us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 | $ 6,000 |
Series B Preferred Stock [Member] | Additional Paid-in Capital [Member] | ||
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance | us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 | $ 154,147,000 |
Series A Preferred Stock [Member] | Preferred Stock [Member] | ||
Shares, Outstanding | us-gaap_SharesOutstanding | 2,181,000 |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance | us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 | $ 2,000 |
Series A Preferred Stock [Member] | Additional Paid-in Capital [Member] | ||
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance | us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 | $ 53,172,000 |